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Whilst pre-exercise muscle glycogen concentrations appear to regulate mitochondrial-related 
cell signalling responses to exercise, the absolute concentrations of muscle glycogen required 
to potentiate such responses are currently unknown. With this in mind, chapter 4 and 5 of this 
thesis were designed to systematically titrate muscle glycogen concentrations and determine 
subsequent mitochondrial-related signalling responses to endurance exercise in an attempt to 
elucidate the potential existence of a glycogen threshold and provide a better definition of its 
upper and lower limits. Collectively, using a sleep-low, train-low model, these studies demon-
strate that reducing pre-exercise muscle glycogen prior to high-intensity endurance exercise 
does not confer any benefit to mitochondrial-related signalling and, in some cases, may impair 
exercise capacity. Nonetheless, these data raise the possibility that obtaining low post-exercise 
glycogen concentrations (regardless of pre-exercise status) may also be an important factor in 
regulating mitochondrial-related signalling. Accordingly, given the potential for exogenous 
CHO to modulate post-exercise muscle glycogen concentrations, chapter 6 examined the ef-
fects of exogenous carbohydrate (CHO) feeding during exercise on mitochondrial-related sig-
nalling. However, exogenous CHO feeding did not alter muscle glycogen utilisation during 
exercise and resulted in comparable increases in post-exercise mitochondrial-related signal-
ling. In conclusion, this thesis provides novel data demonstrating that reducing pre-exercise 
muscle glycogen and/or exogenous CHO restriction during exercise does not confer any ad-
ditional benefit to exercise-induced mitochondrial related signalling. Practically, these data 
suggest that the additional stress of CHO restriction may not be required within skeletal mus-
cle that is already subjected to a sufficient metabolic challenge and may be better suited during 
conditions that do not elicit such cellular perturbations (e.g. prolonged low-intensity exercise 
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This chapter provides a broad overview of the role of CHO availability on modulating as-






















Since the initial discovery and description of glycogen by Claude Bernard (communicated to 
Académie des Sciences on 23rd March 1857) over 160 years ago, a significant body of work 
examining how the storage of carbohydrate as branched polymers effects both metabolism 
and cellular regulation now exists. Furthermore, the advent of the muscle biopsy technique 
during the 1960s (Hultman, 1967) paved the way for the examination of carbohydrate metab-
olism during exercise. Indeed, these early studies (Bergström & Hultman, 1966; Bergström et 
al., 1967; Hermansen et al., 1967) collectively recognised skeletal muscle glycogen as the 
predominant energy substrate used during endurance exercise and its importance in regulating 
the capacity to sustain exercise at a given workload. Later work demonstrated the role of ex-
ogenous carbohydrate (CHO) feeding during exercise in extending the capacity to sustain ex-
ercise at a given intensity (Coggan & Coyle, 1988; Wright et al., 1991; Widrick et al., 1993; 
Febbraio et al., 2000) through a potential sparing of muscle glycogen (Bjorkman et al., 1984; 
Erickson et al., 1987; Stellingwerff et al., 2007) and maintenance of high rates of CHO oxi-
dation as exercise progresses. Collectively, these studies provided the foundations for tradi-
tional sports nutrition guidelines that promote high carbohydrate (CHO) availability before, 
during and after endurance exercise to enhance exercise performance and delay fatigue 
(American Dietetic Association, 1993). 
 
In addition to its role as a simple fuel source, carbohydrate may also act as a regulatory mol-
ecule that is able to modulate the acute molecular response to exercise within skeletal muscle 
(Philp et al., 2012). More specifically, commencing endurance exercise with low endogenous 
CHO (defined as a ‘train-low’ session; Burke et al., 2018) augments key signalling cascades 
and downstream mRNA expression responses associated with oxidative adaptations within 
human skeletal muscle. Furthermore, repeated bouts of train-low exercise (3-10 weeks) has 
been reported to augment selected skeletal muscle markers of training adaptation (Hansen et 
al., 2005; Yeo et al., 2008; Morton et al., 2009; Hulston et al., 2010), enhance both whole 
body and intramuscular lipid oxidation (Hulston et al., 2010) and, in some instances, improve 
exercise capacity and performance (Hansen et al., 2005; Marquet et al., 2016a, 2016b). Whilst 
not all studies demonstrate clear positive effects of train-low models on skeletal muscle adap-
tation (Gejl et al., 2017; Riis et al., 2019) positive outcomes are reported in over 70% of 
available studies (Impey et al., 2018) and have led to increased recognition amongst athletic 
populations (Stellingwerff, 2012). In addition to endogenous muscle glycogen, exogenous 
carbohydrate availability may also play a role in regulating skeletal muscle signalling re-
sponses to exercise (Akerstrom et al., 2006; Lee-Young et al., 2006) although current data  
are contradictory and a more comprehensive understanding of how exogenous CHO regulates 
alternative signalling pathways in response to exercise is required.  
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Given the enhanced molecular signalling responses associated with train-low methodologies 
may, in part, be regulated by muscle glycogen availability, it is prudent to consider the abso-
lute glycogen concentrations required to facilitate these responses and how exogenous CHO 
feeding during exercise may interact with such responses. In this regard, examination of avail-
able train-low studies demonstrate that augmented signalling and transcriptional responses to 
exercise are particularly apparent when absolute pre-exercise muscle glycogen concentrations 
are ≤ 300 mmol·kg-1 dw (Impey et al., 2018), thus suggesting the potential existence of a 
muscle glycogen threshold; an absolute concentration of muscle glycogen which must be sur-
passed in order to augment such responses associated with the train-low model.  
 
However, despite the preliminary evidence for the potential existence of a muscle glycogen 
threshold (defined as a range of muscle glycogen concentrations that is permissive to facili-
tating exercise induced cell signalling responses) the use of a systematic approach to induce 
graded differences in pre-exercise muscle glycogen concentrations is required to provide a 
better definition of its upper and lower limits. Furthermore, the interaction between endoge-
nous and exogenous carbohydrate availability within the context of the glycogen threshold 
hypothesis also warrants further investigation in order to develop a more comprehensive un-
derstanding of the signalling network that regulates these interactions. 
 
Aims and objectives 
The primary aim of this thesis is, therefore, to examine the effects of both endogenous and 
exogenous CHO availability on the regulation of molecular pathways associated with mito-
chondrial biogenesis within human skeletal muscle. On this basis, a secondary aim is to in-
vestigate the existence of a potential muscle glycogen threshold and provide a better definition 
of its potential upper and lower limits. These aims will be achieved by completion of the 
following objectives: 
a) To examine the effects of graded reductions in pre-exercise muscle glycogen (be-
low 300 mmol·kg-1 dw) on skeletal muscle cell signalling and gene expression 
responses associated with the regulation of mitochondrial biogenesis and sub-
strate metabolism. 
b) To examine the effects of graded reductions in pre-exercise muscle glycogen (be-
tween the range of 100-600 mmol·kg-1 dw) on skeletal muscle cell signalling and 
gene expression responses associated with the regulation of mitochondrial bio-
genesis and substrate metabolism. 
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c) To examine the effects of graded exogenous CHO intake during exercise on skel-






























































This chapter provides a synthesis of research findings that describe the regulation of carbo-
hydrate storage and its subsequent metabolism during exercise. A review of the literature in 
relation to muscular adaptation to exercise training, the molecular signals that underpin 
these adaptations and the modulating role of carbohydrate availability then follows. 
 
Elements of this chapter have resulted in the following publication: Hearris et al (2018). 
Regulation of muscle glycogen metabolism during exericse. Implications for endurance 








Skeletal muscle tissue demonstrates remarkable plasticity, whereby it possesses an extraordi-
nary ability to undergo major adaptations in response to exercise training. Of these adapta-
tions, an increase in mitochondrial number and content (Holloszy et al., 1970; Varnauskas et 
al., 1970; Andersen & Henriksson, 1977; Ingjer, 1979; Wibom et al., 1992; Phillips et al., 
1996; MacDougall et al., 1998; Perry et al., 2010), known as mitochondrial biogenesis (Hood, 
2001), is seen as the major hallmark adaptation, allowing for a higher absolute exercise work 
capacity. In addition to the observed changes in mitochondrial content, endurance training 
also induces an increase in the activity and content of proteins within the TCA cycle and ETC 
as well as those involved in substrate transport and utilisation (Holloszy et al., 1970; Gollnick 
et al., 1972; Phillips et al., 1996; Talanian et al., 2010). The functional consequence of these 
adaptations is that exercise in the trained state results in smaller disturbances to cellular ho-
meostasis (i.e. reduced accumulation of ADP, AMP & Pi) resulting in an increased reliance 
on lipid metabolism, with a proportional down-regulation of CHO metabolism for a given 
exercise intensity (Hermansen et al., 1967; Karlsson et al., 1972; Henriksson, 1977; Hurley et 
al., 1986; Coggan et al., 1990; Kiens et al., 1993; Phillips et al., 1996; LeBlanc et al., 2004).  
 
Whilst the signal transduction pathways regulating mitochondrial biogenesis are undoubtedly 
multi-factorial and highly complex, their activation via specific exercise-induced signals ulti-
mately initiates gene transcription and translation to create new functional proteins (Coffey & 
Hawley, 2007). Whilst the traditional approach to activate such signal transduction pathways 
focused on the manipulation of training intensity and duration, it is now apparent that such 
signalling pathways can be modulated by carbohydrate (CHO) availability (Pilegaard et al., 
2002; Wojtaszewski et al., 2003; Steinberg et al., 2006; Yeo et al., 2010; Bartlett et al., 2013) 
whereby commencing endurance exercise with low CHO availability is now recognised as a 
potential strategy to augment exercise induced activation of signal transduction pathways that 
ultimately enhance skeletal muscle adaptation (Impey et al., 2018) and has subsequently 
gained recognition within athletic training paradigms (Stellingwerff, 2012). 
 
This chapter aims to present a contemporary discussion of our understanding of CHO within 
the context of skeletal muscle metabolism, signal transduction pathways and exercise perfor-
mance. This chapter provides an overview of CHO storage followed by a critical review of 
the well-documented effects of both endogenous and exogenous CHO availability on exercise 
performance. Finally, this chapter will close by discussing the molecular networks that govern 
exercise-induced training adaptation and the role of CHO availability in modulating these re-
sponses.  
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2.2 Overview of carbohydrate structure and storage 
 
Carbohydrate is predominantly stored as glycogen in both the liver (~100 g) and skeletal mus-
cle (300-600 g) and demonstrates a relatively small stored energy pool when compared with 
that of lipids. Within skeletal muscle, glycogen is typically expressed as mmol·kg-1 of dry 
weight (dw) where concentrations in whole muscle homogenate can typically vary from 50 to 
800 mmol·kg-1 dw, depending on training status, fatigue status and dietary CHO intake (Areta 
& Hopkins, 2018) (Figure 2.1). Within the classical literature, muscle glycogen is commonly 
expressed as mmol·kg-1 of wet weight (ww), where dry weight values are 4.35 times greater 
than wet weight values based on an expected 77% water content within the muscle (Areta & 
Hopkins, 2018). The glycogen granule itself is constructed from a tiered assembly of glucose 
units, which forms a branched structure via 1:4 and 1:6 α-glycosidic bonds (covalent bonds 
attached between carbon 1:4 and carbon 1:6; Figure 2.2). Glycogen granules are formed on 
the protein glycogenin, and can be as large as 42 nm in diameter and consist of up to 55,000 
glucosyl units (Graham et al., 2010), although the majority of glycogen granules within skel-
etal muscle are typically reported to be 25 nm in diameter and comprise of approximately 8 
tiers (Marchand et al., 2002). The branched structure of glycogen allows for the dense com-
partmentalization of glucose and an enhanced surface area for phosphorylase mediated deg-
radation, permitting rapid mobilization in response to elevated energy requirements such as 
the onset of exercise (Melendez-Hevia et al., 1993).  
 
 
Figure 2. 1. Modelled relationship between variations in muscle glycogen storage of the vastus lat-
eralis according to V̇O2max status in conditions of low, normal and high carbohydrate availability in 





Figure 2. 2. Attachment of glucose units via α-glycosidic bonds. Taken from Murray & Rosenbloom 
(2018). 
 
Beyond the quantification of muscle glycogen in whole muscle homogenate, it is apparent that 
glycogen is distributed across different fibre types as well as being located in specific intra-
cellular locations within the muscle cell itself (Figure 2.3). Through the use of histochemical 
techniques, it is reported that resting glycogen content is not markedly different between type 
I and II fibres (Essen & Henriksson, 1974; Essén et al., 1975), although biochemical quanti-
fication, which provides a more quantitative measure, suggests type II fibres may contain 50-
100 mmol·kg-1 dw more glycogen than type II fibres (Tsintzas et al., 1995, 1996). Further-
more, the advent of transmission electron microscopy (TEM) techniques has allowed for the 
quantification of glycogen within three distinct subcellular pools contained within the myofi-
brils (intra-myofibrillar glycogen, 5-15% of total glycogen pool) between myofibrils (inter-
myofibrillar glycogen, 75% of total glycogen pool) and beneath the sarcolemmal region (sub-
sarcolemmal glycogen, 5-15% of total glycogen pool). Within endurance trained muscle, it 
appears that type I fibres contain 82% more intra-myofibrillar and 31% more subsarcolemmal 
glycogen than type II fibres, with type II fibres containing 11% more inter-myofibrillar gly-
cogen than type I fibres (Nielsen et al., 2011; Nielsen & Ørtenblad, 2013; Ørtenblad et al., 
2013; Gejl et al., 2014) although these fibre type differences do not appear to be present in 





Figure 2. 3. Subcellular glycogen storage within human skeletal muscle. Taken from Murray & Ros-
enbloom (2018).  
2.2.1 Dietary manipulation of skeletal muscle glycogen 
At rest, and under habitual dietary conditions, muscle glycogen concentrations within skeletal 
muscle typically range between 300-600 mmol·kg-1 dw (Areta & Hopkins, 2018), although 
concentrations can be markedly augmented through both exercise and nutritional interven-
tions. The fundamental principles of CHO loading (the process of acutely enhancing endoge-
nous muscle glycogen storage) were originally developed by Scandinavian researchers in the 
late 1960s where it was identified that a super-compensatory increase in muscle glycogen 
could be achieved by performing a bout of exhaustive exercise followed by several days of 
high CHO intake (Bergström & Hultman, 1966; Bergström et al., 1967). However, it was later 
recognised that such extreme exercise/nutrition regimens are unnecessary, where a simple ex-
ercise taper in conjunction with several days of increased dietary CHO intake is sufficient to 
increase glycogen storage (Sherman et al., 1981). In fact, it is now generally accepted that 
trained athletes can increase glycogen storage in both type I and II fibres with 24-48 h of high 
(10 g.kg-1 body mass per day) dietary CHO intake and a concomitant reduction in training 
load (Bussau et al., 2002). From a performance perspective, the general consensus from over 
50 years of research suggests that carbohydrate loading can improve both exercise perfor-
mance (e.g. time taken to complete a set amount of work) by 2-3% and capacity (e.g. time to 
exhaustion) by 20% when exercise is greater than 90 minutes in duration (Hawley et al., 1997). 
The enhanced performance effect is likely to be initially mediated by a delay in the time-point 
at which CHO availability becomes limiting, which is dependent on the maintenance of high 
rates of CHO oxidation (Karlsson & Saltin, 1971). In addition to providing substrate availa-
bility for ATP production, it is now recognized that glycogen availability (especially the 
 25 
intramyofibrillar storage pool) can directly modulate skeletal muscle contractile function. In-
deed, a series of studies from Ørtenblad and colleagues (Ørtenblad et al., 2011; Gejl et al., 
2014) have collectively shown preferential utilization of this storage pool during exercise in a 
manner that also correlates with impaired Ca2+ release from the sarcoplasmic reticulum (SR). 
Consequently, a reduction in SR Ca2+ will per se lead to reductions in tetanic intracellular free 
Ca2+ (Ørtenblad et al., 2013) and is in line with previous observations of faster decreases in 
tetanic Ca2+ in fibres with low muscle glycogen (Chin et al., 1997).  
 
2.3 Carbohydrate and performance 
2.3.3 Pre-exercise carbohydrate ingestion 
Carbohydrate ingestion, 1-4 h prior to exercise, can further augment muscle glycogen concen-
trations by up to 10% (Chryssanthopoulos et al., 2004) and, depending on the time of the 
exercise bout, promote liver glycogen restoration (Coyle et al., 1985; Casey et al., 2000) 
which is commonly depleted following an overnight fast. The increase in CHO storage within 
both storage pools has important performance implications given that muscle and liver glyco-
gen provide an important substrate for muscle contraction during exercise (Baldwin et al., 
1975). With this in mind, pre-exercise carbohydrate ingestion appears to enhance exercise 
performance (Neufer et al., 1987; Sherman et al., 1989, 1991; Wright et al., 1991), when 
consumed 1-4 h prior to exercise, with the enhanced performance effect associated with a 
maintenance of blood glucose during the latter stages of exercise when glycogen concentra-
tions become limiting. In addition to its metabolic affects, pre-exercise CHO feeding is also 
able to attenuate central fatigue through its purported suppression of the fatigue-inducing neu-
rotransmitter, serotonin (Khong et al., 2018). With this in mind, current nutritional guidelines 
for pre-exercise carbohydrate feeding advise an intake of 1-4 g.kg-1 body mass, 3-4 h prior to 
exercise (Thomas et al., 2018).  
2.3.4 Carbohydrate ingestion during exercise 
In addition to high endogenous pre-exercise muscle and liver glycogen stores, numerous stud-
ies have demonstrated the ergogenic effects of CHO provision during moderate- to high-in-
tensity exercise (Coyle et al., 1983; Wright et al., 1991; Febbraio et al., 2000). Indeed, a sys-
tematic review of 61 published performance studies concluded that 82% of studies demon-
strated a significant performance benefit of CHO ingestion during exercise (Stellingwerff & 
Cox, 2014). Furthermore, a meta-analysis of 88 randomised, crossover studies investigating 
CHO ingestion during exercise demonstrated performance benefits of up to 6% (range -2 to 
6%) with CHO supplementation (Vandenbogaerde & Hopkins, 2011). Whilst there are 
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numerous factors responsible for fatigue during prolonged endurance exercise, CHO feeding 
during exercise appears to augment exercise performance via multiple mechanisms including 
muscle (Erickson et al., 1987; Stellingwerff et al., 2007) and liver (Gonzalez et al., 2015) 
glycogen sparing as well as the maintenance of plasma glucose and high rates of CHO oxida-
tion throughout the latter stages of exercise (Febbraio et al., 2000).  
 
Given the well documented observations that fatigue during exercise coincides with the de-
pletion of muscle glycogen (Bergström et al., 1967) the provision of exogenous CHO during 
exercise may be able to spare muscle glycogen through an attenuation of the rate of gly-
cogenolysis and subsequently delay fatigue (Bjorkman et al., 1984; Tsintzas et al., 1996). 
However, the potential sparing of muscle glycogen appears to be fibre type dependent, an 
effect that is likely regulated by the modality, duration and intensity of the exercise bout un-
dertaken. For instance, during constant pace running at 70% V̇O2max, where most type I fibres 
are recruited and type II fibres are relatively inactive during the early stages (Vollestad et al., 
1984), CHO ingestion results in a sparing of muscle glycogen in type I fibres only (Tsintzas 
et al., 1995). Furthermore, this preferential sparing of glycogen in type I fibres is also seen 
with exercise durations of between 1.5 – 2 h (Tsintzas et al., 1996). A sparing of muscle gly-
cogen within type II fibres has also been observed with CHO ingestion during exercise (De 
Bock et al., 2006; Stellingwerff et al., 2007) and these differences are likely to reflect differ-
ences in the fibre recruitment patterns of different exercise modalities as well as methodolog-
ical differences in the quantification of glycogen concentrations within each fibre type.  
 
Exogenous CHO feeding during exercise also promotes the sparing of liver glycogen 
(Gonzalez et al., 2015) through the suppression of hepatic glucose output (Jeukendrup et al., 
1999; Bosch et al., 2007) and thus allows for the maintenance of euglycemia during exercise 
(Coyle et al., 1986). Given that significant reductions in blood glucose coincides with fatigue 
during exercise (Levine et al., 1924; Coyle et al., 1986), the maintenance of euglycemia 
through exogenous CHO feeding appears to delay fatigue by allowing for high rates of CHO 
oxidation to the maintained. Interestingly, it appears that the utilisation of blood glucose is 
sufficient to support the maintenance of CHO oxidation even when muscle glycogen stores 
are depleted (Coyle et al., 1983) and thus provides an important fuel source during the latter 
stages of exercise (Coyle et al., 1986). Additionally, exogenous CHO feeding during exercise 
may also delay fatigue induced by central mechanisms through the preservation of euglycemia 




Whilst it was traditionally accepted that the maximal rates of exogenous CHO oxidation dur-
ing exercise were limited to approximately 1 g.min-1 (Jeukendrup & Jentjens, 2006), primarily 
due to the saturation of the sodium-dependent glucose transporter (SGLT1) within the gut, it 
is now acknowledged that exogenous CHO oxidation rates can be increased to 1.8 g.min-1 with 
the addition of fructose to the CHO mixture via its absorption through an alternative trans-
porter, GLUT5 (Jeukendrup, 2014). The ingestion of these multiple transportable CHO 
(MTC) has been subsequently demonstrated to improve performance when compared with 
glucose alone (Jeukendrup et al., 2005; Currell & Jeukendrup, 2008; Rowlands et al., 2008; 
Triplett et al., 2010) although it is generally accepted their use is primarily suited to endurance 
events lasting longer than 2.5 h (Jeukendrup et al., 2005; Hulston et al., 2009). As such, it is 
suggested that CHO intake at rates of 30-60 g.h-1 should be consumed during events lasting 
60-150 min, whereas in events lasting > 2.5 h, 60-90 g.h-1 (consisting of glucose/fructose mix-
tures) is the recommended rate (Jeukendrup, 2014). Practically, these fuelling requirements 
can be achieved through a combination of solids (e.g. bars), semi-solids (e.g. gels) and fluids 
(e.g. sports drinks) (Pfeiffer et al., 2010a, 2010b) given they allow for similar rates of CHO 
oxidation during exercise. 
2.3.5 Glycogen resynthesis after exercise 
The pattern of muscle glycogen synthesis following exercise occurs in a biphasic manner 
(Price et al., 1994), where, following the termination of exercise there is an initial period of 
rapid resynthesis that occurs independently of insulin and lasts approximately 30-60 min 
(Jentjens & Jeukendrup, 2003) and is only thought to occur when muscle glycogen is signifi-
cantly depleted to low levels (< 150 mmol·kg-1 dw) (Price et al., 1994). This phase of glycogen 
resynthesis is characterised by the translocation of GLUT4 to the plasma membrane and in-
creased glycogen synthase activity, allowing for glucose uptake from the circulation and sub-
sequent storage within the glycogen granule. The translocation of GLUT4 to the plasma mem-
brane is thought to be initiated through the activation of the exercise-inducible kinase, AMPK, 
a signalling protein that is partly regulated through muscle glycogen concentrations 
(Wojtaszewski et al., 2003), given the glycogen binding domain found within the ß-subunit 
of AMPK (McBride et al., 2009). The enhanced enzyme activity of glycogen synthase is reg-
ulated through its dephosphorylation mediated transformation to its active form in response 
to reductions in muscle glycogen concentrations (Ivy & Kuo, 1998). 
 
The second phase of muscle glycogen resynthesis occurs at much slower rates (approximately 
80% lower) (Jentjens & Jeukendrup, 2003) and is characterised by an increase in the sensitiv-
ity of muscle glucose uptake to insulin, which may persist for up to 48 h following exercise 
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and is dependent on dietary CHO intake and absolute muscle glycogen concentrations (Cartee 
et al., 1989). Although the precise mechanisms regulating the post-exercise increase in insulin 
sensitivity are currently unknown, the activation of AMPK appears to be important for the 
insulin-sensitising role of acute exercise, although this effect is diminished within trained skel-
etal muscle (Steenberg et al., 2019; McConell et al., 2020).  
 
Following exercise, glycogen synthesis is augmented when CHO is ingested, whereby re-
ported resynthesis rates generally range between 20-50 mmol·kg-1 dw h-1, depending on the 
quantity, type and timing of CHO ingested (Jentjens & Jeukendrup, 2003). Whilst early work 
suggested that the provision of 0.7 g.kg-1 h-1 CHO immediately after exercise, eliciting a re-
synthesis rate of 20 mmol·kg-1 dw h-1, was sufficient in maximising muscle glycogen resyn-
thesis it is now apparent that higher intakes are required. Later work from Van Loon (van 
Loon et al., 2000) demonstrated increasing the rate of CHO ingestion to 1.2 g.kg-1 h-1 elicited 
much higher rates of glycogen synthesis (44.8 mmol.kg-1 dw h-1) and is now prescribed as the 
recommended intake to maximise glycogen repletion (Thomas et al., 2018) given that inges-
tion of 1.6 g.kg-1 h-1 does not appear to provide any additive benefit (Howarth et al., 2009). 
Interestingly, in conditions where post-exercise carbohydrate intake is suboptimal (i.e. < 1.2 
g.kg-1 h-1), the addition of protein appears to augment glycogen synthesis (van Loon et al., 
2000) and may provide a viable strategy for athletes who fail to meet the upper limit of CHO 
intake.  
 
The type of carbohydrate ingested also appears to be of importance given that high glycaemic 
index (GI) carbohydrates promote markedly higher rates of glycogen resynthesis when com-
pared with low GI carbohydrates (Burke et al., 1993). Furthermore, recent work has also sug-
gested that utilising multiple transportable CHO sources may further augment glycogen syn-
thesis post-exercise. However, the available evidence demonstrates that glucose-fructose or 
glucose-sucrose mixtures do not further enhance muscle glycogen synthesis over glucose 
alone, when ingested at rates of 1.2 and 1.5 g.kg-1.h-1 respectively (Wallis et al., 2008; 
Trommelen et al., 2016). Nevertheless, it is apparent that glucose-fructose (sucrose) mixtures 
enhance the repletion of liver glycogen and minimise gastrointestinal distress when the inges-
tion rate approaches 1.2 g.kg-1.h-1 (Décombaz et al., 2011; Fuchs et al., 2016) and enhance 
subsequent exercise capacity following both short (4 h) (Maunder et al., 2018) and overnight 
(15 h) recovery (Gray et al., 2019). Although the provision of CHO in the form of either solid 
or liquid based sources promotes similar rates of muscle glycogen repletion (Keizer et al., 
1987; Reed et al., 1989) it may be preferred to ingest liquid sources during the first hour of 
recovery as appetite is often supressed post-exercise. Furthermore, the co-ingestion of fat and 
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protein to post-exercise carbohydrate feedings does not appear to limit glycogen storage when 
adequate CHO (7 g.kg-1) is consumed over 24 h (Burke et al., 1995).  
 
Given the enhanced skeletal muscle blood flow and nutrient sensitivity following exercise, the 
immediate provision of carbohydrate appears to augment the rate of muscle glycogen resyn-
thesis when compared with delayed (2 h) provision (Ivy et al., 1988) over 4 h of recovery. 
However, this effect appears to diminish following 8 h of recovery (Parkin et al., 1997) and 
may be explained by a potential slowing of glycogen resynthesis in the latter stages of recov-
ery with immediate CHO provision, in line with the tightly controlled inverse relationship 
between muscle glycogen and glycogen synthase activity. During this recovery window, it 
appears that CHO provision at regular intervals (e.g. 30 min) may augment muscle glycogen 
resynthesis when compared with extended feeding intervals of 2 h. Although no studies have 
directly examined these effects, glycogen synthesis rates appear markedly lower (14-25 
mmol.kg-1 dw h-1) with less frequent CHO provision (Ivy et al., 1988; Reed et al., 1989). 
Nonetheless, when muscle glycogen resynthesis is measured over 24 h of recovery there ap-
pears to be no advantage to increasing the frequency of carbohydrate feedings on muscle gly-
cogen storage (Burke et al., 1996).   
2.3.6 Dietary carbohydrate and training capacity 
Athletes who undertake daily training sessions likely experience day-to-day fluctuations in 
skeletal muscle glycogen, whereby repetitive daily training may lead to a reduction in absolute 
glycogen concentrations if insufficient daily CHO is consumed and subsequently impair train-
ing capacity. Costill et al was the first to demonstrate that consuming a moderate carbohydrate 
diet (40-60% of daily energy intake) resulted in progressive glycogen depletion during three 
consecutive training days (Costill et al., 1971). However, despite reductions in muscle glyco-
gen from 475 to 285 mmol·kg-1 dw with three days of training, no increase in fatigue levels 
were observed. Furthermore, Costill et al also demonstrated that, despite a 15% decline in 
muscle glycogen (562 to 475 mmol·kg-1 dw) following 10 days of increased daily training 
volume, both swimming power and endurance performance were not compromised (Costill et 
al., 1988). However, those who consumed less daily CHO (5.3 g.kg-1) and presented with 
greater reductions in muscle glycogen (~216 mmol·kg-1 dw) were unable to tolerate the in-
crease in training volume and were forced to train at a reduced intensity. In contrast, Kirwan 
et al demonstrated no impairment in training intensity despite marked reductions in muscle 
glycogen concentrations (354 vs. 523 mmol·kg-1 dw) following the consumption of a moder-
ately low CHO diet (3.9 g.kg-1) over 5 days of intensified running training (Kirwan et al., 
1988). In agreement, Sherman et al demonstrated that, despite reductions in muscle glycogen 
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with a daily CHO intakes of 5 g.kg (324-432 mmol·kg-1 dw) exercise time to exhaustion at 
80% V̇O2peak was not impaired when compared with higher daily CHO intakes of 10 g.kg-1 and 
higher muscle glycogen concentrations (540-648 mmol·kg-1 dw) (Sherman et al., 1993).  
 
Collectively, these data demonstrate that daily CHO intakes of 3-5 g.kg-1 per day may result 
in progressive glycogen depletion during periods of carbohydrate dependent training (i.e. pro-
longed endurance exercise > 75% V̇O2max), whereas intakes of 8-10 g.kg-1 per day can mini-
mise or prevent glycogen depletion. Despite this, it appears that progressive reductions in 
muscle glycogen, within normal resting ranges (Areta & Hopkins, 2018) do not impair the 
ability to complete the prescribed training workloads in most cases, although depletion beyond 
these ranges over an extended period may compromise daily training intensity (Costill et al., 
1988). Furthermore, there appears no additional benefit of increasing daily CHO intake be-
yond what is considered sufficient for the given training intensity and volume – a notion pre-
viously suggested by Sherman et al. (1981): 
 
“Anything above a ‘minimal’ level of muscle glycogen is unnecessary for 
performance of a given intensity and duration. More importantly, the prac-
tical question may not be how much can I supercompensate, but rather, 
does my diet contain enough carbohydrate to maintain adequate stores of 
muscle glycogen on a day-to-day basis for training and performance 
runs?” (p. 117). 
 
When taken together, it appears that careful day-to-day periodisation of CHO intake, upon a 
meal-by-meal basis and in accordance with the demands of the specific training session should 
be considered in order to ensure that athletes have sufficient CHO availability to allow for the 
completion of a given workload.   
 
2.4 Endurance training & skeletal muscle adaptation 
Skeletal muscle tissue demonstrates remarkable plasticity, whereby it possesses an extraordi-
nary ability to undergo major adaptations in response to exercise training. The first report of 
biochemical adaptations to endurance training came from the seminal work of John Holloszy, 
in rat skeletal muscle, who demonstrated an increase in the activity of key respiratory chain 
enzymes (cytochrome oxidase & succinate oxidase) and a subsequent doubling in the capacity 
of the mitochondria to oxidise pyruvate (Holloszy, 1967). Holloszy et al also reported a two-
fold increase in cytochrome c protein content which appears to explain the increase in respir-
atory chain enzyme activity, allowing for a rise in the capacity to generate ATP via oxidative 
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phosphorylation. These biochemical adaptations were later reported in human skeletal muscle 
(Morgan et al., 1971; Hoppeler et al., 1973) in addition to an abundance of other adaptive 
responses including fibre type shifts towards an oxidative phenotype, angiogenesis and capil-
larization (Andersen & Henriksson, 1977) and an increased capacity for both glycogen 
(Hickner et al., 1997; Putman et al., 1998) and lipid storage (Van Loon et al., 2004; 
Tarnopolsky et al., 2007), providing greater amounts of substrate for utilisation during exer-
cise. 
 
Of these adaptations, the increase in mitochondrial number and content, known as mitochon-
drial biogenesis (Hood, 2001), is seen as the major hallmark adaptation of endurance training. 
The metabolic adaptations that accompany mitochondrial biogenesis include increases in the 
content and activity of enzymes involved in the TCA cycle and electron transport chain 
(Morgan et al., 1971) as well as those involved in fatty acid transport and oxidation (Talanian 
et al., 2010), glycolytic metabolism and glucose transport (Morgan et al., 1971; Houmard et 
al., 1993). The physiological consequences of such adaptations are a tighter coupling of ATP 
supply with demand and a subsequent reduction in ADP concentrations required to attain the 
same level of O2 consumption per gram of muscle (Holloszy & Coyle, 1984). As a result of 
the enhanced efficiency for energy production of the mitochondria, smaller increases in ADP, 
AMP and Pi are observed during exercise at the same absolute intensity. As these intracellular 
constituents play an important role in the allosteric regulation of glycogenolysis and glycoly-
sis, endurance training results in an increased reliance on lipid metabolism, with a proportional 
down-regulation of CHO metabolism for a given absolute exercise intensity, which is reflected 
in a lower respiratory exchange ratio (RER) (Hermansen et al., 1967; Karlsson et al., 1974; 
Phillips et al., 1996). Taken together, it appears that enhanced endurance performance asso-
ciated with endurance training can be attributed to enhanced resistance to fatigue resulting 
from a tighter coupling of ATP supply with demand, reduced glycogen depletion and lactate 
formation and an enhanced ability to transport and oxidise lipids. 
2.4.1 Signalling transduction pathways 
In accordance with the >100 fold increase in ATP demand (Hochachka & Matheson, 1992) a 
variety of cellular disruptions occur at the onset of endurance exercise including a rise in cy-
toplasmic free Ca2+, increased free AMP, an increased ADP/ATP ratio, reductions in muscle 
glycogen, increased fatty acid availability, lactate accumulation and reactive oxygen species 
production, all of which appear to be implicated in specific signalling cascades regulating 
skeletal muscle plasticity (Hawley et al., 2006, 2014) (Figure 2.4). Indeed, these homeostatic 
perturbations result in the activation of key protein kinases, such as AMP-dependent protein 
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kinase (AMPK), p38 mitogen activated protein kinase (p38 MAPK) and Ca2+/calmodulin de-
pendent protein kinase II (CaMKII) (Combes et al., 2015; Fiorenza et al., 2018). Upon acti-
vation, these kinases converge upon both nuclear and mitochondrial transcription factors and 
co-activators to augment the transcription of genes that dictate the synthesis of both nuclear 
and mitochondrial proteins and the subsequent assembly of protein complexes into a func-
tional respiratory chain. Ultimately, this sequence of events results in an expansion of the 
mitochondrial network within skeletal muscle.  
 
Figure 2. 4. Signalling kinases and their downstream targets. Adapted from Egan et al (2010). Acute 
myofibrillar contraction results in the phosphorylation (P) of AMPK, CaMKII and p38 through molec-
ular sensing of increased ATP turnover, increased calcium release from the SR and mechanical stress, 
respectively. AMPK and CaMKII phosphorylate class II HDACs, leading to their expulsion from the 
nucleus and relieving their inhibitory effect on MEF2 transcriptional activity on the PGC-1α promoter. 
AMPK and CaMKII also phosphorylate CREB, resulting in the activation of CRE sequence of the PGC-
1α promoter. p38 MAPK phosphorylates ATF2 and, in turn, acts on the same CRE site, resulting in 
transcriptional activation. These combined effects on the MEF2 and CRE sequences result in increased 
PGC-1α promoter activity and increased PGC-1α gene transcription. 
 
2.4.2 Cellular energy status & 5’AMP Activated Protein Kinase (AMPK) signalling 
AMPK is a heterotrimeric Ser/Thr kinase comprised of one catalytic α- and two regulatory ß 
and γ subunits. Both the α- and ß- subunits exist in two isoforms (α1 and α2, ß1 and ß2) 
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whereas the γ- subunit exists in three (γ1, γ2 and γ3) (Hardie, 2011).The α-subunit contains a 
Ser/Thr kinase domain which requires phosphorylation from upstream kinases (LBK1 and 
CaMKII) for complete kinase activity (Hawley et al., 2006). The ß-subunit contains a glyco-
gen-binding domain which allows AMPK to interact with glycogen (McBride & Hardie, 2009) 
whilst the γ-subunit contains two pairs of Bateman (cystathionine β-synthase [CBS]) domains 
which appear to play a role in the binding of AMP and ATP (Xiao et al., 2007) (Figure 2.5). 
 
 
Figure 2. 5. Structure of AMPK, its α, ß and γ subunits and its regulation by P, AMP and ATP. 
 
The binding of AMP to the Bateman domains (primarily at sites 1 & 3) brings about the acti-
vation of AMPK via upstream kinases (e.g. LKB1 and CaMKII) (Hawley et al., 2006) whilst 
also inhibiting its dephosphorylation (Davies et al., 1995), whilst ATP competes for the bind-
ing sites and acts to inhibit AMPK activity (Xiao et al., 2011). Under resting conditions, ATP 
is predominantly bound to the Bateman domains and thus renders AMPK inactive. However, 
upon the onset of muscle contraction, ATP becomes hydrolysed into ADP and AMP which 
allow AMP to bind to the Bateman domains and thus activate AMPK (Richter & Ruderman, 
2009). Upon activation, AMPK triggers various metabolic processes that increase energy pro-
duction (e.g. glucose and fatty acid uptake and oxidation; Merrill et al., 1997) whilst concom-
itantly inhibiting processes that require energy consumption (e.g. protein synthesis; Bolster et 
al., 2002). Additionally, AMPK appears to enhance fatty acid oxidation through the inactiva-
tion of acetyl-CoA-carboxylase-ß (ACCß) and the subsequent reduction in malonyl CoA lev-
els (Saha & Ruderman, 2003). Given the inhibitory effects of malonyl CoA on the FFA trans-
porter carnitine palmitoyltransferase 1 (CPT-1), it appears evident that activation of AMPK 




In relation to its role in mitochondrial biogenesis, AMPK plays an important role in the signal 
transduction network regulating training adaptation and can directly phosphorylate the tran-
scriptional co-activator PGC-1α (via Thr177 and Ser538 residues) (Jager et al., 2007) which 
controls the expression of both nuclear and mitochondrial genes (Hood et al., 2016). In this 
regard, chronic activation of AMPK via 5-Aminoimidazole-4-carboxamide ribonucleotide 
(AICAR) administration in rat skeletal muscle enhances the protein expression of mitochon-
drial enzymes citrate synthase (CS) and succinate dehydrogenase (SDH), similar to that ob-
served during endurance training (Winder et al., 2000). The first report of exercise-induced 
AMPK activation came from rodent skeletal muscle (Winder & Hardie, 1996) and was later 
confirmed in human skeletal muscle across a range of exercise modalities, including knee 
extensor (Frøsig et al., 2004) cycling (Chen et al., 2003; Coffey et al., 2006; Little et al., 2011; 
Kristensen et al., 2015) and running (Bartlett et al., 2013) exercise. Within human skeletal 
muscle, AMPK is activated during exercise in an intensity-dependent and isoform specific 
manner. Indeed, it appears that the α-subunit is particularly sensitive to changes in exercise 
intensity, whereby high intensity exercise provides a more potent stimulus for increased α-
subunit activity compared with low intensity exercise. For example, AMPKα2 activity is aug-
mented when exercise intensity is increased from 40 to 80% V̇O2peak (Chen et al., 2003) or 
from 50 to 75% V̇O2max (Wojtaszewski et al., 2000) whilst augmented AMPKThr172 phosphor-
ylation has been observed following work-matched cycling at 80% V̇O2max compared with 
40% V̇O2max (Egan et al., 2010). AMPK also appears to be activated in an isoform-specific 
manner, where AMPKα2 displays a more pronounced sensitivity and activation compared 
with AMPKα1, which appears to be relatively unresponsive to either low- or high-intensity 
exercise (Fujii et al., 2000; Wojtaszewski et al., 2000). 
 
Despite increases in the protein content and basal activity of several AMPK subunits following 
cumulative bouts of exercise training (Frøsig et al., 2004), it is apparent that endurance train-
ing attenuates the activation of AMPK during a single bout of criterion exercise (Nielsen et 
al., 2003; Yu et al., 2003; McConell et al., 2005). The blunted AMPK response following 
endurance training is likely explained by smaller disturbances in cellular homeostasis (i.e. free 
AMP, ADP) during exercise (Holloszy & Coyle, 1984) and thus it appears that progressive 
increases in training intensity are necessary to maintain an adequate training stimulus follow-
ing endurance training.  
 
Whilst AMPK activity has been shown to be regulated by exercise training, it appears that its 
activity can also be modulated by carbohydrate availability. The notion for a regulatory role 
of muscle glycogen on AMPK signalling in human skeletal muscle was first provided by 
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Wojtaszewski et al. (2003) who demonstrated higher basal activity of both AMPKα1 and α2 
isoforms under conditions of low muscle glycogen (~160 mmol·kg-1 dw), compared with gly-
cogen loaded conditions (~900 mmol·kg-1 dw). Importantly, concentrations of both creatine 
phosphate and adenine nucleotides were similar despite large differences in muscle glycogen 
concentrations, suggesting that changes in AMPK signalling were modulated by fuel-depend-
ent mechanisms, independent of energy status. Subsequently, commencing exercise with low 
muscle glycogen appears to also augment AMPKThr172 phosphorylation (Yeo et al., 2010) and 
the nuclear abundance of AMPKα2 protein (Steinberg et al., 2006) when compared with high 
muscle glycogen. Alongside muscle glycogen, exogenous CHO availability also appears to 
modulate exercise-induced AMPK signalling as both fasted exercise (Stocks et al., 2019) and 
exogenous CHO restriction during exercise (Akerstrom et al., 2006) augment AMPKThr172 
phosphorylation and AMPKα2 activity, respectively. These effects are potentially mediated 
via the presence of the glycogen-binding domain on the ß-subunit (McBride & Hardie, 2009) 
whereby the physical attachment of glycogen inhibits AMPK activity and translocation to the 
nucleus.  
2.4.3 Mechanical stress & mitogen-activated protein kinase (p38 MAPK) signalling 
p38 MAPK, a member of the mitogen-activated protein kinase family, is commonly viewed 
as a stress inducible kinase due to its activation in response to a range of stimuli such as envi-
ronmental, oxidative, inflammatory and mechanical stress. Similar to AMPK, p38 MAPK has 
been identified as an upstream regulator of PGC-1α activity and thus, an important regulatory 
kinase involved in the signal transduction pathway regulating exercise-induced mitochondrial 
biogenesis. Indeed, initial data in mice demonstrated p38 MAPK phosphorylation occurs con-
currently with increases in PGC-1α mRNA expression, a response that appears to occur 
through a p38 MAPK mediated increase in PGC-1α promotor activity (Akimoto et al., 2005). 
Furthermore, it was also demonstrated that expression of a muscle-specific p38 MAPK acti-
vator, in transgenic mice, resulted in enhanced expression of both PGC-1α and COXIV in 
skeletal muscle (Akimoto et al., 2005). Subsequent in vivo studies have suggested that p38 
MAPK exerts its effects on PGC-1α through myocyte enhancing factor 2 (MEF2) and activat-
ing transcription factor 2 (ATF2) binding sites on the PGC-1α promotor (Akimoto et al., 
2008).  
 
With this in mind, activation of p38 MAPK has been observed in response to both cycling 
(Gibala et al., 2009; Egan et al., 2010) and running (Boppart et al., 2000; Bartlett et al., 2012) 
exercise in human skeletal muscle. Interestingly, p38 MAPK may also be regulated by carbo-
hydrate availability, whereby commencing exercise with low muscle glycogen has been 
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shown to enhance p38 MAPK phosphorylation (Chan et al., 2004). However, it appears that 
this response may be specific to nuclear p38 MAPK as p38 MAPK phosphorylation appears 
unresponsive to carbohydrate availability in both whole muscle homogenate (Yeo et al., 2010; 
Bartlett et al., 2013; Stocks et al., 2019) and cytosolic fractions (Chan et al., 2004).  
2.4.4 Calcium flux & calcium/calmodulin-dependent protein kinase (CaMKII) signalling 
Calcium plays an essential role in facilitating the crossbridge interaction between myosin and 
actin filaments during myofibrillar contraction, during which, calcium oscillations are trans-
lated into regulatory signals that modulate the activity of calmodulin-dependent protein ki-
nases (CaMKs). CaMKII is the dominant isoform in human skeletal muscle (Rose et al., 2006) 
and is recognised as a powerful activator of PGC-1α transcription and mitochondrial biogen-
esis through MEF2 and cAMP response element binding protein (CREB) phosphorylation. 
Indeed, CaMKII activates MEF2 via phosphorylation of histone deacetylase (HDAC) pro-
teins, thus removing their inhibition of MEF2 (McKinsey et al., 2000), allowing it to bind to 
the MEF2 elements in the PGC-1α promotor region and subsequently activate transcription. 
Similarly, CaMKII can also increase PGC-1α transcription via CREB phosphorylation 
through the cAMP-responsive elements (CRE) site on PGC-1α (Baar, 2014).  
 
In response to exercise, CaMKII phosphorylation is increased in an intensity-dependent man-
ner (Rose et al., 2006; Egan et al., 2010) and may also be influenced by the pattern of muscle 
contraction given that CaMKII phosphorylation appears to be augmented with intermittent 
type exercise (Combes et al., 2015; Fiorenza et al., 2018). To date, it is unclear whether 
CaMKII phosphorylation is affected by nutrient availability. Although CaMKII phosphoryla-
tion appears unresponsive to exercise performed in the fasted state (Stocks et al., 2019) some 
evidence suggests a potential relationship between kinase phosphorylation and muscle glyco-
gen (Fiorenza et al., 2018). Furthermore, low muscle glycogen (especially glycogen contained 
within the intramyofibrilliar pool) also impairs the release of Ca2+ from the sarcoplasmic 
reticulum (Ørtenblad et al., 2011; Gejl et al., 2014) and may act as a potential mechanism 
whereby carbohydrate availability is able to modulate CaMKII phosphorylation.  
2.4.5 Tumor suppressor protein p53 
The tumor suppressor protein p53 is a transcriptional regulator that is commonly known for 
its effects on cell cycle arrest, apoptosis, DNA repair, differentiation and cell senescence 
(Bartlett et al., 2014). In addition to these primary functions, p53 also plays a vital role in the 
maintenance of energy homeostasis and mitochondrial biogenesis. The role of p53 in mito-
chondrial biogenesis is demonstrated through its ability to regulate the transcriptional activity 
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of synthesis of COX 2 (SCO2), a protein required for the assembly of mitochondrial encoded 
COX II subunit of the COX complex (Hood et al., 2016). Furthermore, p53 ablation manifests 
in reduced COX activity, which demonstrates the transcriptional control p53 has in coordinat-
ing the expression of both COX subunit I and II. The COX complex, which is made up of 13 
subunits in total, plays a vital role in aerobic respiration by accepting electrons from cyto-
chrome C and transferring them to an oxygen molecule. p53 also plays an important role in 
modulating mtDNA-encoded gene expression and stability through its physical interaction 
with transcription factor A (Tfam) where it can regulate the binding of Tfam to mtDNA. Fur-
thermore, given the identification of a p53 response element within the promoter region of 
PGC-1α, p53 also appears to be able to influence the expression of PGC-1α protein whereby 
PGC-1α expression is reduced within the muscle of p53 KO animals (Saleem et al., 2009). 
 
Activation of p53 appears to occur through AMPK and/or p38 MAPK signalling cascades, 
resulting in its phosphorylation at serine 15 which is typically linked to increased stability and 
activity. This is further supported by the fact that phosphorylation of p53 occurs in concert 
with the classical increases in AMPK and p38 MAPK phosphorylation in response to an acute 
bout of exercise (Bartlett et al., 2012). In the context of exercise, activation of p53 appears to 
be mediated by exercise/nutrient interventions that elicit sufficient cellular stress. Indeed, the 
aforementioned exercise-induced p53 phosphorylation (Bartlett et al., 2013) is augmented un-
der conditions of low muscle glycogen availability whilst cell models that induce glucose 
deprivation result in p53 phosphorylation via AMPK signalling pathways (Jones et al., 2005). 
Interestingly, although p53 phosphorylation does not appear to be modulated by exercise in-
tensity within whole muscle homogenate under work-matched conditions (Bartlett et al., 
2012) nuclear p53 phosphorylation has been demonstrated to be augmented by exercise inten-
sity (Granata et al., 2017). With this in mind, the subcellular location of p53 may have a dis-
tinct effect on the transcription of both nuclear and mitochondrial genes. Indeed, translocation 
of p53 to both the nucleus (Tachtsis et al., 2016) and mitochondria (Saleem & Hood, 2013) 
have been reported in response to exercise. Similarly, exercise intensity appears to be im-
portant in modulating p53 protein content which correlate with increases in mitochondrial 
respiration (Granata et al., 2016a). Given that these changes are also apparent with increasing 
training volume (Granata et al., 2016b), these data collectively illustrate that increases in p53 
content require an augmented stress response via significant metabolic perturbations to home-
ostasis which can be achieved through modification of nutritional status, exercise volume and 




2.4.6 Peroxisome Proliferator Activated Receptor Gamma Coactivator 1-alpha (PGC-1α) 
PGC-1α, a member of the peroxisome proliferator-activated receptor γ coactivator family, is 
widely recognised as the ‘master regulator’ of mitochondrial biogenesis and exerts its effects 
as a transcriptional co-activator for an array of nuclear and mitochondrial transcription factors 
(Hawley et al., 2014). As a co-activator, PGC-1α does not bind to DNA itself but recruits 
histone acetyl transferase (HAT) enzymes to a number of different DNA bound transcription 
factors, including the myocyte enhancer factors 2 (MEF2) and the nuclear respiratory factor 1 
and 2 (NRF-1/2), to subsequently modify the chromosome structure to one that favours tran-
scription (Wu et al., 1999; Handschin et al., 2003). In binding with NRF-1 and NRF-2, PGC-
1α is able to coordinate the regulation of both nuclear and mitochondrial genomes given that 
these transcription factors are located in the promoter regions of multiple genes encoding mi-
tochondrial proteins (NuGEMPs).  
 
PGC-1α signalling can be enhanced by either increasing its activity or its protein expression. 
As such, it appears that increases in PGC-1α activity mediates the initial phase of exercise-
induced increases in muscle mitochondrial content given that these increases in mitochondrial 
enzyme expression occur before an increase in PGC-1α protein (Wright et al., 2007b). The 
activity of PGC-1α appears to be regulated by association with the repressor protein p160myb 
which can disrupt PGC-1α’s association with transcription factors and subsequently inhibit 
gene transcription (Fan et al., 2004). However, phosphorylation of PGC-1α appears to disrupt 
this association and allows for the recruitment of PGC-1α to transcription factors. The second 
strategy to enhance PGC-1α signalling is to enhance its protein expression (Baar & McGee, 
2008) which occurs as a result of repeated, transient increases in PGC-1α mRNA as seen with 
repeated exercise stimuli (Perry et al., 2010). Indeed, a single bout of exercise can induce a 
~1.5-10 fold increase in PGC-1α mRNA (Perry et al., 2010), the magnitude of which is de-
pendent on exercise intensity whereby high intensity exercise provides a more potent stimulus 
for PGC-1α mRNA expression when compared with low intensity exercise (Egan et al., 2010). 
The transcription of PGC-1α is primarily controlled by proteins binding to either the MEF2 
or the cyclic AMP responsive element (CRE) within its promoter (Akimoto et al., 2008) and 
through the interaction with MEF2, PGC-1α is able to coactivate its own expression 
(Handschin et al., 2003). However, in order to prevent an excess of PGC-1 within the muscle, 
MEF2 transcriptional activity is supressed by the transcriptional repressor HDAC5 which is 
able to modify the local chromosome structure to one that silences transcription (Mckinsey et 
al., 2001). It appears that AMPK is able to regulate PGC-1α expression by phosphorylating 
the transcriptional repressor HDAC5 (Mcgee & Hargreaves, 2008), resulting in its removal 
from the nucleus, via the 14-3-3 transport protein, and allowing for chromatin remodelling 
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and enhanced transcriptional activity of MEF2. AMPK also appears to directly phosphorylate 
the CRE protein (Thomson et al., 2008) and subsequently enhance PGC-1α transcription. Fur-
thermore, the activity of AMPK has also been identified as an essential component regulating 
the cellular shuttling of PGC-1α (Smith et al., 2013) whereby exercise induced AMPK acti-
vation promotes its translocation to both the nucleus and mitochondria (Little et al., 2011; 
Safdar et al., 2011).  
 
 
Figure 2. 6. An overview of the signal transduction network regulating PGC-1α activity. AMPK in-
duced phosphorylation of HDAC5 disrupts the interaction between MEF2 and HDAC5 which leads to 
the removal of HDAC5 from the nucleus by the chaperone protein 14-3-3 and allows MEF2 to bind to 
the PGC-1α promoter. AMPK can also directly phosphorylate CREB.  
 
In relation to its role within mitochondrial biogenesis, overexpression of PGC-1α protein (~ 
10-30 fold) within skeletal muscle results in enhanced expression of mitochondrial enzymes, 
oxidative capacity and enhanced endurance performance whilst skeletal muscle from PGC-1α 
transgenic mice have a ~3 fold increase in time to fatigue when electrically stimulated (Lin et 
al., 2002; Arany et al., 2007). Furthermore, muscle specific overexpression of PGC-1α in vivo, 
induces increases in mitochondrial enzymes and the capacity to oxidise lipids within the mi-
tochondria (Benton et al., 2008). Collectively, these data demonstrate the important regulatory 
role PGC-1α plays in coordinating mitochondrial biogenesis. Nonetheless, endurance training 
adaptations (i.e. increases in mitochondrial morphology and function and exercise capacity) 
can still be achieved to the same extent following muscle specific PGC-1α knock out (KO), 
demonstrating the multifaceted nature of the signal transduction networks that regulate mito-
chondrial biogenesis, and downplay the role of PGC-1α as the ‘sole’ regulatory protein (Rowe 
et al., 2012).  
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2.4.7 Time course of molecular events leading to training induced skeletal muscle adapta-
tion 
Chronic muscle adaptations to exercise training are attributed to the effects of repeated, acute 
perturbations in cellular homeostasis and subsequent transient increases in mRNA transcrip-
tion (Perry et al., 2010) which facilitate an adaptive response via gradual structural remodel-
ling and long-term functional improvements. However, the time course of exercise induced 
increases in mRNA and protein content are discordant with one another, and changes in 
mRNA do not always predict changes in protein content (Cochran et al., 2014).  
 
 
Figure 2. 7. Schematic representation of the time-course of selected contraction-induced physiological, 
biochemical and molecular responses in skeletal muscle that result in adaptation to training. Acute ex-
ercise results in changes in metabolism (e.g. increased ADP, lactate and free Ca2+). These exercise 
signals subsequently regulate the activity of signalling proteins via phosphorylation in order to control 
the activity of downstream transcription factors and co-activators to influence gene expression. Over 
time, transient increases in mRNA expression result in an increase in the synthesis of new proteins.  
 
To date, only two studies (Perry et al., 2010; Egan et al., 2013) have documented the time 
course of several transcriptional, translational and morphological processes involved in mito-
chondrial biogenesis. These investigations demonstrate an increase in mRNA in the initial 
hours following exercise which returns to baseline at 24 h. The exercise-induced increase in 
mRNA appears to occur before the initial increase in protein content for specific mitochondrial 
enzymes and transcriptional proteins, including PGC-1α. Following multiple bouts of exer-
cise, and subsequent repeated transient increases in mRNA, the content of various proteins 
demonstrate a sustained increase before a plateau is reached in the final bouts of training (Fig-
ure 2.8). These data also demonstrate that the mRNA response to exercise is attenuated as the 
muscle adapts and suggest that a continual modification of exercise intensity/duration and/or 




Figure 2. 8. An overview of the time course of PGC-1α mRNA expression and protein content through-
out 2 weeks of exercise training. Numbers in brackets along the x-axis represent the training session 
number. Adapted from Perry et al (2010). 
 
2.5 CHO availability modulates training induced skeletal muscle adaptations 
Undertaking endurance exercise with restricted CHO availability induces significant meta-
bolic and signalling shifts compared with when exercise is undertaken with high CHO avail-
ability. Indeed, at comparable work intensities, exercise with low CHO availability substan-
tially reduces glycogen utilisation (Arkinstall et al., 2004) whilst concomitantly increasing 
circulatory free fatty acid (FFA) availability (Wojtaszewski et al., 2003) and circulatory cate-
cholamines (Hansen et al., 2005). Consequently, the altered metabolic milieu created through 
exercising with low CHO availability has a direct impact on molecular signalling events con-
trolling training adaptation, allowing for a compensatory response to such a metabolic chal-
lenge.  
 
For instance, AMPKThr172 (Yeo et al., 2010), ACC Ser79 and p53Ser15 (Bartlett et al., 2013) phos-
phorylation, AMPKα2 activity (Wojtaszewski et al., 2003) and its nuclear abundance 
(Steinberg et al., 2006) are all augmented when exercise is commenced with low CHO avail-
ability. However, it is unclear whether commencing exercise with low CHO availability, 
through a variety of train-low methodologies, modulates the activity of other key signalling 
kinases such as p38 MAPK or CaMKII (Yeo et al., 2010; Bartlett et al., 2013; Lane et al., 
2015; Stocks et al., 2019). In addition to modulating such signalling events, commencing ex-
ercise with low CHO availability also augments the mRNA expression of the PGC-1α gene 
as well as those involved in both mitochondrial biogenesis and substrate utilisation (Pilegaard 
et al., 2002; Bartlett et al., 2013; Psilander et al., 2013; Lane et al., 2015; Stocks et al., 2019). 
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When taken together, these data suggest that commencing exercise with low CHO availability 
primarily augments AMPK-PGC1α mediated signalling to ultimately enhance the mRNA ex-
pression of a wide variety of mitochondrial and nuclear encoded genes, although its regulation 
of alternative signalling cascades is not well understood and requires further understanding.  
 
A variety of acute and chronic train-low interventions to investigate the efficacy of CHO re-
striction on training adaptations and exercise performance. An overview of specific train-low 
models is discussed below and relevant experimental details from seminal studies are summa-
rised in Table 2.1. 
2.5.1 Twice per day training 
On the basis of the molecular evidence derived from acute exercise studies, initial training 
studies adopted a “training twice every second day versus once daily” model. Using this 
model, Hansen et al. (2005) subjected seven untrained males to 10 weeks of knee extensor 
exercise training under conditions of either high or low muscle glycogen (Hansen et al., 2005). 
Subjects trained both legs according to two different schedules, whereby one leg trained every 
day (HIGH) whilst the contralateral leg trained twice a day (2 h apart), every other day (LOW) 
(Figure 2.9). As such, one leg (LOW) commenced every second training session under condi-
tions of low glycogen whilst the other leg performed each session under conditions of high 
muscle glycogen (HIGH), whilst allowing total work done to be matched for both legs. Fol-
lowing 10 weeks of training, the leg that commenced 50% of training sessions with low mus-
cle glycogen (~ 200 mmol·kg-1 dw) demonstrated a superior increase in the maximal activity 
of both citrate synthase (CS) and β-hydroxyacyl-CoA dehydrogenase (β-HAD), compared 
with the contralateral leg. Furthermore, the LOW leg also demonstrated an almost two-fold 
increase in exercise capacity when compared with the HIGH leg, demonstrating a potent effect 
of altering substrate availability on exercise-induced adaptation and subsequent performance. 
Whilst these data are intriguing, the use of a knee extensor model and the clamping of training 
intensity bear little resemblance to the customary training undertaken by athletic populations 






Figure 2. 9. Schematic representation of the twice-per day model used by Hansen et al (2005). Black 
dots represent each individual training session. 
 
Yeo and colleagues employed a similar twice per day model using a cycling protocol repre-
sentative of real-world practices (Yeo et al., 2008). Similar to that of Hansen (2005), subjects 
trained according to two different schedules; One group (HIGH) trained once daily (6 
days/week for 3 weeks), whereas the other trained twice per day, every other day (LOW), 
combining classical ‘aerobic’ training in the morning (100 min steady state cycling at 70% 
V̇O2peak) with high-intensity interval training in the afternoon (HIT; 8x5 min bouts at maximal 
effort with 1-min recovery between bouts). As such, the LOW group performed the HIT train-
ing with reduced muscle glycogen (~250 mmol·kg-1 dw) when compared with the HIGH group 
(~400 mmol·kg-1 dw). In support of Hansen’s earlier work, these data demonstrate greater 
increases in the maximal activity of both citrate synthase and β-HAD and protein content of 
electron transport protein COXIV when 50% of training sessions were commenced with low 
muscle glycogen. Training with low muscle glycogen also augmented rates of whole body 
lipid utilisation (Yeo et al., 2008), which appear to be derived primarily from intramuscular 
triglycerides (Hulston et al., 2010). Interestingly, the superior adaptations observed in the low 
glycogen training group were achieved despite an inability to maintain the training intensity 
observed within the high glycogen group (78 vs. 87% Wmax) within weeks 1-2 (Yeo et al., 
2008). Notwithstanding this, it appears that the train-low model induces sufficient perturba-
tions to the homeostatic milieu and may even compensate for an initial reduction in training 
intensity, in order to ultimately drive the observed enhanced training response. 
 
Whilst the aforementioned studies demonstrate a clear effect of training twice-per-day, poten-
tially through the manipulation of endogenous muscle glycogen, it appears that exogenous 
CHO feeding between exercise sessions (despite muscle glycogen being reduced from the first 
session) may negate the associated benefits of the twice-per-day model. Indeed, when CHO 
is fed in the recovery period following the initial exercise session and during the subsequent 
second exercise bout, the training-induced increases in oxidative enzyme activity (succinate 
dehydrogenase) observed without exogenous CHO are completely abolished (Morton et al., 
2009). Taken together, these data demonstrate that both endogenous glycogen and exogenous 
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carbohydrate availability exert potential regulatory effects on training induced muscle adap-
tations, although the interaction between both substrates requires further investigation. None-
theless, despite the apparent muscle-specific benefits of twice-per-day training, this approach 
is yet to exert clear performance benefits in whole-body exercise models.  
2.5.2 Fasted training 
Performing endurance training in the fasted state represents a simpler train-low model where 
breakfast is consumed following morning training. Although pre-exercise muscle glycogen is 
not altered as a result of the overnight fast, liver glycogen and circulating glucose remains 
lower whilst FFA availability is increased  compared with when breakfast is fed (Montain et 
al., 1991; Horowitz et al., 1997). Upon this basis, exercising in the fasted state increases post-
exercise AMPK and CREB signalling (Akerstrom et al., 2006; Stocks et al., 2019) and mRNA 
expression of genes controlling substrate utilisation (PDK4, GLUT4, CD36, CPT-1) and mi-
tochondrial function (UCP3) (Civitarese et al., 2005; Cluberton et al., 2005) compared with 
when carbohydrate is fed both before and during exercise. In light of this, chronic periods of 
fasted training elicit similar adaptations to those observed when training with low muscle gly-
cogen. Nybo and colleagues (Nybo et al., 2009) demonstrated that 8 weeks of endurance train-
ing (50-90 min of high-intensity intervals at 70-85% V̇O2max) in the fasted state enhanced 
training induced increases in β-HAD activity and the capacity to store muscle glycogen, com-
pared with CHO being fed before and during training. These results were later confirmed by 
Van Proeyen et al (2011) who reported significant increases in the maximal activity of both 
CS and β-HAD following 6 weeks of fasted endurance training (1-1.5 h cycling at 70% 
V̇O2max) (Van Proeyen et al., 2011). Commencing training in the fasted state also has profound 
effects on substrate metabolism, whereby chronic periods of fasted training result in a decrease 
in exercise-induced muscle glycogen breakdown (De Bock et al., 2008) and increases intra-
myocellular (IMCL) breakdown in type I fibres (Van Proeyen et al., 2011).These data collec-
tively demonstrate that restricting exogenous carbohydrate both before and during exercise 
enhances post-exercise gene expression and subsequent oxidative enzyme activity following 
a period of endurance training. However, despite the superior biochemical adaptations with 
fasted training, the purported metabolic advantage is yet to result in improvements in exercise 
performance.  
2.5.3 Sleep-Low, Train-Low 
Using a sleep low, train low model, subjects perform an evening training session to deplete 
endogenous CHO stores, restrict carbohydrate overnight and complete a fasted training ses-
sion the subsequent morning. In this way, the total accumulative time spent with reduced 
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muscle glycogen could extend to 12-14 hours depending on both the timing and duration of 
training sessions and the sleep period. This model allows overcomes the short time-proximity 
of the twice-per-day model, while allowing for the manipulation of endogenous CHO stores 
between sessions. Acute studies utilising the sleep-low, train-low model demonstrate signifi-
cant activation of signalling kinases (AMPK, p38 MAPK), transcription factors (p53) and 
expression of a variety of metabolic genes controlling mitochondrial biogenesis and substrate 
utilisation compared with high glycogen trials (Wojtaszewski et al., 2003; Bartlett et al., 2013; 
Lane et al., 2015). Bartlett et al (2013) demonstrated that this train-low model leads to signif-
icant phosphorylation of both ACC and p53 and expression of PGC-1α, COXIV, Tfam & 
PDK4 genes both at rest and 3 h post-exercise. In contrast, when exercise was commenced 
with high muscle glycogen and exogenous carbohydrate was provided before, during and after 
exercise, the aforementioned activation of signalling kinases and gene expression were com-
pletely abolished, despite the intense nature of the exercise bout (6 x 3 min at 90% V̇O2max). 
Although these data present two extreme differences in carbohydrate availability, enhanced 
activation of signalling kinases (Wojtaszewski et al., 2003; Steinberg et al., 2006), and ex-
pression of genes that underpin exercise induced training responses (Psilander et al., 2013; 
Lane et al., 2015) with the sleep low, train low model have also been reported elsewhere. 
Furthermore, repeated bouts of sleep-low, train-low is the only train-low model shown to en-
hance performance in trained endurance athletes (Marquet et al., 2016a, 2016b) although not 
in all cases (Riis et al., 2019). 
2.5.4 Periodized approach and an amalgamation of train-low paradigms 
In the real-world training environments of elite endurance athletes, it is likely that an amal-
gamation of the aforementioned train-low paradigms are practiced (either through default of 
their current training structure or via coach and sport scientist-led practices), as opposed to 
undertaking one strategy in isolation (Stellingwerff, 2012). As such, an understanding of the 
efficacy of amalgamating train-low models and how best to periodize this type of training into 
an athletes training schedule is warranted. Investigations to date have failed to observe any 
superior adaptations when a variety of train-low strategies are incorporated into 3-4 weeks of 
intensified endurance training compared with when adequate carbohydrate is provided for all 
training sessions. For instance, incorporating periods of fasted and twice-per-day training as 
well as post-exercise CHO restriction amongst elite race walkers, appeared to offer no perfor-
mance advantage when compared with traditional practices of undertaking all sessions with 
high carbohydrate availability (Burke et al., 2017). In agreement, Gejl et al (2017) observed 
similar increases in maximal CS activity and subsequent exercise performance measures (30 
min time trial) following 4 weeks of training with periodic CHO restriction (twice-per-day 
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model) compared with when all sessions were commenced with CHO provision before and 
after training (Gejl et al., 2017). 
 
Whilst both studies adopted a number of accepted train-low models, examination of the peri-
odisation of these sessions and/or acute muscle glycogen data may provide some explanation 
for the aforementioned results. For instance, despite Burke et al incorporating periods of 
twice-per-day training it could be questioned whether the model of periodisation was suffi-
cient to induce sufficient glycogen depletion to allow the second daily session to be com-
menced with low glycogen, given that CHO was fed before and during training (Burke et al., 
2017). In support of this, Gejl et al reported that muscle glycogen concentrations remained 
above 400 mmol·kg dw-1 following the second session of the twice-per-day model demon-
strating the difficulty in inducing sufficient glycogen depletion in well-trained athletes (Gejl 
et al., 2017). In comparison, others have reported muscle glycogen concentrations of ~100 
mmol·kg dw-1 following the completion of the twice daily training model (Morton et al., 2009; 
Yeo et al., 2010) demonstrating that more pronounced glycogen depletion may be required to 
drive the adaptive responses associated with the train-low model. Taken together, these data 
suggest the existence of a ‘glycogen threshold’, a critical absolute level of muscle glycogen 
concentrations which must be exceeded in order for significant activation of specific cell sig-
nalling pathways and subsequent muscular adaptations to occur. 
 
Table 2. 1. Overview of the methodological details and study outcomes of both acute and chronic 
train-low studies according to the relevant train-low paradigm used  
 
Reference Subjects Duration Exercise Protocol & Glycogen Status (mmol/kg dw) Skeletal Muscle Adaptations 
Exercise Performance 
Outcomes 
Twice per day model 
Hansen et al 
[9] 
7 untrained men 10 weeks 
5 days x 
week 
Knee extensor exercise. One leg trained 50% 
of sessions with low glycogen (LOW) whist 
the other trained all sessions with high 
glycogen (HIGH). Second session glycogen in 
LOW: Pre: 200, Post: 100 mmol/kg dw 
respectively. 
Greater increase in CS activity in 
LOW condition 
 
Increased β-HAD activity in LOW 
condition only 
Improved TTE for knee 
extensor exercise 
Yeo et al [17] 14 trained male 
cyclists/triathletes 
3 weeks 
4 x week 
100 min steady state cycling (63% PPO) 
followed by 8 x 5 min intervals at maximal 
pace either 2 h (LOW) or 24 h (HIGH) later. 
Pre interval exercise glycogen: (LOW: 256, 
HIGH: 390). Post exercise glycogen (LOW: 
124, HIGH: 229). 
Increased CS & β-HAD activity in 
LOW condition only 
 
Increased COXIV protein content in 
LOW condition only 
 
Similar improvements 
(10%) in 60 min TT for both 
groups 
Morton et al 
[18] 
23 active men 6 weeks 
4 x week 
6 x 3 min running (90% VO2max). NORM 
trained once per day whilst LOW+PLA & 
LOW+GLU trained twice per day (every other 
day). LOW+GLU ingested CHO before and 
during every second training session. Pre 
exercise glycogen: (LOW: 232 and 253, HIGH: 
412 and 387 in gastrocnemius and vastus 
lateralis respectively). Post exercise glycogen: 
(LOW: 107 and 176, HIGH: 240 and 262 in 
gastrocnemius and vastus lateralis 
respectively). 
 
Greater increase in SDH activity in 
LOW+PLA compared with LOW+GLU 
& NORM  
Similar improvements in 










100 min steady state cycling (63% PPO) 
followed by 8 x 5 min intervals at maximal 
pace either 2 h (LOW) or 24 h (HIGH) later.   
Pre-interval exercise glycogen: (LOW: 256, 
HIGH: 390). Post exercise glycogen (LOW: 
124, HIGH: 229). 
Greater phosphorylation of 
AMPK
Thr172
 in LOW 
N/A 
Hulston et al 
[19] 
14 trained male 
cyclists 
3 weeks 
6 x week 
90 min cycling at 70% VO2max followed by (2 h 
apart) HIT (8 x 5 min) in LOW group. HIGH 
group performed alternate days of either 
steady state or HIT cycling. Acute glycogen 
status not measured 
β-HAD protein content increased in 
LOW only 
 
Increased fat utilisation from 
muscle triglycerides in LOW only 
Similar improvements in 
60 min TT for both groups 
 
Cochran et al 
[22] 
10 active men Acute 
exercise 
HIT cycling (5 x 4-min at 90-95% heart rate 
reserve) twice per day (separated by 3 h). 
One group consumed CHO (2.3 g.kg) between 
sessions (HIGH) whereas the other restricted 
CHO intake (LOW). Pre PM exercise glycogen: 
(LOW: 256, HIGH: 390). Post exercise 
glycogen (LOW: 124, HIGH: 229) 
Greater phosphorylation of 
p38MAPK in LOW following PM 
exercise 
 
Similar increase in PGC-1α & COXIV 
gene expression  
N/A 
Cochran et al 
[20] 
18 active men 2 weeks 
3 days x 
week 
HIT cycling (5 x 4 min at 60% PPO) twice per 
day (separated by 3 h). One group consumed 
CHO (2.3 g.kg) between sessions (HIGH) 
whereas the other restricted CHO intake 










Similar increase in maximal CS 
activity & protein content of both 
CS and COXIV  
Greater improvement in 
250 kJ TT performance in 
LOW group. 
 
Fasted training model 
Akerstrom et 
al [27] 
9 active men Acute 
exercise 
2 h one-legged knee extensor exercise (60% 
Wmax) in either a fasted (FAST) or fed 
(exogenous CHO during) (FED) state. Pre 
exercise glycogen: (500 mmol/kg dw in both 
groups). Post exercise glycogen: (300 & 200 in 
FED and FAST respectively). 
Reduced AMPKα2 activity in FED N/A 
Lee-Young et 
al [49] 
9 active men Acute 
exercise 
120 min cycling (65% VO2peak) exercise in 
either a fasted (FAST) or fed (exogenous CHO 
during) state. Pre exercise glycogen: (500 
mmol/kg dw in both groups). Post exercise 
glycogen: (150 & 100 in FED and FAST 
respectively). 
Similar increases in AMPKα2 activity 
and AMPKα2Thr172 & ACC-βSer222 
phosphorylation  
N/A 
De Bock et al 
[31] 
20 active men 6 weeks 
3 x week 
1 – 2 h cycling (75% VO2peak).  One group 
trained in the fasted state (FAST) with the 
other consuming CHO before and during 
exercise (FED). Acute glycogen status not 
measured 
 
FABPm increased in FAST condition 
only 
N/A 
Nybo et al 
[32] 
15 untrained men 8 weeks 
3-4 x week 
3-6 min of high intensity intervals (70-85% 
VO2max). Subjects either received CHO or 
placebo (PLA) during exercise. Acute glycogen 
status not measured. 
Greater increases in β-HAD activity 
& basal muscle glycogen content in 
PLA group only. 
 
Similar improvements in 
peak power, VO2max & 15 
min TT performance 
Van Proeyen 
et al [30] 
20 active men 6 weeks 
4 x week 
1 – 1.5 h cycling (70% VO2max). One group 
trained in the fasted state (FAST) with the 
other consuming CHO before and during 
exercise (FED). Acute glycogen status not 
measured. 
 
CS & β-HAD maximal activity 
increased in FAST condition only 
Similar improvements in 1 






Sleep low model 
Pilegaard et 
al [15] 
















Study A: 1-legged glycogen depleting exercise 
followed by 2-legged cycling (2 h at 45% 
VO2max) the subsequent day. Pre-exercise 
glycogen: (LOW: 337, HIGH: 609). Post 
exercise glycogen (LOW: 306, HIGH: 423). 
 
Study B: 3 h of 2-legged knee extensor 
exercise with either normal (NORM) or LOW 
glycogen. Pre-exercise glycogen: (LOW: 240, 
HIGH: 398). Post exercise glycogen (LOW: 
101, HIGH: 153). 
Study A: Enhanced gene expression 





Study A&B: Enhanced gene 
expression of PDK4 & UCP3 post-












et al [36] 
8 trained men Acute 
exercise 
60 min cycling at 70% VO2peak with either 
LOW or HIGH muscle glycogen (from 
exercise/diet manipulation the previous day).  
Pre exercise glycogen: (LOW: 163, HIGH: 
909). Post exercise glycogen: (LOW: 150, 
HIGH: 400). 
Increased AMPKα2 activity in LOW 
only 
 
Greater phosphorylation of 
ACCSer221 in LOW 
N/A 
Chan et al 
[37] 
8 active men Acute 
exercise 
60 min cycling (70% VO2peak) with either HIGH 
or LOW glycogen (achieved by exercise/diet 
manipulation the previous evening). Pre 
exercise glycogen: (LOW: 163, HIGH: 375). 
Post exercise glycogen: (LOW: 17, HIGH: 102). 
Greater phosphorylation of p38 
MAPK in LOW 
 





7 active men Acute 
exercise 
60 min cycling at 70% VO2max with either 
reduced (LOW) or normal (NORM) muscle 
glycogen. Pre exercise glycogen: (LOW: 150, 
HIGH: 390). Post exercise glycogen: (LOW: 17, 
HIGH: 111). 
Greater AMPKα2 activity, 
phosphorylation of ACCSer221 and 
nuclear translocation of AMPKα2 in 
LOW only 
 





Bartlett et al  
[38] 
8 active men Acute 
exercise 
HIT running (6 x 3 min at 90% VO2max). LOW 
performed glycogen-depleting cycling the 
night before and restricted CHO overnight. 
HIGH consumed high CHO breakfast & CHO 
during exercise. Pre exercise glycogen: (LOW: 
100, HIGH: 500). Post exercise glycogen: 
(LOW: 80, HIGH: 300). 
 
Phosphorylation of ACCSer79 & 
p53Ser15 in LOW only 
 
Enhanced gene expression of PGC-








6 x 10 min cycling (64% VO2max) with either 
HIGH or LOW glycogen (achieved by 
exercise/diet manipulation 14 h previously).  
Pre exercise glycogen: (LOW: 166, HIGH: 
478). Post exercise glycogen: (LOW: 130, 
HIGH: 477). 
Enhanced gene expression of PGC-
1α in LOW 
 
Increased gene expression of PDK4 
& COXI in LOW only 
N/A 
Lane et al 
[39] 




Evening bout of high-intensity cycling (8 x 5 
min at 82.5% PPO) followed by 120 min 
steady state cycling (50% PPO) the 
subsequent morning. LOW group restricted 
CHO overnight whereas HIGH group 
consumed high CHO diet (4 g.kg BM). Pre 
exercise glycogen: (LOW: 349, HIGH: 459). 
Post exercise glycogen: (LOW: 266, HIGH: 
338). 
 
Greater phosphorylation of ACCSer79 
post AM exercise in LOW 
 
Enhanced gene expression of CD36, 
FABP3 & PDK4 post AM exercise in 
LOW 
N/A 





6 x week 
HIT (8 x 5 min cycling at 85% MAP or 6 x 5 
min running at individual 10 km intensity) in 
the evening followed by LIT (60 min cycling at 
65% MAP) the subsequent morning. One 
group consumed CHO between training 
sessions (HIGH) whereas the other restricted 
CHO intake (LOW). Acute glycogen status not 
measured. 
N/A Improved 10 km running 
TT performance & 
improved TTE cycling 
(150% peak aerobic 




2.5.5 The glycogen threshold hypothesis 
Given that the enhanced training response associated with train-low models is potentially me-
diated by muscle glycogen availability, it is prudent to consider the absolute glycogen con-
centrations required to facilitate this response. With this in mind, the majority of studies that 
adopt train-low models commence exercise with glycogen concentrations between 100-300 
mmol·kg-1 dw (Cochran et al., 2010; Yeo et al., 2010; Bartlett et al., 2013; Taylor et al., 2013; 
Impey et al., 2016). When exercise is commenced with pre-exercise muscle glycogen 
 
Marquet et al 11 trained male 
cyclists 
1 week 
6 x week 
HIT (8 x 5 min cycling at 85% MAP) in the 
evening followed by LIT (60 min cycling at 
65% MAP) the subsequent morning. One 
group consumed CHO between training 
sessions (HIGH) whereas the other restricted 
CHO intake (LOW).  Acute glycogen status not 
measured. 
N/A Improved 20 km cycling TT 
performance in LOW group 
only 
Riis et al 13 trained males 4 weeks 
6 x week 
HIT (10 x 5 min cycling at 90% HRmax) in the 
evening followed by LIT (75 min at 65-75% 
HRmax). LOW group restricted CHO intake 
overnight whilst HIGH group consumed CHO 
following evening and prior to morning 
exercise.  Acute glycogen status not 
measured. 
No change in proteins involved in 
lipid metabolism (ATGL, HSL, CGI-53 
or G0S2) in either group. 
Similar improvements in 
30 min cycling TT for both 
groups 
Recover low model 
Pilegaard et 
al 
9 active men Acute 
exercise 
75 min cycling (75% VO2max) followed by 24 h 
recovery with either HIGH or LOW CHO diet. 
Glycogen was restored to 576 and 348 with 
HIGH and LOW CHO diets respectively at 24 
h. 
Gene expression of PDK4, UCP3, LPL 
& CPT1 remained elevated for 8-24 
h with CHO restriction post-
exercise. 
N/A 




4 h cycling (56% VO2max) followed by 4 h 
recovery feeding with either HIGH (1 g.kg.h) 
or LOW (water only) CHO. Post exercise 
glycogen: (LOW: 234, HIGH: 245). 4 h 
glycogen: (LOW: 264, HIGH: 444). 
Similar gene expression of PGC-1α, 
Tfam, NRF-1, COXIV, PDK4, LPL, 
PPAR, UCP3 & GLUT 4 in both 
groups 
N/A 
High fat feeding 
Hammond et 
al 
10 active men Acute 
exercise 
High-intensity running (8 x 5 min @ 85% 
VO2peak) followed by steady state running (60 
min at 70% VO2peak) 3.5 h later. Steady state 
running was either commenced with high or 
low (but high fat) CHO availability. Muscle 
glycogen was similar in both groups (200 







p70S6K activity was supressed with 
high fat feeding 
 
Similar gene expression of PGC-1α, 








Impey et al 
[48] 




Based on the principle of fuel for the work 
required. 4 x 30 s HIT cycling (150% PPO) & 
45 min steady state cycling (50% PPO) 
followed by 1 min efforts (80% PPO) until 
exhaustion with either HIGH or LOW glycogen 
(by previous exercise/diet manipulation for 
36 h previously). HIGH consumed CHO 
before, during & after exercise whereas LOW 
consumed leucine enriched protein.  
36 h of prior CHO restriction 
enhanced p53, SIRT1 & Tfam gene 
expression.  CHO restriction before 
and during exercise induced work 
efficient AMPK signalling. Post-
exercise CHO restriction and 
keeping glycogen <100 mmol/kg dw 
reduced p70S6K activity 
 
Exercise capacity (1 min 
efforts at 80% PPO) 
enhanced in HIGH trial 
(158 vs. 100 min) 
Burke et al 
[45] 
22 international 
male race walkers  
3 weeks 
7 x week 
3 weeks of intensified training (race walking, 
resistance training, cross training). Athletes 
consumed 3 different diets across the 
training period: a) high CHO b) LCHF c) 
periodised CHO intake with periods of low 
CHO training. Acute glycogen status not 
measured. 
N/A Similar improvements in 
VO2peak between all groups 
 
Improved 10 km race times 
in high CHO and periodised 
CHO groups (no change in 
LCHF) 
 
LCHF diet increased O2 cost 
of race walking  
 
Gejl et al [55] 26 elite male 
endurance 
athletes 
4 weeks  
7 x week 
4 weeks of intensified training. Athletes 
either performed all sessions with high CHO 
availability or followed a periodised model, 
performing 3 sessions per week with reduced 
CHO availability. Glycogen content was 400 
mmol/kg dw following LOW carbohydrate 
availability training session. 
 
Similar increase in maximal CS 
activity 
 
No increase in β-HAD activity in 
either group 
Similar improvement in 




concentrations within this range, the activity of key cell signalling kinases, transcription fac-
tors and expression of various metabolic genes are augmented (Figure 2.10). Furthermore, in 
accordance with data derived from acute exercise, selected markers of skeletal muscle adap-
tation are also augmented when train-low sessions are repeatedly performed below the pro-
posed glycogen threshold (Hansen et al., 2005; Yeo et al., 2008; Morton et al., 2009) whilst 
failure to induce sufficient glycogen depletion using the twice per day model does not induce 
an augmented training response (Gejl et al., 2017). Support for the notion of a glycogen thresh-
old is also provided from studies that have fed CHO during exercise. For instance, Akerstrom 
and colleagues (2006) demonstrated that when glycogen depletion during exercise is attenu-
ated through exogenous CHO provision the activity of AMPK is attenuated. In contrast, ex-
ogenous CHO feeding that does not attenuate muscle glycogen depletion, and subsequently 
allows depletion to low levels (< 200 mmol·kg-1 dw) has no impact on AMPK activity. (Lee-
Young et al., 2006). Taken together, these data suggest the potential existence of a muscle 
glycogen threshold, whereby exceeding an absolute level of muscle glycogen concentrations 
is especially potent in modulating the acute and chronic skeletal muscle adaptations associated 
with train-low models.   
 
Nonetheless, the potential existence of a glycogen threshold is not to say that adaptation to 
endurance training is not possible without performing exercise within a specific absolute range 
of muscle glycogen concentrations. Rather, such a threshold highlights the possibility that the 
enhanced adaptations associated with the train-low model are more pronounced once a certain 
level of glycogen depletion is induced. In this regard, in order to induce comparable adapta-
tions when exercise is commenced with muscle glycogen concentrations outside of such a 
range, significant increases in glycolytic flux, achieved via high intensity or prolonged exer-
cise at lower intensities are likely required in order to drive sufficient glycogen depletion. For 
example, Impey et al, (2016) recently demonstrated comparable signalling and gene expres-
sion responses when exercise was commenced with high muscle glycogen (600 mmol·kg-1 
dw). However, such responses were achieved with significantly less work (~60 min) when 
performed with low muscle glycogen (100 mmol·kg-1 dw) suggesting train-low exercise in-





Figure 2. 10. Overview of studies supporting the glycogen threshold hypothesis. Studies are catego-
rised into those examining A cell signalling and B gene expression responses to exercise, with the 
specific protein or mRNA target that is augmented in response to low muscle glycogen highlighted on 
the y-axis. The green bars represent the trial within the specific study that has been completed with high 
muscle glycogen whilst the red bars represent the trial completed with low muscle glycogen. The length 
of the bar corresponds to the magnitude of glycogen utilisation during the specific exercise bout. Where 
individual muscle glycogen data is available, black circles represent pre- and white circles represent 
post- exercise muscle glycogen concentrations. Adapted from Impey et al (2018).  
 
2.6 Summary 
From its early recognition as a primary energy source during exercise, the role of carbohydrate 
has evolved into an important regulatory molecule with the ability to modulate acute cell sig-
nalling pathways that control many hallmark muscle adaptations associated with exercise 
training. Whilst such responses can be achieved using a variety of train-low paradigms, it 
appears that the augmented signalling and transcriptional responses associated with train-low 
are reliant on the absolute concentrations of muscle glycogen and suggest the potential exist-
ence of a muscle glycogen threshold. As such, the chapters in this thesis attempt to investigate 
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the potential existence of a muscle glycogen threshold and to provide a definition of its poten-
tial upper and lower limits. Furthermore, the interaction between endogenous and exogenous 
carbohydrate availability within the context of the glycogen threshold hypothesis also war-
rants further investigation in order to develop a more comprehensive understanding of the 






























































3.1 General Methodology 
3.11 Location of testing and ethical approval 
Exercise tests, biochemical and molecular analysis were completed within the laboratories of 
the Research Institute for Sport & Exercise Sciences. Ethical approval for all of the experi-
mental protocols and related procedures was granted from the local ethics committee at Liv-
erpool John Moores University. Analysis of skeletal muscle cell signalling for study 1 was 
performed at the University of Birmingham.  
 
3.12 Subject characteristics 
All of the subjects who participated in each study were young, healthy and either recreation-
ally active (study 1) or trained amateur cyclists (study 2 and 3). A comparison of subjects’ 
physical and physiological characteristics are shown in Table 3.1. All subjects gave written, 
informed consent to participate in the study after details and procedures of the study had been 
fully explained. None of the subjects had any history of neurological disease, skeletal muscle 
abnormality or were under any pharmacological interventions during any study. All subjects 
were instructed to refrain from exercise, caffeine and alcohol intake at least 24 h prior to any 
lab visit. 
 
Table 3. 1. Physical & physiological characteristics of subjects (mean ± SD) 
 Study 1 Study 2 Study 3 
Age (years) 22 ± 3 30 ± 10 31 ± 7 
Height (m) 1.77 ± 0.05 1.77 ± 0.09 1.77 ± 0.08 
Body mass (kg) 76.0 ± 12.7 72.6 ± 9.4 73.6 ± 6.1 
V̇O2peak (ml.kg-1.min-1) 48.9 ± 7.0 60.4 ± 7.7 60.5 ± 5.4 
Peak power output (W) 272 ± 21.1 338 ± 44.6 383± 21 
 
3.2 Cardio-Respiratory Measures 
3.21 Heart rate 
Subjects were fitted with a Bluetooth heart rate sensor for the measurement of heart rate (Polar 
H7, Kempele, Finland) during all exercise bouts. 
3.22 Assessment of respiratory gasses during exercisef 
Subjects were fitted with a facemask (for the assessment of V̇O2peak) or mouthpiece (for the 
measurement of respiratory gases during all other exercise testing sessions). Expired oxygen 
and carbon dioxide breath-by-breath measurements were obtained throughout exercise using 
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a CPX Ultima series online gas analysis system (Medgraphics, Minnesota, USA and Moxus 
Modular Metabolic System, AEI Technologies, Illinois, USA) after calibration with known 
reference gases. 
 
Figure 3. 1. (A) Example of face mask and (B) mouthpiece used for the collection of respiratory 
gases during exercise 
3.23 Assessment of substrate utilisation during exercise 
Rates of carbohydrate and lipid oxidation during exercise were estimated via indirect calorim-
etry (CPX Ultima, Medgraphics, Minnesota, USA in study 1 and 2, and Moxus Modular Met-
abolic System, AEI Technologies, Illinois, USA in study 3) using the equations of Jeukendrup 
& Wallis (2005) which assumes a negligible contribution from protein oxidation. 
 
Carbohydrate oxidation (g.min-1): (4.21 x V̇CO2) – (2.962 x V̇O2) 
Fat oxidation (g.min-1): (1.695 x V̇O2) – (1.701 x V̇CO2) 
 
Oxidation of 1 gram of carbohydrate was assumed to be energetically equivalent to 17 KJ 
whilst oxidation of 1 gram of fat was assumed equivalent to 37.7 KJ. Volumes of oxygen and 
carbon dioxide are expressed in litres.min-1 throughout the calculation. 
 
Indirect calorimetry principle  
The method of indirect calorimetry uses measurements of gas exchange at the lungs (whole 
body O2 consumption and CO2 production) as an approximate measure of substrate oxidation 
during exercise given that carbohydrates, fats and proteins differ in their chemical composition 
and thus, the amounts of O2 needed and CO2 produced when oxidised (Table 3.2). Therefore, 
rates of substrate utilisation for energy production can be estimated through the measurement 
of O2 consumed and CO2 produced during exercise.  
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Table 3. 2. Energy and volumes of O2 needed and CO2 produced in the oxidation of carbohydrate, fat 
and amino acids. Taken from Jeukendrup & Wallis (2005).  






RQ Energy equivalent 
of O2 (kcal.L) 
Glucose 3.74 0.7455 0.7426 0.996 5.02 
Glycogen 4.15 0.8283 0.8251 0.996 5.02 
Fatty acid 9.75 2.0092 1.4136 0.704 4.85 
Amino acid 4.09 0.9842 0.7931 0.807 4.16 
 
3.24 Assessment of peak oxygen uptake (V̇O2peak) and peak aerobic power 
Peak oxygen consumption (V̇O2peak) and peak aerobic power output (PPO) were determined 
during an incremental cycle test, performed on an electronically braked cycle ergometer (Lode 
Excalibur Sport, Lode, Netherlands). Following the completion of a 10-minute warm up at 75 
W, the test began at 100 W and consisted of 2-minute stages with 30 W increments in re-
sistance until volitional exhaustion. Subjects received strong verbal encouragement through-
out the test and exhaustion was defined as an inability to maintain a cadence of 60 rev.min-1 
for 10 consecutive seconds. Breath-by-breath measurements of expired gases were obtained 
throughout the duration of the test via a CPX Ultima series online gas analysis system (Med-
graphics, Minnesota, US) calibrated with known internal reference gases. The highest 30 s 
average of O2 uptake was considered to represent V̇O2peak which was stated as being achieved 
by the following end point criteria: 1) heart rate within 10 beats.min-1 of age-predicted maxi-
mum, 2) respiratory exchange ratio (RER) > 1.1, and 3) a plateau of oxygen consumption 
despite increased workload. Peak aerobic power was taken as the power during the final com-
pleted stage of the incremental test. 
 
3.3 Measurements of Psycho-Physiological Variables 
3.31 Ratings of perceived exertion 
Subjects’ reported ratings of perceived exertion during exercise were recorded using a 15-
point scale (Borg, 1982) (Figure 3.2). Subjects were familiarised to the scale during prelimi-




Figure 3. 2. Borg scale used for the assessment of ratings of perceived exertion (RPE) 
 
3.4 Procurement, Storage and Analysis of Muscle & Blood Samples 
Blood samples were drawn from a superficial vein in the anti-cubital crease of the forearm 
using a standard venepuncture technique. Samples were collected into serum separator tubes 
(SST), K2EDTA and lithium heparin vacutainers (BD Biosciences, UK). K2EDTA and lithium 
heparin vacutainers were stored on ice whilst SST vacutainers were stored at room tempera-
ture for a minimum of 30 minutes until centrifugation at 1500 g for 15-minutes at 4°C. Fol-
lowing centrifugation, aliquots of plasma and serum were stored at -80°C for later analysis. 
3.4.1 Circulating metabolite analysis 
Samples were analysed for plasma glucose, lactate, non-esterified fatty acids (NEFA) and 
glycerol concentrations using commercially available kits and a Randox Daytona spectropho-
tometer (Randox Laboratories, Ireland). The coefficient of variation for plasma glucose, lac-
tate, non-esterified fatty acids (NEFA) and glycerol between duplicate samples was <5%. 
 
Spectrophotometry principle  
The spectrophotometry method works by measuring the amount of light that each sample ab-
sorbs which is then used for the determination of plasma metabolite concentrations by plotting 
the absorbance value against the absorbance of standards of known concentrations.  
 
Within the spectrometer, the lens transmits a straight beam of light (photons) that passes 
through the prism in order to be split into several component wavelengths. The desired wave-
length is then selected by the silt and is transmitted through the sample in cuvette. The number 
 58 
of photons that is absorbed by the sample is then detected by the photometer (Figure 3.3) 
which allows for determination of the plasma metabolite concentration of each sample. 
 
 
Figure 3. 3. An overview of the general principle of spectrophotometry 
 
3.4.2 Muscle biopsies 
Muscle biopsies were obtained from separate incision sites on the vastus lateralis muscle. Each 
incision site was located 2 cm apart and the biopsied leg was alternated for each trial to reduce 
the inflammatory response associated with repeated biopsies (Ekblom, 2017). Muscle samples 
for studies 1 and 2 were obtained using a Bard monopty disposable core biopsy instrument 
(12 gauge x 10 cm length, Bard Biopsy Systems, Tempe, USA) (Figure 3.4) and using the 
Well-Blakely conchotome technique for study 3, all under local anaesthesia (0.5% Marcaine) 
and immediately frozen in liquid nitrogen to minimise tissue degradation and stored at -80°C 
for later analysis. 
 
  
Figure 3. 4. Anatomical location of the muscle biopsy site (Vastus Lateralis), the Bard biopsy needle 
instrument used and a muscle biopsy procedure from an investigation within this thesis 
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3.4.3 Gene expression analysis 
Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was employed for 
the analysis of mRNA quantification in studies 1 & 2. 
 
Polymerase chain reaction (PCR) principle 
Once mRNA has been isolated from a biological sample (i.e. human skeletal muscle), the 
isolated mRNA is synthesised into complimentary DNA (cDNA) by reverse transcription us-
ing reverse transcriptase enzymes and nucleoside triphosphates (dNTPs). The complimentary 
DNA is then denatured into single stranded DNA via heating allowing for the annealing of 
sequence specific primers and the subsequent transcription of the target sequence via RNA 
polymerase (Figure 3.5). The amplified product can be detected by labelling the cDNA with 
SYBR green fluorescent dye that emit fluorescence, which increases proportionally with the 
amplification of the cDNA molecules and can be detected in real-time following each cycle 
of the reaction, allowing for precise semi-quantitative analysis of mRNA content. 
 
Figure 3. 5. Schematic representation of the key steps in real time quantitative polymerase chain re-
action 
 
Homogenisation of skeletal muscle samples 
Skeletal muscle samples (~30-50 mg) were transferred to 2 ml lysing tubes containing ceramic 
beads (Roche Diagnostics, UK) and 500 µl of TRI reagent (Sigma Aldrich, UK) and homog-
enised through physical disruption (MagNA lyser, Roche Diagnostics, UK) at 6,000 rpm for 
3 x 40 seconds, separated by 5 minutes of cooling on ice. TRI reagent contains phenol and 
guanidine thiocyanate that are capable of lysing cells and dissolving all other cell components 
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other than RNA and DNA. Furthermore, TRI reagent inhibits the activity of both DNAse and 
RNAse enzymes and subsequently helps to maintain RNA integrity. Following homogenisa-
tion, the tissue lysate was transferred from the lying tube into a pre-labelled RNAse-free Ep-
pendorf. 
 
RNA isolation method 
One hundred µl of chloroform was subsequently added to the tissue-lysate sample and shaken 
vigorously by hand and left to stand at room temperature for 10 minutes before centrifugation 
at 12,000 x g for 15 minutes at 4°C. Centrifugation allowed for the sample to be separated 
into its red phenol, middle interphase and aqueous upper phase (Figure 3.5) The upper aqueous 
phase was carefully removed, transferred into a new pre-labelled RNAse-free Eppendorf and 
mixed with 250 µl of isopropanol. The sample was mixed by tube inversion and left to stand 
at room temperature for 10 minutes before further centrifugation at 12,000 x g for 10 minutes 
at 4°C. The resultant supernatant was discarded and the RNA pellet was washed with 1 ml of 
75% ethanol. The sample was then vortexed on a low speed setting to wash the RNA pellet 
and centrifuged for 5 minutes at 7,600 x g at 4°C. The ethanol was removed and the wash 
process repeated. Following the second centrifugation, the ethanol was discarded and the pel-
let was left to air dry before re-suspension in RNAse and DNAse free, DEPC water (Thermo 
Fischer Scientific, UK). Samples were subsequently heated in a block heater at 35°C for 10 
minutes prior to measurement of RNA quality and quantity. 
 
 
Figure 3. 6. Visual representation of phase separation that occurs with TRI reagent 
 
Assessment of RNA quality 
Both RNA purity and concentration were assessed by UV spectroscopy, using a Nandodrop 
spectrophotometer (Thermo Fisher Scientific). The absorbance of the diluted RNA sample 
was measured at known purity ratios of 260/280 and 260/230, where absorbance at 260 nm 
(A260) provides a specific measurement of nucleic acid concentration and absorbance at 280 
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nm (A280) and 230 nm (A230) measures protein and background absorption, respectively, as an 
indication of possible contaminants. In general, an A260/A280 ratio of 1.8 to 2.1 indicates very 
pure RNA with the A260/A230 ratio being higher than that of A260/A280 with common values 
ranging from 1.8-2.2. Despite this, there appears to be no acceptable lower limit for this ratio 
with previous research demonstrating no correlation between A260/A230 and qPCR amplifica-
tion efficiency (Kuang et al., 2018). Both A260/A230 and A260/A280 ratios for each experimental 
study are reported in their respective experimental chapters. 
 
 
Figure 3. 7. (A) Example nucleic acid spectral image used to assess RNA purity and (B) Spectral im-
age of samples contaminated with either guanidine or phenol 
 
Upon measuring a sample for RNA purity and concentration, a blank sample measurement 
was performed by pipetting 1 µl of RNAse and DNAse free DEPC water onto the spectropho-
tometer for analysis. 1 µl of diluted sample was then pipetted directly onto the measurement 
pedestal for RNA assessment. 
 
Method of RNA quantification 
Absorbance at 260 nm was used to determine the RNA concentration given that an A260 read-
ing of 1.0 is equivalent to 40 µg.ml-1 of RNA. The Nanodrop software used for the quantifi-










• C is the nucleic acid concentration (ng.µl-1) 
• A is the absorbance in AU 
• ε is the wavelength-dependent extinction coefficient (ng-cm.µl-1). For 
RNA, the wavelength-dependent extinction constant is 40nm-cm.µl-1 
• b is the path length in cm 
 
Equation 3.1. The modified Beer-Lambert equation used in the current thesis to determine RNA con-
centration via spectrophotometric analysis 
 
Polymerase chain reaction 
For all gene expression data presented within this thesis purified RNA was diluted to 7.3 ng.µl-
1 in 9.5 µl volume, making 70 ng total reactions (study 1) or 5.2 ng.µl-1 in 9.5 µl volume, 
making 50 ng total reactions (study 2 – in an attempt to conserve total RNA in 3/48 samples 
and enable the running of all genes of interest across all samples) in RNAse and DNAse free 
DEPC water (Thermo Fischer Scientific, UK) and amplified using specific primer sequences 
in a rotor-gene Q PCR machine using a one-step Quantifast SYBR Green kit (Qiagen, UK). 
The use of the polymerase chain reaction method allows DNA to be synthesised from a single 
stranded RNA template (Step 2 of Figure 3.5). This complimentary DNA is then denatured to 
a single stranded DNA template which is subsequently used to create two new strands of DNA. 
When this process is repealed for 40 cycles more than one billion copies of the original DNA 
segment are produced. Briefly, double stranded cDNA was first synthesised from the RNA 
template using dNTP nucleotides and reverse transcriptase enzymes at 50°C for 10 minutes 
followed by transcriptase inactivation and initial denaturation (95°C for 5 minutes). Following 
the initial denaturation step, complimentary DNA was then denatured to single stranded DNA 
at 95°C for 10 seconds allowing for subsequent annealing of primers and extension of DNA 
strand at 60°C for 30 seconds. The cycle of denaturation and annealing/extension was repeated 
for 40 cycles (Figure 3.8A). The SYBR Green mixture contains a fluorescent dye that binds 
to all double stranded DNA and emits fluorescence upon binding. With the use of the rotor 
gene software, the fluorescence signal after each cycle is quantified in real-time and the data 
are plotted against the cycle number to produce an amplification profile (Figure 3.8B).  
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Figure 3. 8. (A) Visual representation of the polymerase chain reaction protocol used within the ex-
periments of this thesis and (B) example of real time fluorescent detection curves. 
 
PCR Analysis 
PCR efficiency was calculated to determine the increase in the amplicon per cycle, with 100% 
efficiency demonstrating a perfect doubling of the amplicon at each cycle. Mean PCR effi-
ciency of all target genes for study 1 and study 2 were 90.3 ± 3.0% and 90.1 ± 7.7% with a 
mean variation of 3.3% and 7.8% between samples, respectively. The mean PCR efficiency 
of the selected housekeeper gene for study 1 and 2 were 89.7 ± 2.7% and 93.5 ± 5.5%, respec-
tively, with a mean variation of 3.0 and 5.9% between samples. Melt curve analysis was also 
performed to assess whether a single, specific product had been amplified and to allow exclu-
sion of non-specific amplification or primer-dimer issues. In this regard, the temperature at 
which base-base hydrogen bonding between two DNA strands is broken depends on their 
length, guanine-cytosine content and their complementarity, thus, a unique melt curve will be 
produced for each specific DNA fragment. All melt curve analysis presented single peaks for 




Figure 3. 9. Melt curve analysis for (A) reference gene and (B) gene of interest following RT-qPCR 
 
Changes in mRNA content were calculated using the comparative Ct (ΔΔCt) equation (Equa-
tion 3.2) (Schmittgen & Livak, 2008). GAPDH (study 1) or B2M (study 2) was used as the 
reference gene and did not change significantly between groups or time points. Mean CT val-
ues for each reference gene for each experimental study are reported in their respective exper-
imental chapters. mRNA expression for all target genes was calculated relative to the reference 
B A 
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gene for the corresponding time point and normalised to a single pre-exercise time point for 
each individual subject which acted as the calibration condition. The specific reference sample 
is detailed within each respective chapter.  
 
Equation A: ΔCt = Mean Ct (target gene) - Mean Ct (housekeeper gene) 
Equation B: ΔCt = Mean Ct (target gene calibrator) - Mean Ct (reference gene calibtator) 
Equation C: ΔΔCt = ΔCt of equation 1 - ΔCt of equation 2 
Equation D: 2ΔΔCt = normalised expression ratio (fold change)  
 




Primer sequences were designed through the use of Primer-BLAST software. Where possible, 
primers were designed to yield products spanning exon-exon boundaries to prevent non-spe-
cific amplification of genomic DNA containing introns which will be removed during RNA 
splicing. All primers were between 18 and 25 base pairs (bp) and amplified a product between 
67 and 201 bp. All primers were purchased from Sigma Aldrich (Suffolk UK) with sequences 
for each gene presented in each respective chapter.  
3.4.4 Muscle glycogen concentrations 
Muscle glycogen concentration was determined using the acid hydrolysis method described 
by Van Loon et al (van Loon et al., 2000). Approximately 1-5 mg of freeze dried tissue was 
powdered and dissected free of all visible non-muscle tissue and subsequently hydrolysed by 
incubation in 500 µl of 1 M HCl for 3 hours in a water bath set at 100°C. Samples were 
removed from the water bath every 45 minutes and briefly vortexed before being returned to 
boil. After cooling for 20 minutes at room temperature, samples were neutralised by the addi-
tion of 250 µl of 0.12 mol.L-1  / 2.1 mol.L-1 KOH, saturated with KCl and centrifuged at 500 
x g for 10 minutes at 4°C. Following centrifugation, 200 µl of supernatant was frozen at -80°C 
and subsequently later analysed in duplicate for glucose concentration according to the hexo-
kinase method using a commercially available kit (GLUC-HK, Randox Laboratories, UK) as 
described in section 3.4.1. Glycogen concentration is expressed as mmol·kg-1 dw and the intra-
assay coefficient of variation between duplicates was <5%.  
 
Acid hydrolysis principle 
The acid hydrolysis method allows for the cleavage of glyosidic bonds which are necessary 
for the attachment of glucose molecules to one another, allowing for the breakdown of di- and 
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polysaccharide chains into single sugar monosaccharides. Once boiled, an acid-base neutrali-
sation reaction is performed with the addition of KOH, saturated with KCl in order to neutral-
ise the pH of the sample.  
3.4.5 Western blot analysis 
Approximately 20 mg of frozen tissue was homogenised in 200 μl of ice-cold RIPA buffer 
(50 mM HCl, 150 mM NaCl, 2 mM EDTA, 1% NP-40 and 0.1% SDS) containing protease 
and phosphatase inhibitors (Pierce, Thermo Scientific) and agitated end-over-end for 1 h at 
4°C before centrifugation at 14,000 x g for 10 min. Following protein quantification, each 
sample was diluted with equal volumes of 4X Laemmli buffer and distilled water (dH2O). to 
a concentration of 2 μg.μl-1 and boiled for 5 min at 95°C. 
 
Subcellular fractionation of skeletal muscle tissue 
Isolation of nuclear and cytosolic fractions was performed on skeletal muscle samples ob-
tained from study 2 based on the method described by Dimauro et al. (2012). Approximately 
20 mg of frozen tissue was homogenised in 300 μl of STM buffer (comprised of 250 mM 
sucrose, 50 mM Tris-HCl pH 7.4, 5 mM MgCl2 and 10X protease and phosphatase inhibitor 
cocktail). The homogenate was then centrifuged at 800 x g for 15 minutes at 4°C. The resulting 
supernatant was removed into a separate Eppendorf tube for subsequent isolation of the cyto-
solic fraction whilst the pellet was resuspended in 300 μl of STM buffer and centrifuged at 
500 x g for 15 minutes at 4°C. The nuclear pellet was again resuspended in 300 μl of STM 
buffer and centrifuged at 1,000 x g for 15 minutes at 4°C with the supernatant discarded. The 
nuclear pellet was subsequently resuspended in 200 μl of NET buffer (comprised of 20 mM 
HEPES pH 7.9, 1.5 mM MgCl2, 0.5 M NaCl, 0.2 mM EDTA, 20% glycerol, 1% 100X Triton 
and 10X protease and phosphatase inhibitor cocktail), kept on ice for 30 min before being 
sonicated for 1 min. Finally, lysates were centrifuged at 9,000 x g for 30 min at 4°C with the 
supernatant removed to a new tube, labelled as the nuclear fraction and stored at -80°C prior 
to protein quantification. Cytosolic fractions were isolated by centrifuging the supernatant, 
achieved from the first centrifugation step, at 800 x g for 10 minutes at 4°C. The supernatant 
was again centrifuged at 11,000 x g for 10 minutes at 4°C, with the resultant supernatant 
precipitated in 1.2 ml ice-cold 100% acetone at -20°C for 1 h followed by centrifugation at 
12,000 x g for 5 min at 4°C. The resultant pellet was then resuspended in 100 μl STM buffer, 
labelled as the cytosolic fraction and stored at -80°C prior to protein quantification.  
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Validation of the purity of the nuclear and cytosolic fractions was determined by the presence 
of either histone 3 (H3) (nuclear) and lactate dehydrogenase (LDH) (cytosolic) ‘house-keep-
ing’ protein markers, respectively, via SDS-PAGE and western blotting.  
 
 




Total protein concentrations for each sample were determined using the bicinchoninic acid 
(BCA) assay method.  
 
BCA assay principle 
The BCA assay is a colorimetric technique used for the quantification of total protein within 
a sample. The method works via the reduction of a Cu2+ ion to Cu1+ which is then chelated by 
BCA and results in the formation of a purple coloured reaction product. This reaction product 
demonstrates strong absorbance at 520 nm which demonstrates a near linear relationship with 
increasing protein concentrations.  
 
 




Preparation of standards and reagents for BCA assay 
Bovine serum albumin (BSA) standards were prepared at concentrations of 2, 1.5, 1, 0.75, 0.5, 
0.25 and 0.125 mg.ml-1 through the serial dilatation of 2 mg BSA with dH2O. 
 
The BCA reagents were purchased as part of a commercially available BCA protein assay kit 
(Pierce, Rockford, USA) which contains two reagents; A & B. Reagent B (4% cupric sulphate) 
was thoroughly mixed with reagent A (sodium carbonate, sodium bicarbonate, BCA and so-
dium tartrate in 0.1 M of sodium hydroxide) in a trough at a ratio of 1:50. 
 
BCA assay method 
Ten μl of standard, samples and a blank (dH2O) were pipetted in triplicate into a 96-well plate. 
Two hundred μl of the working agent was subsequently added to all wells using a multichannel 
pipette (excluding the blank) and the plate was incubated at 37°C for 30 min. Following incu-
bation, the absorbance was recorded at 570 nM using a Clariostar plate reader (BMG Lab 
Tech, Germany). A standard curve was generated by plotting the average blank-corrected 570 
nM measurement of each standard against its known concentration in mg.ml-1. Sample con-
centrations were subsequently calculated from the standard curve.  
 
SDS-PAGE & Western Blotting principle 
SDS polyacrylamide gel electrophoresis (PAGE) allows for the separation of proteins accord-
ing to their molecular weight via the application of an electrical charge running between the 
anode (+) and cathode (-) chambers whilst proteins are subsequently transferred from the gel 
to a nitrocellulose membrane. Following protein transfer, the membrane is ‘blocked’ with 
blocking agents (either BSA or non-fat milk) in order to block all areas of the membrane that 
do not contain any protein in order to reduce any non-specific binding of primary antibodies 
and reduce overall background signal. Primary antibodies bind to specific portions of the pro-
tein of interest or epitopes whereas secondary antibodies bind to the fragment crystallizable 
(Fc) region of the primary antibody to allow for subsequent detection (Bass et al., 2017). Sec-
ondary antibodies are required for the detection of primary antibodies bound to the target an-
tigen as primary antibodies are not typically conjugated to a label (i.e. conjugated to a reported 
function such as horseradish peroxidase) for detection. Furthermore, multiple secondary anti-
bodies can bind to a single primary antibody, thus amplifying the detectable signal (Bass et 
al., 2017). Upon detection, the luminol based chemiluminescence substrate is applied to the 
membrane and, in the presence of HRP (from the secondary antibody) and peroxide, results 
in the oxidation of luminol and forms a product that emits light at 425 nm. This light is then 




Figure 3. 12. An overview of the sequential stages of the Western blot process 
 
SDS-PAGE and western blotting 
Equivalent amounts of protein (20-30 μg) from each sample was separated by gel electropho-
resis is 12% TGX Precast Midi Protein gels (Bio-Rad Laboratories, Germany) by SDS-
page (15 minutes at 100V, followed by 60 minutes at 150V). Proteins were subsequently semi-
dry transferred onto nitrocellulose membrane (Bio-Rad Laboratories, Germany) for 30 
minutes at 30V in transfer buffers. Following transfer, membranes were imaged using stain-
free technology (Bio-Rad Laboratories, Germany) to check transfer efficiency and subse-
quently blocked for 1 hour at room temperature in Tris-buffered saline (TBST 0.19 M Tris pH 
7.6, 1.3 M NaCl, 0.1% Tween-20) with 5% milk. Membranes were then incubated overnight 
at 4°C in primary antibodies (Cell Signalling, UK) at concentrations of 1:1000 in 1X TBST. 
The subsequent morning, membranes were washed for 3 x 5 min in TBST and incubated in 
anti-species horseradish peroxidase-conjugated secondary antibody at concentrations of 
1:1000-10000 (Polyclonal Goat Anti-Rabbit HRP, Cell Signalling, UK) in TBST with 2.5% 
milk for 1 h at room temperature. Membranes were again washed in TBST for a further 3 x 5 
min and finally exposed in a chemiluminescence solution (Pierce ECL Western Blotting Sub-
strate, Thermo Scientific, UK) and visualised using a Bio-Rad Chemi-doc system whilst band 
densities were determined semi-quantitatively using ImageLab software (Bio-Rad Laborato-
ries, Germany). The volume density of each target band was normalised to the total amount 
of protein loaded into each lane using Stain-Free technology (Bio-Rad Laboratories, Ger-




Figure 3. 13. An overview of the quantification method used for band densitometry analysis.  
 
3.4.6 Statistical analysis 
All statistical analyses were performed using the statistical package for social sciences (SPSS, 
Version 24, IBM, USA). For the comparison of multiple groups means, an analysis of variance 
(ANOVA) was used. Where a significant main effect was observed, pairwise comparisons 
were analysed according to Bonferroni post-hoc tests in order to locate specific differences. 
All data in text, figures and tables are presented as means ± standard deviation (SD) with P 
values ≤ 0.05 indicating statistical significance. All figures were designed in Prism (Version 



































Graded reductions in pre-exercise muscle glycogen im-
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We examined the effects of graded muscle glycogen on exercise capacity and the modulation 
of skeletal muscle signalling pathways associated with the regulation of mitochondrial bio-
genesis. In a repeated measures design, eight males completed a sleep-low, train-low model 
comprising an evening glycogen depleting cycling protocol followed by an exhaustive exer-
cise capacity test (8 x 3 min at 80% PPO, followed by 1 min efforts at 80% PPO until exhaus-
tion) the subsequent morning. Following glycogen depleting exercise, subjects ingested a total 
of 0 g.kg-1 (L-CHO), 3.6 g.kg-1 (M-CHO) or 7.6 g.kg-1 (H-CHO) of carbohydrate during a 
6 h period prior to sleeping, such that exercise was commenced the next morning with 
graded (P < 0.05) muscle glycogen concentrations (Mean ± SD) (L-CHO: 88 ± 43, M-
CHO: 185 ± 62, H-CHO: 278 ± 47 mmol·kg-1 dw). Despite differences (P < 0.05) in exer-
cise capacity at 80% PPO between trials (L-CHO: 18 ± 7, M-CHO: 36 ± 3, H-CHO: 44 ± 9 
min) exercise induced comparable AMPKThr172 phosphorylation (~4 fold) and PGC-
1α mRNA expression (~5 fold) post- and 3 h post-exercise, respectively. In contrast, exercise 
nor CHO availability affected the phosphorylation of p38MAPKThr180/Tyr182, CaMKIIThr268 or 
mRNA expression of p53, Tfam, CPT-1, CD36 or PDK4. Data demonstrate that when exer-
cise is commenced with muscle glycogen below 300 mmol·kg-1 dw, further graded reductions 




















Skeletal muscle glycogen is recognised as the predominant energy substrate used during in-
tense aerobic exercise (Hawley & Leckey, 2015) and plays an important role in regulating the 
capacity to sustain exercise at a given workload above 60% V̇O2max (Bergström et al., 1967; 
Hermansen et al., 1967; Hawley et al., 1997). Additionally, muscle glycogen acts as a regu-
latory molecule (Philp et al., 2012) that is able to modulate cell signalling and transcriptional 
responses to exercise and subsequently augment selected skeletal muscle markers of training 
adaptation (e.g succinate dehydrogenase, citrate synthase and β-hydroxyacyl-CoA-dehydro-
genase enzyme activity and cytochrome c oxidase subunit IV content). Most notably, exercise 
commenced with reduced muscle glycogen (as defined as a ‘train-low’ session (Stellingwerff 
et al., 2019)) augments the AMPK-PGC-1α signaling axis (Steinberg et al., 2006; Yeo et al., 
2010; Bartlett et al., 2013; Psilander et al., 2013) and results in the augmented expression of 
target genes with putative roles in the regulation of mitochondrial biogenesis and substrate 
utilisation (Pilegaard et al., 2002; Bartlett et al., 2013; Lane et al., 2015). Whilst a multitude 
of research designs have been used to study the physiological and molecular responses to 
‘train-low’ exercise, the recently developed ‘sleep-low, train-low’ model (which requires ath-
letes to perform an evening training session, restrict carbohydrate (CHO) during overnight 
recovery, and then complete a fasted training session the subsequent morning) provides a po-
tent strategy to augment mitochondrial related cell signalling (Bartlett et al., 2013; Lane et al., 
2015; Burke et al., 2018). Furthermore, repeated bouts of sleep-low, train-low is the only train-
low model shown to enhance performance in trained endurance athletes (Marquet et al., 
2016a, 2016b).  
 
Given the enhanced training response associated with the sleep-low, train-low model is po-
tentially regulated by muscle glycogen availability, it is prudent to consider the absolute gly-
cogen concentrations required to facilitate this response. In this regard, examination of avail-
able data demonstrate that the augmented signalling and transcriptional responses associated 
with train-low models are particularly apparent when absolute pre-exercise muscle glycogen 
concentrations are ≤300 mmol·kg-1 dw (Impey et al., 2018). Such data suggest the presence 
of a muscle glycogen threshold, whereby a critical absolute level of glycogen must be sur-
passed in order to induce the augmented cell signalling responses associated with the train-
low model (Pilegaard et al., 2002). In accordance with data derived from acute exercise pro-
tocols, the notion of a glycogen threshold is also apparent when investigating selected skeletal 
muscle markers of training adaptation (Impey et al., 2018). For example, train-low sessions 
commenced with glycogen concentrations < 300 mmol·kg-1 dw (Hansen et al., 2005; Yeo et 
al., 2008; Morton et al., 2009) result in augmented oxidative enzyme activity and/or content 
following 3-10 weeks of training. In contrast, when ‘train-low’ sessions are commenced with 
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markedly higher pre-exercise muscle glycogen concentrations (400-500 mmol·kg-1 dw) skel-
etal muscle markers of training adaptation are not augmented (Gejl et al., 2017). Nonetheless, 
whist training with low muscle glycogen augments selected signalling events, absolute train-
ing volume (Impey et al., 2016) and/or intensity (Yeo et al., 2008; Hulston et al., 2010; Lane 
et al., 2013) may be reduced due to a lack of muscle substrate and/or an impairment in the 
contractile apparatus of skeletal muscle (Ørtenblad et al., 2011; Gejl et al., 2014). When taken 
together, the challenge that exists is to therefore facilitate the pro-signalling environment 
whilst simultaneously maintaining the ability to complete the desired workload and intensity 
in order to promote training adaptation.  
 
As such, the aim of the present study was to examine the effects of graded pre-exercise gly-
cogen concentrations on both exercise capacity and the modulation of selected skeletal muscle 
signalling pathways with putative roles in the regulation of mitochondrial biogenesis. This 
model of graded pre-exercise muscle glycogen was achieved through a sleep-low, train-low 
model that adopted CHO intakes considered practically viable (within the time-course of 
sleep-low designs) and representative of real-world refeeding strategies. Whilst the use of such 
sleep-low, train-low models are primarily designed for athletic populations, the use of recrea-
tional populations allows for a greater understanding of the molecular events that occur in 
response to such ‘train-low’ designs, given the difficulties of collecting muscle biopsies from 
elite athletes. It was hypothesised that the activation of skeletal muscle signalling pathways 




Eight recreationally active males (mean ± SD: age, 22 ± 3 years; body mass 76.0 ± 12.7 kg; 
height, 177.9 ± 5.7 cm) took part in this study. Mean V̇O2peak and peak power output (PPO) 
for the cohort were 48.9 ± 7.0 mL kg-1 min-1 and 273 ± 21 W, respectively. None of the subjects 
had any history of musculoskeletal or neurological disease nor were they under any pharma-
cological treatment during the course of the testing period. All subjects provided written in-
formed consent and all procedures conformed to the standards set by the Declaration of Hel-
sinki (2008). The study was approved by the local Research Ethics Committee of Liverpool 





4.3.2 Experimental Design  
Using a sleep-low, train-low model and a repeated measures design, with each experimental 
trial separated by a minimum of 7 days, subjects undertook an evening bout of glycogen de-
pletion exercise followed by the consumption of graded quantities of CHO (L-CHO: 0 g, M-
CHO: 3.6 g kg-1, H-CHO: 7.6g kg-1) across a 6 h period, so that exhaustive exercise was com-
menced the next morning with three different levels of pre-exercise muscle glycogen concen-
trations. Skeletal muscle biopsies were obtained from the vastus lateralis immediately before, 
post- and 3 h post-exercise. During the H-CHO and M-CHO trials, an additional muscle bi-
opsy was obtained at a matched time point corresponding to the point of exhaustion in the L-
CHO trial, allowing for work-matched comparison between trials. Consequently, all subjects 
completed the L-CHO trial first, whilst the subsequent M-CHO and H-CHO trials were com-
pleted in a randomised and counterbalanced order. An overview of the experimental protocol 
is shown in Figure 4.1. 
 
 
Figure 4. 1. Schematic overview of the experimental sleep-low, train-low protocol. Following 24 h of 
standardised dietary conditions, subjects completed an evening bout of glycogen depleting cycling ex-
ercise. Upon completion, subjects received three graded levels of CHO in order to manipulate pre-
exercise muscle glycogen the subsequent morning. Following an overnight fast, subjects completed an 
exhaustive bout of cycling exercise. Muscle biopsies were obtained pre-exercise, at the point of exhaus-
tion (post exercise) and 3 h post exercise. During H-CHO and M-CHO trials, an additional muscle 
biopsy was obtained at a time point corresponding to the point of exhaustion in the L-CHO trial, allow-





4.3.3 Assessment of peak oxygen uptake 
At least 7 days prior to experimental trials, all subjects were assessed for peak oxygen con-
sumption (V̇O2peak) and peak power output (PPO) on an electronically braked cycle ergometer 
(Lode Excalibur Sport, Groningen, Netherlands). Following the completion of a 10 min warm-
up at 75 W, the test began at 100 W and consisted of 2 minute stages with 30 W increments 
in resistance until volitional exhaustion. V̇O2peak was stated as being achieved by the following 
end-point criteria: (1) heart rate within 10 beats min-1 of age-predicted maximum, (2) respira-
tory exchange ratio > 1.1 and (3) plateau of oxygen consumption despite increased workload. 
Peak aerobic power was taken as the final stage completed during the incremental test.  
4.3.4 Overview of sleep-low, train-low model 
Phase 1: Glycogen depletion exercise 
In the 24 h preceding glycogen depleting exercise (i.e. from 12 pm the day prior), subjects 
received a standardised high CHO diet (8 g kg-1 CHO, 2 g kg-1 protein and 1 g kg-1 fat) and 
refrained from alcohol and vigorous physical exercise for the previous 48 h. The standardised 
diet was provided to subjects and consisted of 3 main meals and 3 CHO rich snacks, with 
subjects required to stop eating 3 h prior to commencing glycogen depleting exercise. On the 
day of glycogen depleting exercise, subjects reported to the laboratory at approximately 3 pm 
to perform a bout of intermittent glycogen depleting cycling, as previously completed in our 
laboratory (Taylor et al., 2013; Impey et al., 2016). Following a self-selected warm-up, sub-
jects cycled for 2 min at 90% PPO, followed immediately by a 2 min recovery period at 50% 
PPO. This work to rest ratio was repeated until subjects could do longer sustain the workload 
at 90% PPO for 2 min at which point, exercise intensity was reduced to 80% PPO with the 
same work to rest ratio. When subjects were unable to maintain this intensity, it was reduced 
to 70% PPO and finally 60% PPO, maintaining the same work to rest ratio throughout. When 
subjects were unable to maintain the workload at 60% PPO for 2 min the exercise protocol 
was terminated. The pattern of exercise and total time to exhaustion in the subject’s initial trial 
was recorded and replicated in all subsequent trials. Subjects were permitted to consume water 
ad libitum during exercise, with the pattern of ingestion replicated during subsequent trials.  
Phase 2: Carbohydrate re-feeding strategy 
To facilitate the overnight sleep-low model, subjects were fed 30 g of whey protein isolate 
(Science in Sport, Nelson, UK) mixed with 500 ml of water immediately following the cessa-
tion of glycogen depleting exercise to reflect real-world practice as per current nutritional 
guidelines (Thomas et al., 2018). Subjects in the L-CHO trial then refrained from eating for 
the remainder of the evening whereas subjects within the M-CHO and H-CHO trials were 
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provided with a mixture of CHO drinks (Maltodextrin, Science in Sport, Nelson UK) and gels 
(GO isotonic energy gel, Science in Sport, Nelson UK) to be consumed at hourly intervals. In 
the M-CHO trial, subjects were provided with CHO at a rate of 1.2 g kg-1 h-1 for 3 h whereas 
subjects in the H-CHO trial were provided with 1.2 g kg-1 h-1 for 3 h followed by a high car-
bohydrate meal (4 g kg-1 CHO, 51 ± 1 g protein and 17 ± 1 g fat) consisting of bread, soup, 
rice, fresh juice, rice pudding and jam after 4 h of recovery. In this way, total CHO intakes in 
the L-CHO, M-CHO and H-CHO trials equated to 0, 3.6 and 7.6 g kg-1, respectively, with 
fluid intake allowed ad libitum.   
 
Phase 3: High intensity interval cycling and exercise capacity test 
To facilitate the train-low exercise session, subjects arrived the subsequent morning between 
8-9 am, in a fasted state, where a venous blood sample was collected from the antecubital vein 
and a muscle biopsy taken from the vastus lateralis. Subjects then completed the high-intensity 
interval (HIIT) cycling protocol, consisting of 8 x 3 min intervals at 80% PPO, interspersed 
with 1 min rest. During exercise, heart rate (HR) was continuously measured and the final HR 
for each 3 min interval was recorded, whilst ratings of perceived exertion (RPE) were recorded 
upon completion of each interval. Expired gas was collected via a mouthpiece connected to 
an online gas analysis system (CPX Ultima, Medgraphics, Minnesota, US) for the final 1.5 
min of each interval and substrate utilisation was assessed using the equations of Jeukendrup 
& Wallis (Jeukendrup & Wallis, 2005) given the validity of indirect calorimetry for the as-
sessment of substrate utilisation at exercise intensities up to 80-85% V̇O2max (Romijn et al., 
1992). Upon completion of the high-intensity cycling protocol, subjects were provided with 5 
min of active recovery prior to commencing an exercise capacity test consisting of intermittent 
“1 min efforts” corresponding to 80% PPO interspersed with 1 min recovery periods at 40% 
PPO. This intermittent protocol was followed until the subjects reached volitional exhaustion 
and has been previously utilised in our laboratory (Impey et al., 2016). 
4.3.5 Blood analysis 
Venous blood samples were collected in vacutainers containing K2EDTA, lithium heparin or 
serum separation tubes and stored on ice or at room temperature until centrifugation at 1500 
g for 15 min at 4oC. Samples were collected immediately prior to exercise, at the point of 
exhaustion (post exercise) and 3 h post exercise, whilst an additional sample was obtained at 
a time point corresponding to the point of exhaustion in the L-CHO trial during the M-CHO 
and H-CHO trials. Plasma was aliquoted and stored at -80oC until analysis. Samples were later 
analysed for plasma glucose, lactate, non-esterified fatty acids (NEFA) and glycerol using 
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commercially available enzymatic spectrophotometric assays (RX Daytona Analyser, Ran-
dox, UK) as per manufacturer instructions. 
4.3.6 Muscle biopsies 
Skeletal muscle biopsies (~60 mg) were obtained from the vastus lateralis immediately prior 
to exercise, at the point of exhaustion (post exercise) and 3 h post exercise. During the M-
CHO and H-CHO trials, an additional muscle biopsy was obtained at a time point correspond-
ing to the point of exhaustion in the L-CHO trial, thereby allowing for ‘work-matched’ com-
parison between trials. For the work-matched biopsy, subjects dismounted the cycle ergometer 
and were moved to the adjacent biopsy suite. Following collection of the biopsy sample (~5 
min), subjects recommenced cycling exercise. Muscle biopsies were obtained from separate 
incision sites 2-3 cm apart using a Bard Monopty Disposable Core Biopsy Instrument (12 
gauge x 10 cm length, Bard Biopsy Systems, Tempe, AZ, USA) under local anaesthesia (0.5% 
Marcaine) and immediately frozen in liquid nitrogen and stored at -80oC for later analysis.  
4.3.7 Muscle glycogen concentration  
Muscle glycogen concentrations were determined according to the acid hydrolysis method 
described by Van Loon et al (van Loon et al., 2000). Approximately 2-5 mg of freeze-dried 
tissue was powdered, dissected of all visible blood and connective tissue and subsequently 
hydrolysed by incubation in 500 μl of 1 M HCl for 3 h at 95oC. After cooling to room temper-
ature, samples were neutralised by the addition of 250 μl 0.12 mol L-1 Tris/2.1 mol L-1 KOH 
saturated with KCl. Following centrifugation, 200 μl of supernatant was analysed in duplicate 
for glucose concentration according to the hexokinase method using a commercially available 
kit (GLUC-HK; Randox Laboratories, Antrim, UK). Glycogen concentration is expressed as 
mmol·kg-1 dry weight and intra-assay coefficients of variation were <5%. 
4.3.8 RNA isolation and analysis 
Muscle samples (~20 mg) were homogenised in 1 ml TRIzol reagent (Thermo Fisher Scien-
tific, UK) and total RNA isolated according to the manufacturer’s guidelines. Concentrations 
and purity of RNA were assessed by UV spectroscopy at optical densities (OD’s) of 260 and 
280 nm, using a Nanodrop 3000 (Fisher, Rosklide, Denmark) with an average 260/280 ratio 





4.3.9 Reverse transcriptase quantitative Real-Time Polymerase Chain Reaction (rt-qRT-
PCR) 
RT-PCR amplifications were performed using QuantiFastTM SYBR® Green RT-PCR one-step 
kit on a Rotogene 300Q (Qiagen, Crawley, UK) supported by Rotogene software (Hercules, 
CA). RT-qTR-PCR was performed as follows: hold 50oC for 10 min (reverse transcrip-
tion/cDNA synthesis), 95oC for 5 min (transcriptase inactivation and initial denaturation step), 
and PCR steps of 40 cycles; 95oC for 10 sec (denaturation), 60oC for 30 sec (annealing and 
extension). Upon completion, dissociation/melting curve analyses were performed to reveal 
and exclude nonspecific amplification or primer-dimer issues (all melt analysis in this study 
presented single reproducible peaks for each target gene suggesting amplification of a single 
product). Following initial screening of suitable reference genes, GAPDH showed the most 
stable Ct values across all RT-PCR runs and subjects, regardless of experimental condition 
(25.3 ± 1.0) and was therefore selected as the reference gene in all RT-PCR assays. The aver-
age PCR efficiency for all RT-PCR runs (90 ± 2%) was similar for all genes across all time 
points and experimental conditions. As such, the relative gene expression levels were calcu-
lated using the comparative Ct (ΔΔCt) equation (Schmittgen & Livak, 2008) where the relative 
expression was calculated as 2-ΔΔct where Ct represents the threshold cycle. mRNA expression 
for all target genes was calculated relative to the reference gene (GAPDH) within the same 
subject and condition and relative to the pre-exercise value in the H-CHO condition.     
 
Table 4. 1. Primers used for real-time RT-PCR  
 
4.3.10 SDS page & Western blotting 
Muscle samples were prepared, separated by SDS-PAGE and transferred to nitrocellulose 
membranes according to the method outlined in section 3.4.5. Following transfer, membranes 
were stained for protein with Ponceau S (Sigma-Aldrich, Gillingham, UK), blocked in TBS-
Tween containing 3% non-fat milk for 1 h and incubated overnight in primary antibodies 
(1:1000) (AMPKα (2603), p-AMPKThr172 (2531), ACC (3676), p-ACCSer79 (3661), p38MAPK 
(9212), p-p38MAPKThr180/Tyr182 (4511), CaMKII (3362) and p-CaMKIIThr268 (12716) from Cell 
Signaling Technologies), before incubation in relevant secondary antibodies (1:2000) (anti-
Gene Forward primer Reverse primer 
PGC-1 TGCTAAACGACTCCGAGAA TGCAAAGTTCCCTCTCTGCT 
p53 ACCTATGGAAACTACTTCCTGAAA CTGGCATTCTGGGAGCTTCA 
Tfam TGGCAAGTTGTCCAAAGAAACCTGT GTTCCCTCCAACGCTGGGCA 
CD36 AGGACTTTCCTGCAGAATACCA ACAAGCTCTGGTTCTTATTCACA 
PDK4 TGGTCCAAGATGCCTTTGAGT GTTGCCCGCATTGCATTCTT 
CPT1 GACAATACCTCGGAGCCTCA AATAGGCCTGACGACACCTG 
GAPDH AAGACCTTGGGCTGGGACTG TGGCTCGGCTGGCGAC 
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rabbit (7074) from Cell Signaling Technologies) for 1 h at room temperature. Proteins were 
detected via chemiluminescence (Millipore, Watford, UK) and quantified by densitometry as 
outlined in section 3.4.5. 
4.3.11 Statistical analysis 
All statistical analyses were performed using Statistical Package for the Social Sciences (SPSS 
Version 24). Comparison of average physiological responses and exercise capacity were ana-
lysed using a one-way repeated-measures general linear model whereas changes in physiolog-
ical and molecular responses between conditions (i.e. muscle glycogen, mRNA expression 
and activity of signalling molecules) were analysed using a two-way repeated measures gen-
eral linear model, where the within factors were time and condition. Here, the post-exercise 
sampling point in the L-CHO trial was also used as the work-matched sampling point as this 
corresponded to the same sampling point and allowed for comparison between trials. Where 
a significant main effect was observed, pairwise comparisons were analysed according to Bon-
ferroni post-hoc tests in order to locate specific differences. All data in text, figures and tables 
are presented as means ± SD with P values ≤ 0.05 indicating statistical significance.  
 
4.4 Results 
4.4.1 Skeletal muscle glycogen and exercise capacity 
The exercise and nutritional strategy employed was successful in achieving graded levels of 
pre-exercise muscle glycogen (H-CHO; 278 ± 47, M-CHO; 185 ± 62, L-CHO; 88 ± 43 
mmol·kg-1 dw) such that exercise was commenced with three distinct levels of muscle glyco-
gen (P = 0.016) (Figure 2A). Exhaustive exercise significantly reduced (P < 0.001) muscle 
glycogen concentration to comparable levels (<100 mmol·kg-1 dw) with no difference be-
tween conditions (P = 0.11). In accordance with the observed differences in pre-exercise mus-
cle glycogen concentration, total exercise time spent at 80% PPO in the H-CHO trial (44 ± 9 
min) was significantly greater than both M-CHO (36 ± 3 min) (P = 0.037) and L-CHO (18 ± 
6 min) trials (P < 0.001) whilst the M-CHO trial was significantly greater than the L-CHO 
trial (P < 0.001) (Figure 2B). Given the low pre-exercise muscle glycogen concentration of 
subjects in the L-CHO trial, 6 of the 8 subjects were unable to complete the prescribed HIIT 
protocol. As such, exercise capacity data is presented as the total amount of time spent at 80% 
PPO and is inclusive of the exercise performed during the prescribed HIIT protocol and sub-
sequent capacity test and excludes all time spent at rest/recovery.  
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Figure 4. 2. (A) Skeletal muscle glycogen concentration and (B) Exercise capacity at 80% PPO (re-
flective of set work protocol plus time to exhaustion). #P < 0.05, significantly different from pre-exer-
cise, §P < 0.05, significantly different from H-CHO, ‡P < 0.05, significantly different from M-CHO. 
Data is presented as means and individual data points represent individual subjects. 
4.4.2 Physiological and metabolic responses to exercise 
Subject’s average heart rate (Figure 3A) across the HIIT session, when matched for work done 
(H-CHO; 163 ± 16, M-CHO; 167 ± 15, L-CHO; 171 ± 17 beats.min-1) was significantly higher 
in the L-CHO trial compared with H-CHO (P = 0.031) only. Similarly, subject’s average RPE 
(Figure 3B) across the HIIT session (H-CHO; 13 ± 1, M-CHO; 14 ± 1, L-CHO; 16 ± 1 arbi-
trary units) was significantly higher in the L-CHO trial compared with both M-CHO (P = 
0.041) and H-CHO (P = 0.012) trials, respectively. Exhaustive exercise resulted in a signifi-
cant reduction in plasma glucose (P = 0.036), where plasma glucose was significantly lower 
in the L-CHO trial when compared with the H-CHO trial only (P = 0.015) (Figure 3C). Ex-
haustive exercise resulted in a significant increase in plasma lactate (P = 0.001), NEFA (P < 
0.001) and glycerol (P = 0.012) but did not display any significant differences between trials 
(Figures 3D, E and F, respectively). However, when matched for work done, plasma NEFA 
(P = 0.01) and plasma glycerol (P = 0.017) was increased to a significantly greater extent in 
the L-CHO trial when compared with the H-CHO trial only. In addition, subjects in the L-
CHO trial oxidised significantly less CHO (P = 0.048) and greater amounts of lipid (P = 0.004) 
during the HIT exercise when compared with the H-CHO trial only (Figure 3G and H, respec-
tively).  

























































Figure 4. 3. (A) Heart rate, (B) RPE and plasma (C) Glucose, (D) Lactate, (E) NEFA (F) glycerol pre-
exercise, at work-matched time points and post-exercise, (E) Average rate of CHO and (F) lipid oxida-
tion during exercise. #P < 0.05, significantly different from pre-exercise, §P < 0.05, significantly dif-
ferent from H-CHO. Data is presented as mean ± SD (A-D) and individual data points represent indi-










































































































































































4.4.3 Regulation of mitochondrial biogenesis related cell signalling  
Exhaustive exercise induced significant increases in AMPKThr172 phosphorylation (P = 0.017) 
but did not display any significant differences between trials (P = 0.548) (Figure 4A). Simi-
larly, exhaustive exercise induced significant increases in ACCSer79 phosphorylation (P = 
0.005), although phosphorylation was higher in the M-CHO trial when compared with the L-
CHO trial only (P = 0.021) (Figure 4B). When exercise duration was matched to the post-
exercise sampling point in the L-CHO group, the increase in AMPKThr172 phosphorylation re-
mained comparable between groups (P = 0.269) and the increase in ACCSer79 phosphorylation 
still remained higher in the M-CHO trial when compared with the L-CHO trial (P = 0.021). 
In contrast, exhaustive exercise did not induce phosphorylation of p38MAPKThr180/Tyr182 (P = 
0.656) (Figure 4C) or CaMKIIThr286 (P = 0.707) (Figure 4D) (P < 0.05). Representative West-
ern blots are shown in Figure 4E. With regard to exercise induced gene expression, exhaustive 
exercise induced a significant increase in PGC-1α mRNA expression at 3 h post-exercise (P 
= 0.001) but did not display any significant differences between trials (Figure 5A). In contrast, 
p53, Tfam, CPT-1, CD36 and PDK4 mRNA expression (Figures 5B, C, D, E, F, respectively) 












Figure 4. 4. (A) AMPKThr172 phosphorylation, (B) ACCSer79 phosphorylation, (C) p38Thr180/Tyr182 phos-
phorylation, (D) CaMKIIThr286 phosphorylation and (E) representative Western blot images at pre-exer-
cise, work-matched time point and post-exercise. #P < 0.05, significantly different from pre-exercise, *P 
< 0.05, significantly different from L-CHO. Data is presented as means and individual data points rep-

















































































Figure 4. 5. (A) PGC-1α, (B) p53, (C) Tfam, (D) CPT-1, (E) CD36 and (F) PDK4 mRNA expression 
pre- and 3 h post-exercise. #P < 0.05, significantly different from pre-exercise. Data is presented as 
means and individual data points represent individual subjects.  
 
4.5 Discussion 
Using a sleep-low, train-low model, we examined the effects of three distinct levels of pre-
exercise muscle glycogen on exercise capacity and the modulation of selected skeletal muscle 
signalling pathways with putative roles in mitochondrial biogenesis. We provide novel data 
by demonstrating that 1) graded reductions in pre-exercise muscle glycogen of 100 mmol·kg-
1 dw reduce exercise capacity at 80% PPO by ~20-50% and 2) despite significant differences 
in pre-exercise muscle glycogen availability, we observed comparable increases in 
AMPKThr172 phosphorylation and PGC-1α mRNA. In contrast to our hypothesis, these data 
suggest that graded levels of muscle glycogen below 300 mmol·kg-1 dw do not augment skel-
etal muscle cell signalling, a finding that may be related to the fact that commencing exercise 
with <300 mmol·kg-1 dw is already a critical level of absolute glycogen (as suggested by 
Impey et al. (Impey et al., 2018)) that is required to induce a metabolic milieu conducive to 
cell signalling. In relation to the goal of promoting cell signalling, our data therefore suggest 
that reducing pre-exercise glycogen concentrations below 300 mmol·kg-1 dw in recreationally 
trained individuals does not confer any additional benefit within the context of the sleep-low, 
train-low model.  
 
To achieve the intended model of graded glycogen concentrations, we adopted a sleep-low, 
train-low design whereby subjects performed an evening bout of glycogen depleting exercise 



























































































































































the time-course of the sleep-low model. This strategy was effective in achieving graded dif-
ferences in pre-exercise muscle glycogen concentration (278 vs. 185 vs. 88 mmol·kg-1 dw in 
H-CHO, M-CHO and L-CHO, respectively) and represent muscle glycogen resynthesis rates 
(approximately 30 mmol·kg-1 h-1) commonly observed with CHO feeding rates of 1-1.2 g kg-
1 h-1 (Jentjens & Jeukendrup, 2003). A novel aspect of the chosen study design was that we 
employed a sampling point in both the H-CHO and M-CHO trials that was matched to the 
point of exhaustion in the L-CHO trial, thus allowing for the assessment of mitochondrial 
related signalling events at both work-matched and exhaustive exercise time points, whilst 
also allowing for the assessment of exercise capacity. In accordance with differences in mus-
cle glycogen, both NEFA availability and lipid oxidation were greater in the L-CHO trial when 
compared with the H-CHO trial at the work-matched sampling point. However, at the point 
of exhaustion, plasma NEFA and glycerol were comparable between all conditions which is 
likely reflective of the post-exercise muscle glycogen concentrations in all three conditions 
given the well documented effects of muscle glycogen (Arkinstall et al., 2004) on substrate 
utilisation during exercise. 
 
Consistent with the well documented effects of muscle glycogen on exercise capacity 
(Bergström et al., 1967; Hermansen et al., 1967) we observed that even small differences in 
pre-exercise muscle glycogen concentrations (~100 mmol·kg-1 dw) can induce changes in ex-
ercise capacity at 80% PPO of between ~20-50% (8-18 minutes). Whilst we acknowledge that 
the lack of blinding to each experimental condition may have influenced exercise capacity 
(despite subjects receiving no feedback during exercise), it is unclear whether prior knowledge 
of CHO intake alone would enhance exercise performance (Hulston & Jeukendrup, 2009). 
Nonetheless, these data are consistent with previous data (Casey et al., 2000; Areta & 
Hopkins, 2018) that suggest differences in muscle glycogen of 100-120 mmol·kg-1 dw enhance 
exercise capacity at 70% V̇O2max by 5-12 minutes. As such, the 8 minute difference in exercise 
capacity between M-CHO and H-CHO trials is likely more representative of changes in mus-
cle glycogen concentration. Whilst the present data may help to characterise what is consid-
ered a worthwhile change in absolute muscle glycogen concentration in determining exercise 
capacity, it should be acknowledged that these changes should be considered in the context of 
each individual given the interindividual variability between subjects in the present study. 
Furthermore, as the capacity for glycogen storage is enhanced and its utilisation during exer-
cise reduced amongst well-trained populations (Karlsson et al., 1974; Henriksson, 1977; Areta 
& Hopkins, 2018) such small differences in muscle glycogen (as observed within the present 
study) may allow for extended exercise times amongst well-trained individuals.  
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In relation to post-exercise mitochondrial related signalling, it is widely accepted that com-
mencing work-matched exercise protocols with reduced muscle glycogen induces greater 
skeletal muscle signalling (Impey et al., 2018). For example, AMPKThr172 phosphorylation 
(Yeo et al., 2010), AMPK-α2 activity (Wojtaszewski et al., 2003) and nuclear abundance 
(Steinberg et al., 2006) are all augmented when acute exercise is commenced with reduced 
pre-exercise muscle glycogen. In contrast, no enhancement in AMPKThr172 or ACCSer79 phos-
phorylation was observed at our work-matched time point (i.e. following the completion of 
~20 min high-intensity cycling) despite graded reductions in pre-exercise muscle glycogen 
concentrations. This apparent lack of augmented cell signalling may be explained by subjects 
already commencing exercise with pre-exercise glycogen concentrations below 300 mmol·kg-
1 dw, an absolute concentration that was previously suggested to facilitate the enhanced cell 
signalling responses associated with low glycogen availability (Impey et al., 2018). Indeed, 
the range of pre-exercise muscle glycogen concentrations are distinctly lower than previous 
work that report greater skeletal muscle signalling following work-matched exercise proto-
cols. For example, high glycogen trials are commonly commenced with muscle glycogen con-
centrations between 400 and 600 mmol·kg-1 dw (Roepstorff et al., 2005; Bartlett et al., 2013) 
and remain above 300 mmol·kg-1 dw post-exercise (Wojtaszewski et al., 2003; Roepstorff et 
al., 2005; Bartlett et al., 2013). In such instances, these researchers observed attenuated 
(Wojtaszewski et al., 2003) or abolished (Roepstorff et al., 2005; Bartlett et al., 2013) activa-
tion of cell signalling pathways. Interestingly, despite the completion of significantly more 
work in both the M-CHO and H-CHO trials, no further increases in AMPKThr172 phosphory-
lation were observed following exhaustive exercise. Whilst both AMPK activity and ACC 
phosphorylation are known to be regulated by exercise duration (Stephens et al., 2002) these 
responses appear to be closely linked to changes in muscle glycogen concentrations (Stephens 
et al., 2002; Fiorenza et al., 2018). In this way, the lack of augmented signalling in response 
to further exercise in the present study may be explained by the relatively small changes in 
muscle glycogen from the work-matched time point to exhaustion.  
 
In contrast to AMPK and ACC, we did not observe any change in the phosphorylation status 
of p38MAPKThr180/Tyr182 or CAMKII Thr286 either in response to exercise or muscle glycogen 
concentration, though we note the large inter-individual variability and recommend the use of 
larger sample sizes in future. These data are in agreement with previous work that demonstrate 
no change in p38MAPK or CAMKII phosphorylation using a variety of train-low methodolo-
gies, including sleep-low, train-low (Bartlett et al., 2013; Lane et al., 2015), twice-per day 
training (Yeo et al., 2010) and fasted training (Stocks et al., 2019). Whilst augmented 
p38MAPK phosphorylation has been observed when pre-exercise muscle glycogen is reduced 
(163 vs. 375 mmol·kg-1 dw), this is only apparent within the nucleus and not the cytoplasm 
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(Chan et al., 2004). As such, further work should utilise cellular fractionation methodologies 
in order to investigate the cellular localisation of such exercise-inducible kinases.  
 
Despite the observed augmented mRNA expression of PGC-1α within the post-exercise re-
covery period, exhaustive exercise did not augment the mRNA expression of other mitochon-
drial (p53 or Tfam) or substrate utilization related genes (PDK4, CPT1 or CD36). Although 
the time-course of mRNA expression for these genes is not well understood, the lack of change 
in mRNA expression in the present study may be explained by the present chosen sampling 
points in accordance with the sleep-low, train-low exercise model. Indeed, given that the pre-
exercise biopsy was sampled within ~14 h of glycogen depleting exercise, it is difficult to 
determine whether mRNA expression was already elevated at pre-exercise. For instance, time-
course studies have revealed that the mRNA expression of Tfam (Perry et al., 2010), PDK4 
and CPT1 (Pilegaard et al., 2005) is enhanced for up to 24 h post-exercise which coincides 
with the present pre-exercise sampling time point (~14 h between the two exercise bouts). 
However, given the time-course of phosphorylation of our chosen protein targets (1-3 h) 
(Cochran et al., 2010) it is highly unlikely that any of these proteins would be phosphorylated 
at pre-exercise as a result of the previous evenings glycogen depletion exercise.  
 
Practically, these data suggest that in the context of the sleep-low, train-low model, where 
muscle glycogen is depleted to very low levels (~100 mmol·kg-1 dw), insufficient time is 
available to restore muscle glycogen to normal levels. As such, individuals undertaking sleep-
low, train-low models, that reduces muscle glycogen to very low levels, should consume CHO 
in accordance with the energetic requirements of the subsequent morning session, given that 
withholding CHO intake overnight appears to confer no additional benefit in relation to cell 
signalling but impairs exercise capacity. In contrast, it appears that when muscle glycogen is 
not depleted to such low levels (> 300 mmol·kg-1 dw), withholding CHO intake in the post-
exercise period may prolong the acute cell signalling and gene expression responses 
(Pilegaard et al., 2005; Lane et al., 2015). With this in mind, it should be noted that driving 
glycogen depletion below 300 mmol·kg-1 dw would likely be more difficult and require con-
siderably more work in well-trained individuals (Gejl et al., 2017) given they display an en-
hanced capacity for glycogen storage and reduced utilisation during exercise (Karlsson et al., 
1974; Henriksson, 1977; Coyle et al., 1988; Areta & Hopkins, 2018). In practice, it appears 
that careful consideration of the individuals training status and the metabolic demands of each 
training session is required to ensure appropriate day-to-day periodisation of CHO in order to 
ensure absolute training intensity is not compromised whilst also creating a metabolic milieu 
conducive to facilitating the metabolic adaptations associated with ‘train low’. 
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In summary, we provide novel data by demonstrating that graded reductions in pre-exercise 
muscle glycogen below 300 mmol·kg-1 dw (as achieved using a sleep-low, train-low model) 
impairs exercise capacity but does not augment skeletal muscle cell signalling responses. Prac-
tically, these data suggest that, within the context of the sleep-low, train-low model (when 
muscle glycogen is depleted to very low levels) overnight CHO restriction is not required to 
augment skeletal muscle cell signalling, and thus, CHO should be consumed in accordance 
with the metabolic demands of the subsequent morning session. Future studies should inves-
tigate step-wise reductions in pre-exercise muscle glycogen, within a wider range (i.e. 100-
600 mmol·kg-1 dw), in order to investigate the existence of a potential glycogen threshold and 


























Graded reductions in pre-exercise skeletal muscle glycogen 
concentration does not augment exercise-induced nuclear 
AMPK and PGC-1α protein content 
 
 
This work was presented at the European College of Sport Science (ECSS) conference, Dub-



















We examined the effects of graded muscle glycogen on the subcellular location of AMPK and 
PGC-1α protein content and mRNA expression of genes associated with the regulation of 
mitochondrial biogenesis and substrate utilisation in human skeletal muscle. In a repeated 
measures design, eight trained male cyclists completed acute high-intensity interval (HIT) 
cycling (8 x 5 min at 80% peak power output) with graded concentrations of pre-exercise 
muscle glycogen. Following initial glycogen depleting exercise, subjects ingested  2 g kg-1 (L-
CHO), 6 g kg-1 (M-CHO) or 14 g kg-1 (H-CHO) of carbohydrate during a 36 h period, such 
that exercise was commenced with graded (P < 0.05) muscle glycogen concentrations (H-
CHO; 531 ± 83, M-CHO; 332 ± 88, L-CHO; 208 ± 79 mmol·kg-1 dw). Exercise depleted 
muscle glycogen to < 300  mmol·kg-1 dw in all trials (H-CHO; 270 ± 88, M-CHO; 173 ± 74, 
L-CHO; 100 ± 42 mmol·kg-1 dw) and induced comparable increases in nuclear AMPK protein 
content (~2 fold) and PGC-1α (~5 fold), p53 (~1.5 fold) and CPT-1 (~2 fold) mRNA between 
trials (all P < 0.05). The magnitude of increase in PGC-1α mRNA was also positively corre-
lated with post-exercise glycogen concentration (P < 0.05). In contrast, exercise nor carbohy-
drate availability affected the subcellular location of PGC-1α protein or PPAR, SCO2, SIRT1, 
DRP1, MFN2 or CD36 mRNA. Using a sleep-low, train-low model with a high-intensity en-
durance exercise stimulus, we conclude that pre-exercise muscle glycogen does not modulate 



















The concept of deliberately commencing endurance exercise with reduced muscle glycogen 
(i.e. the train-low paradigm (Burke et al., 2018)) is now recognised as a potent nutritional 
strategy that is able to modulate cell signalling (Wojtaszewski et al., 2003; Yeo et al., 2010; 
Bartlett et al., 2013) and transcriptional responses (Pilegaard et al., 2002; Bartlett et al., 2013; 
Psilander et al., 2013) to acute exercise. Furthermore, repeated bouts of train-low exercise can 
subsequently augment many hallmark muscle adaptations inherent to the endurance pheno-
type. Indeed, the strategic periodisation of dietary CHO intake to facilitate the commencement 
of exercise with low muscle glycogen  during 3-10 weeks of training enhances mitochondrial 
enzyme activity and protein content (Hansen et al., 2005; Yeo et al., 2008; Morton et al., 
2009), whole body and intra-muscular lipid metabolism (Hulston et al., 2010) and, in some 
instances, improves exercise capacity (Hansen et al., 2005) and performance (Marquet et al., 
2016a, 2016b). Whilst not all studies demonstrate clear positive effects of such train-low mod-
els on skeletal muscle adaptation and performance (Burke et al., 2017; Gejl et al., 2017; Riis 
et al., 2019) the train-low paradigm has nonetheless gained increased recognition amongst 
athletic populations (Stellingwerff, 2012). 
 
Most notably, skeletal muscle glycogen appears to exert its regulatory effects primarily 
through the AMPK-PGC-1α signalling axis, whereby AMPKα2 activity (Wojtaszewski et al., 
2003), phosphorylation (Yeo et al., 2010) and nuclear abundance (Steinberg et al., 2006) are 
all augmented under conditions of low muscle glycogen. These effects may partly be mediated 
through the glycogen binding domain present on the β sub-unit of AMPK (McBride et al., 
2009) which allows for the physical tethering of AMPK to the glycogen granule and may 
subsequently inhibit its translocation to the nucleus and its activation of transcriptional regu-
latory proteins such as PGC-1α. In this regard, the subcellular localisation of AMPK may play 
an important role in the signal transduction pathway regulating train-low responses, whereby 
its translocation to the nucleus could allow for interaction with transcriptional regulatory pro-
teins, such as PGC-1α, to control gene expression (McGee et al., 2003). Indeed, endurance 
exercise also appears to increase the nuclear abundance of PGC-1α (Little et al., 2011), via 
AMPK phosphorylation (Little et al., 2010), and may constitute the initial phase of exercise-
induced adaptive responses.  
 
Despite the potential regulatory role of muscle glycogen availability on exercise-induced cell 
signalling, the absolute concentrations of muscle glycogen required to facilitate such re-
sponses is currently unknown. Recent suggestions propose the potential existence of a muscle 
glycogen threshold, whereby the augmented signalling and transcriptional responses associ-
ated with train-low models are particularly apparent when absolute pre-exercise muscle 
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glycogen concentrations are ≤300 mmol·kg-1 dw (Impey et al., 2018). However, using a sleep-
low, train-low model, chapter 4 of this thesis demonstrated no additional benefit of stepwise 
reductions in pre-exercise muscle glycogen concentrations below 300 mmol·kg-1 dw (100-300 
mmol·kg-1 dw) on exercise-induced cell signalling or gene expression following exhaustive 
exercise. This apparent lack of augmented response may be explained by subjects commenc-
ing exercise with pre-exercise glycogen concentrations below 300 mmol·kg-1 dw and the use 
of exhaustive exercise which reduced post-exercise muscle glycogen concentrations below 
100 mmol·kg-1 dw in all conditions. Nonetheless, whilst reducing pre-exercise muscle glyco-
gen concentrations below 300 mmol·kg-1 dw appears to confer no additional benefit to mito-
chondrial related signalling, it still remains unclear whether concentrations of 300 mmol·kg-1 
dw are indicative of a train-low session. As such, in order to elucidate the potential existence 
of a muscle glycogen threshold and allow for a better definition of its potential upper and 
lower limits, investigations using a wider range of pre-exercise muscle glycogen concentra-
tions (i.e. 100-600 mmol·kg-1 dw) and work-matched, non-exhaustive exercise are now re-
quired. 
 
With this in mind, the aim of the present study was to examine the effects of wide-ranging 
graded glycogen concentrations on the modulation of AMPK-PGC-1α signalling and the tran-
scription of genes with putative roles in the regulation of mitochondrial biogenesis. Our model 
of graded pre-exercise muscle glycogen concentrations was achieved through a modified 
sleep-low, train-low model previously used within our laboratory (Impey et al., 2016), provid-
ing an additional day between exercise sessions in order to allow sufficient time for the resto-
ration of muscle glycogen between exercise bouts and to subsequently achieve our intended 
pre-exercise muscle glycogen concentrations. It was hypothesised that stepwise reductions in 




Eight endurance-trained amateur male cyclists (mean ± SD: age, 30 ± 10 years; body mass 
72.6 ± 9.4 kg; height, 177.0 ± 8.9 cm) took part in this study. Mean V̇O2peak and peak power 
output (PPO) for the cohort were 60.4 ± 7.7 mL kg-1 min-1 and 338 ± 45 W, respectively. None 
of the subjects had any history of musculoskeletal or neurological disease nor were they under 
any pharmacological treatment during the course of the testing period. All subjects provided 
written informed consent and all procedures conformed to the standards set by the Declaration 
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of Helsinki (2008). The study was approved by the local Research Ethics Committee of Liv-
erpool John Moores University.  
5.3.2 Experimental Design  
In a repeated-measures design, with each experimental trial separated by a minimum of 7 days, 
subjects undertook an evening bout of glycogen depletion exercise followed by the consump-
tion of graded quantities of CHO (L-CHO: 2 g kg-1, M-CHO: 6 g kg-1, H-CHO: 14g kg-1) 
across a ~36 h period so as to manipulate pre-exercise muscle glycogen prior to a bout of high-
intensity interval exercise (8 x 5 min at 80% PPO) with all trials performed in a randomised 
and counterbalanced order. Skeletal muscle biopsies were obtained from the vastus lateralis 
immediately before, post- and 3 h post-exercise. An overview of the experimental protocol is 
shown in Figure 5.1. 
 
 
Figure 5. 1. Schematic overview of the experimental protocol. Subjects completed an evening bout of 
glycogen depleting cycling exercise and, upon completion, received three graded quantities of CHO in 
order to manipulate pre-exercise muscle glycogen across 36 h. Following an overnight fast, subjects 
completed a bout of high-intensity interval cycling. Muscle biopsies were obtained pre-exercise, post-
exercise and 3 h post-exercise.  
5.3.3 Assessment of peak oxygen uptake 
At least 7 days prior to experimental trials, all subjects were assessed for peak oxygen con-
sumption (V̇O2peak) and peak power output (PPO) on an electronically braked cycle ergometer 
(Lode Excalibur Sport, Groningen, Netherlands). Following the completion of a 10 min warm-
up at 75 W, the test began at 100 W and consisted of 2 min stages with 30 W increments in 
resistance until volitional exhaustion. V̇O2peak was stated as being achieved by the following 
end-point criteria: (1) heart rate within 10 beats min-1 of age-predicted maximum, (2) 
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respiratory exchange ratio > 1.1 and (3) plateau of oxygen consumption despite increased 
workload. Peak aerobic power was taken as the final stage completed during the incremental 
test.  
5.3.4 Overview of sleep-low, train-low model 
Phase 1: Glycogen depletion exercise 
In the 24 h preceding glycogen depleting exercise, subjects recorded all food and drink con-
sumed and were asked to replicate this for all subsequent trials and also refrained from alcohol 
and vigorous physical exercise for the previous 48 h. On the day of glycogen depleting exer-
cise, subjects reported to the laboratory at approximately 5 pm to perform a bout of intermit-
tent glycogen depleting cycling, as previously completed in our laboratory (Taylor et al., 2013; 
Impey et al., 2016) and detailed within section 4.3.4. The pattern of exercise and total time to 
exhaustion in the subject’s initial trial was recorded and replicated in all subsequent trials. 
Subjects were permitted to consume water ad libitum during exercise, with the pattern of in-
gestion replicated during subsequent trials.  
Phase 2: Carbohydrate re-feeding strategy 
To facilitate the goal of achieving graded differences in muscle glycogen concentrations be-
tween trials, subjects were provided with varying amounts of carbohydrate during the ~36 h 
recovery period prior to the subsequent bout of high-intensity interval exercise. Within the 
immediate ~4 h recovery period following glycogen depleting exercise, subjects in the H-
CHO trial were provided with CHO at a rate of 1 g kg-1 h-1 for 3 h from a mixture of CHO 
drinks and gels (Science in Sport, Nelson UK) followed by a high carbohydrate meal provid-
ing a further 1 g kg-1 CHO. Subjects in the M-CHO trial consumed 1 g kg-1 CHO immediately 
following exercise whilst subjects in the L-CHO trial refrained from CHO intake throughout 
the remainder of the evening. Across all trials, subjects also consumed 30 g of whey protein 
isolate (Science in Sport, Nelson, UK) mixed with 500 ml of water immediately following the 
cessation of glycogen depleting exercise to reflect real-world practice as per current nutritional 
guidelines (Thomas et al., 2018). Over the course of the following day, subjects consumed 
either 10 g kg-1 (H-CHO), 5 g kg-1 (M-CHO) or 2 g kg-1 (L-CHO) carbohydrate (i.e. between 
9 am and 9 pm). In this way, total CHO intakes in the H-CHO, M-CHO and L-CHO trials 
equated to 14, 6 and 2 g kg-1 CHO, respectively, over the course of the ~ 36 h following gly-
cogen depletion. In all trials, subjects also consumed 2 g kg-1 protein and 1 g kg-1 fat with fluid 




Phase 3: High intensity interval cycling  
Subjects arrived at the laboratory between 8-9 am, in a fasted state, where a venous blood 
sample was collected from the antecubital vein and a muscle biopsy taken from the vastus 
lateralis. Subjects then completed the high-intensity interval (HIIT) cycling protocol, consist-
ing of 8 x 5 min intervals at 80% PPO, interspersed with 1 min rest. During exercise, heart 
rate (HR) was continuously measured and the final HR for each 5 min interval was recorded, 
whilst ratings of perceived exertion (RPE) were recorded upon completion of each interval. 
Expired gas was collected via a mouthpiece connected to an online gas analysis system (CPX 
Ultima, Medgraphics, Minnesota, US) for the final 2.5 min of every alternative interval (i.e. 
intervals 2, 4, 6 and 8) and substrate utilisation was assessed using the equations of Jeukendrup 
& Wallis (Jeukendrup & Wallis, 2005) given the validity of indirect calorimetry for the as-
sessment of substrate utilisation at exercise intensities up to 80-85% V̇O2max (Romijn et al., 
1992). Following the completion of the exercise capacity test and collection of the post-exer-
cise biopsy, subjects were fed 30 g whey protein (Science in Sport, Nelson, UK) mixed with 
500 ml of water. 
5.3.5 Blood analysis 
Venous blood samples were collected in vacutainers containing K2EDTA, lithium heparin or 
serum separation tubes and stored on ice or at room temperature until centrifugation at 1500 
g for 15 min at 4oC. Samples were collected immediately prior to and after exercise. Plasma 
was aliquoted and stored at -80oC until analysis. Samples were later analysed for plasma glu-
cose, lactate, non-esterified fatty acids (NEFA) and glycerol using commercially available 
enzymatic spectrophotometric assays (RX Daytona Analyser, Randox, UK) as per manufac-
turer instructions. 
5.3.6 Muscle biopsies 
Skeletal muscle biopsies (~60 mg) were obtained from the vastus lateralis immediately prior 
to exercise, following completion of the exercise bout and 3 h post exercise. Muscle biopsies 
were obtained from separate incision sites 2-3 cm apart using a Bard Monopty Disposable 
Core Biopsy Instrument (12 gauge x 10 cm length, Bard Biopsy Systems, Tempe, AZ, USA) 
under local anaesthesia (0.5% Marcaine) and immediately frozen in liquid nitrogen and stored 
at -80oC for later analysis.  
5.3.7 Muscle glycogen concentration  
Muscle glycogen concentrations were determined according to the acid hydrolysis method 
described by Van Loon et al (van Loon et al., 2000). Approximately 2-5 mg of freeze-dried 
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tissue was powdered, dissected of all visible blood and connective tissue and subsequently 
hydrolysed by incubation in 500 μl of 1 M HCl for 3 h at 95oC. After cooling to room temper-
ature, samples were neutralised by the addition of 250 μl 0.12 mol L-1 Tris/2.1 mol L-1 KOH 
saturated with KCl. Following centrifugation, 200 μl of supernatant was analysed in duplicate 
for glucose concentration according to the hexokinase method using a commercially available 
kit (GLUC-HK; Randox Laboratories, Antrim, UK). Glycogen concentration is expressed as 
mmol·kg-1 dry weight and intra-assay coefficients of variation were <5%. 
5.3.8 RNA isolation and analysis 
Muscle samples (~20 mg) were homogenised in 1 ml TRIzol reagent (Thermo Fisher Scien-
tific, UK) and total RNA isolated according to the manufacturer’s guidelines. Concentrations 
and purity of RNA were assessed by UV spectroscopy at optical densities (OD’s) of 260 and 
280 nm, using a Nanodrop 3000 (Fisher, Rosklide, Denmark) with an average 260/280 ratio 
of 1.93 ± 0.08. A quantity of 50 ng RNA was used for each 20 μl PCR reaction. 
5.3.9 Reverse transcriptase quantitative Real-Time Polymerase Chain Reaction (rt-qRT-
PCR) 
RT-PCR amplifications were performed using QuantiFastTM SYBR® Green RT-PCR one-step 
kit on a Rotogene 300Q (Qiagen, Crawley, UK) supported by Rotogene software (Hercules, 
CA). RT-qTR-PCR was performed as follows: hold 50oC for 10 min (reverse transcrip-
tion/cDNA synthesis), 95oC for 5 min (transcriptase inactivation and initial denaturation step), 
and PCR steps of 40 cycles; 95oC for 10 sec (denaturation), 60oC for 30 sec (annealing and 
extension). Upon completion, dissociation/melting curve analyses were performed to reveal 
and exclude nonspecific amplification or primer-dimer issues (all melt analysis in this study 
presented single reproducible peaks for each target gene suggesting amplification of a single 
product). Following initial screening of suitable reference genes, β-2 microglobulin (B2M) 
showed the most stable Ct values across all RT-PCR runs and subjects, regardless of experi-
mental condition (25.3 ± 1.0) and was therefore selected as the reference gene in all RT-PCR 
assays. The average PCR efficiency for all RT-PCR runs (90 ± 2%) was similar for all genes 
across all time points and experimental conditions. As such, the relative gene expression levels 
were calculated using the comparative Ct (ΔΔCt) equation (Schmittgen & Livak, 2008) where 
the relative expression was calculated as 2-ΔΔct where Ct represents the threshold cycle. mRNA 
expression for all target genes was calculated relative to the reference gene (B2M) within the 






Table 5. 1. Primers used for real-time RT-PCR  
 
5.3.10 Subcellular fractionation 
Isolation of nuclear and cytosolic fractions was performed using the method described by Di-
mauro et al (2012) as outlined in section 3.4.5. Protein concentrations were determined for 
both fractions via BCA assay (Thermo Fisher Scientific, UK) and validation of the enrichment 
of nuclear and cytosolic fractions was determined by examination of histone 3 (CST: 9715) 
and lactate dehydrogenase (CST: 2012) ‘house-keeper’ protein markers, respectively, via 
SDS-PAGE and western blotting (Figure 5.4B)  
5.3.11 SDS page & Western blotting 
Following the determination of protein concentration within each fraction, samples were re-
suspended in 4X Laemlli buffer, boiled for 5 min at 95°C and separated by SDS-PAGE using 
12% Mini-Protean TGX Stain-Free Gels (Bio-Rad). After electrophoresis, gels were activated 
according to manufacturer instructions and semi-dry transferred to nitrocellulose membranes. 
Following transfer, a stain-free image was obtained for total protein loading normalisation. 
Membranes were subsequently blocked in TBS-Tween containing 5% non-fat milk for 1 h 
and incubated overnight in primary antibodies (AMPKα (CST: 2603) and PGC-1α (Calbio-
chem: st-1202) before incubation in relevant secondary antibody (anti-rabbit (CST: 7074) for 
1 h at room temperature the following morning. Proteins were detected via chemilumines-
cence (Thermo Fisher Scientific, UK) and quantified by densitometry. The volume density of 
each target band was normalised to the total amount of protein loaded into each lane using 
Stain-Free technology (Figure 5.4A).  
5.3.12 Statistical analysis 
All statistical analyses were performed using Statistical Package for the Social Sciences (SPSS 
Version 24). Comparison of average physiological responses (e.g. total substrate oxidation) 












were analysed using a one-way repeated-measures general linear model whereas changes in 
physiological and molecular responses between conditions (i.e. muscle glycogen, mRNA ex-
pression and activity of signalling molecules) were analysed using a two-way repeated 
measures general linear model, where the within factors were time and condition. Where a 
significant main effect was observed, pairwise comparisons were analysed according to Bon-
ferroni post-hoc tests in order to locate specific differences. All data in text, figures and tables 
are presented as means ± SD with P values ≤ 0.05 indicating statistical significance. 
 
5.4 Results 
5.4.1 Skeletal muscle glycogen 
The exercise and nutritional strategy employed was successful in achieving graded levels of 
pre-exercise muscle glycogen (H-CHO; 531 ± 83, M-CHO; 332 ± 88, L-CHO; 208 ± 79 
mmol·kg-1 dw) such that exercise was commenced with three distinct levels of muscle glyco-
gen (P < 0.001) (Figure 5.2A). Exercise significantly reduced (P < 0.001) muscle glycogen 
concentrations, with post-exercise muscle glycogen concentrations (H-CHO; 270 ± 88, M-
CHO; 173 ± 74, L-CHO; 100 ± 42 mmol·kg-1 dw) remaining higher in the H-CHO trial when 
compared with the L-CHO trial only (P = 0.013). Furthermore, muscle glycogen utilisation 
during exercise was significantly higher in the H-CHO trial (260 ± 90 mmol·kg-1 dw) when 
compared with the L-CHO trial (107 ± 55 mmol·kg-1 dw) only (P = 0.011) with no significant 
differences observed between M-CHO and either H-CHO or L-CHO trials (P > 0.05).  
 
 
Figure 5. 2. (A) Skeletal muscle glycogen concentration and (B) utilisation during exercise. #P < 0.05, 
significantly different from pre-exercise, §P < 0.05, significantly different from H-CHO, ‡P < 0.05, 

























































5.4.2 Physiological and metabolic responses to exercise 
Subject’s average heart rate (Figure 5.3A) (H-CHO; 173 ± 9, M-CHO; 174 ± 8, L-CHO; 176 
± 7 beats.min-1) and RPE (Figure 5.3B) (H-CHO; 15 ± 1, M-CHO; 16 ± 2, L-CHO; 16 ± 2 
arbitrary units) across the HIIT session was similar between trials (P > 0.05). Despite remain-
ing unchanged following HIIT exercise, plasma glucose was significantly lower in the L-CHO 
when compared with the H-CHO trial only (P = 0.039). In contrast, the HIIT session resulted 
in a significant increase in plasma lactate (P = 0.012), NEFA (P = 0.002) and glycerol (P < 
0.001). Furthermore, plasma NEFA was significantly elevated in the L-CHO trial when com-
pared with the H-CHO trial only (P = 0.003) whilst plasma glycerol was significantly elevated 
when compared with both H-CHO (P = 0.003) and M-CHO trials (P = 0.002) (Figures 5.3 C-
F respectively). Similarly, subjects in the L-CHO trial achieved significantly lower rates of 
CHO oxidation and greater rates of lipid oxidation when compared with both M-CHO and H-
CHO trials (P < 0.005) although no significant differences were observed between M-CHO 




Figure 5. 3. (A) Heart rate, (B) RPE and plasma (C) Glucose, (D) Lactate, (E) NEFA (F) glycerol pre- 
and post-exercise, (E) Average rate of CHO and (F) lipid oxidation during exercise. #P < 0.05, signifi-
cantly different from pre-exercise, §P < 0.05, significantly different from H-CHO, ‡P < 0.05, signifi-
cantly different from M-CHO. Data is presented as mean ± SD  
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5.4.3 Regulation of mitochondrial biogenesis related cell signalling  
HIIT exercise induced an increase in the content of AMPK protein (P = 0.025) within the 
nucleus with no significant change within the cytosol (P = 0.20). Despite this, there was no 
significant effect of pre-exercise muscle glycogen concentrations on AMPK localisation (P = 
0.207). In contrast, HIIT exercise did not induce any change in the content of PGC-1α protein 
in either nuclear (P = 0.31) or cytosolic (P = 0.36) fractions (Figure 5.5 B-E). With regard to 
exercise induced gene expression, HIIT exercise induced a significant increase in PGC-1α, 
p53 and CPT-1 mRNA expression at 3 h post-exercise (P < 0.05) but did not display any 
significant differences between trials (Figure 5.5 A, B, I). However, PPAR, SCO2, SIRT1, 
DRP1, MFN2 and CD36 mRNA expression (Figures 5.5C, D, E, F, G, H respectively) were 
unaffected by either glycogen availability or the HIIT exercise protocol (P > 0.05). 
 
     
 
Figure 5. 4. (A) Whole lane stain-free imaging for both nuclear and cytosolic fractions and (B) his-
tone H3 and LDHA used as indicators of nuclear and cytosolic enrichment, respectively.  
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Figure 5. 5. (A) Representative Western blot images in nuclear and cytosolic fractions (B) nuclear 
AMPK, (C) cytosolic AMPK, (D) nuclear PGC-1α, (E) cytosolic PGC-1α, (F) nuclear/cytosolic AMPK 











































































































































Figure 5. 6. (A) PGC-1α, (B) p53, (C) PPAR, (D) SCO2, (E) SIRT1, (F) DRP1, (G) MFN2, (H) CD36 
and (I) CPT-1 mRNA expression pre- and 3 h post-exercise. #P < 0.05, significantly different from pre-
exercise. Data is presented as means ± SD 
 
5.5 Discussion 
The aim of the present study was to test the hypothesis that graded pre-exercise muscle gly-
cogen concentrations modulate the exercise-induced nuclear abundance of AMPK and PGC-
1α protein content as well as the transcription of genes with putative roles in the regulation of 
mitochondrial biogenesis. Using trained male cyclists, we demonstrate that commencing an 
acute bout of work-matched and non-exhaustive HIT cycling with graded pre-exercise muscle 
glycogen (within a range of 600-200 mmol·kg-1 dw) does not modulate such early signalling 












































































































































































































































that the metabolic stress of HIT exercise may override any potential effect of pre-exercise 
muscle glycogen and induce negligible modulatory effects on skeletal muscle that is already 
subjected to the local metabolic challenge of high-intensity exercise.  
 
Based on the data obtained in chapter 4 of this thesis, we adopted a modified sleep-low, train-
low design, creating an extended recovery period following glycogen depleting exercise, in 
which larger amounts of CHO could be consumed, allowing for the investigation of a wider 
range of pre-exercise muscle glycogen concentrations (i.e. > 300 mmol·kg-1 dw). This strategy 
was effective in achieving graded differences in pre-exercise muscle glycogen concentration 
(H-CHO; 531 ± 83, M-CHO; 332 ± 88, L-CHO; 208 ± 79 mmol·kg-1 dw) and represent high, 
normal and low resting muscle glycogen concentrations of trained individuals (Areta & 
Hopkins, 2018). Whilst we acknowledge that the manipulation of CHO intake also results in 
considerable differences in total energy intake, such short-term differences in energy intake 
do not appear to influence the molecular response to exercise (Hammond et al., 2019). In 
contrast to chapter 4, we also employed a work-matched, non-exhaustive exercise protocol to 
allow for a matched comparison of metabolic and signalling responses and to prevent the de-
pletion of muscle glycogen to similarly low levels across all trials. Interestingly, despite dif-
ferences in pre-exercise muscle glycogen, subjects RPE was similar between trials, thus sug-
gesting that the previously reported reductions in self-selected power output with low muscle 
glycogen may not be associated with changes in perception of effort (Yeo et al., 2008).  
 
In relation to post-exercise signalling, the exercise-induced increase in nuclear AMPK protein 
content was not augmented in response to stepwise reductions in pre-exercise muscle glyco-
gen concentrations and is in contrast to previous reports of enhanced nuclear AMPK content 
when exercise is commenced with low pre-exercise muscle glycogen (Steinberg et al., 2006). 
Given that nuclear AMPK translocation in response to exercise may be partly regulated by 
absolute glycogen concentrations (due to the physical tethering of AMPK to the glycogen 
granule; Steinberg et al., 2006) the magnitude of muscle glycogen utilisation during exercise 
may also be important for AMPK’s disassociation from the granule and subsequent translo-
cation to other subcellular regions. With this in mind, the similar rates of glycogen utilisation 
(~50%) between trials, leading to absolute post-exercise glycogen concentrations < 300 
mmol·kg-1 dw, may explain the comparable increases in nuclear AMPK content across all 
trials and subsequent discrepancies with previous work. Whilst the absolute concentrations of 
muscle glycogen required to facilitate the subcellular shuttling of AMPK are relatively un-
known, post-exercise glycogen concentrations in the present study are markedly higher (H-
CHO; 270 ± 88, M-CHO; 173 ± 74, L-CHO; 100 ± 42 mmol·kg-1 dw) when compared with 
that of the low glycogen trial in previous work (17 ± 6 mmol·kg-1 dw) (Steinberg et al., 2006). 
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In fact, post-exercise muscle glycogen concentrations in the present L-CHO trial are compa-
rable to the control condition (111 ± 35 mmol·kg-1 dw) of previous work (Steinberg et al., 
2006) and may suggest that the augmentation of nuclear AMPK may only occur at extremely 
low absolute glycogen concentrations normally associated with exhaustion. 
 
Irrespective of muscle glycogen, the use of high-intensity endurance exercise within the pre-
sent study is known to induce significantly greater metabolic stress and augments the phos-
phorylation and activation of AMPK when compared with low-intensity exercise models 
(Wojtaszewski et al., 2000; Egan et al., 2010; Combes et al., 2015; Fiorenza et al., 2018). 
Given that such metabolic fluctuations ultimately regulate signalling kinase activity, the com-
pletion of high-intensity endurance exercise may provide a sufficient local metabolic chal-
lenge to skeletal muscle whereby reducing pre-exercise muscle glycogen induces negligible 
modulatory effects on skeletal muscle. Whilst augmented signalling in response to high-in-
tensity exercise commenced with low muscle glycogen has been previously observed (Yeo et 
al., 2010), recent data suggest this may be explained by the metabolic stress of training twice-
per-day, as opposed to low pre-exercise glycogen concentrations per se (Andrade-Souza et 
al., 2019). Furthermore, as the exercise-induced activation of AMPK is reduced in trained 
individuals (McConell et al., 2020), the use of trained cyclists within the present study may 
offer further explanation for the discrepancy in results when compared with those of Steinberg 
et al. (2006).   
 
Despite exercise-induced increases in nuclear AMPK we failed to observe concomitant in-
creases in nuclear PGC-1α. These data are in contrast to most (Little et al., 2010, 2011; 
Andrade-Souza et al., 2019) but not all (Tachtsis et al., 2016) reports of enhanced nuclear 
PGC-1α in response to acute endurance exercise. Our data are, however, in support of previous 
findings that demonstrate exercise-induced increases in nuclear PGC-1α is unaffected by mus-
cle glycogen availability (Andrade-Souza et al., 2019). The lack of change in nuclear PGC-
1α in the present study may be explained by our chosen sampling time point, given that, in 
some cases, increases in nuclear PGC-1α have only been observed 3 h post-exercise (Little et 
al., 2011). Thus, it is plausible that the immediate post-exercise increase in nuclear AMPK 
may result in a temporal and coordinated increase in nuclear PGC-1α later in the recovery 
period, given the requirement for AMPK in order to achieve full activation of PGC-1a and 
thus, its nuclear translocation (Safdar et al., 2011). Alternatively, it is possible that post-exer-
cise increases in nuclear PGC-1α may represent increased protein stability, and not transloca-
tion from the cytoplasm per se, a response that appears to be linked with increased p38 MAPK 
activity (Puigserver et al., 2001). Although not measured in the present study, p38 MAPK 
phosphorylation does not appear to be affected by either glycogen availability or a similar 
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bout of high-intensity interval exercise (Yeo et al., 2010) and may explain the lack of nuclear 
PGC-1α observed post-exercise. Nonetheless, as PGC-1α has been shown to activate its own 
promoter through a feed-forward loop (Handschin et al., 2003), the lack of nuclear PGC-1α 
following exercise is somewhat surprising given the exercise-induced increase in PGC-1α 
mRNA. When taken together, these data suggest a potential disconnect between exercise-in-
duced nuclear PGC-1α protein and PGC-1α mRNA expression (Granata et al., 2017) and point 
towards the involvement of other proteins involved in the signal transduction pathway.  
 
In relation to exercise-induced gene expression, we demonstrate that graded reductions in pre-
exercise muscle glycogen across a wide range of concentrations (100 - 600 mmol·kg-1 dw) do 
not augment the expression of genes with putative roles in mitochondrial biogenesis and sub-
strate utilisation, providing further support to the findings from Chapter 4. Although in con-
trast to the previously reported effects of muscle glycogen concentrations on the regulation of 
gene expression (Pilegaard et al., 2002, 2005; Bartlett et al., 2013; Psilander et al., 2013), 
these data may be explained by the attainment of post-exercise muscle glycogen concentra-
tions (i.e. < 300 mmol·kg-1 dw) associated with augmented gene expression responses to ex-
ercise (Impey et al., 2018) and raise the possibility that absolute post-exercise muscle glyco-
gen concentrations may also be an important factor in regulating mitochondrial-related skele-
tal muscle signalling responses to exercise. In line with this rationale, our laboratory has pre-
viously demonstrated comparable increases in AMPK activity and mRNA expression of its 
downstream targets with the depletion of muscle glycogen to similar concentrations (~100 
mmol·kg-1 dw), despite marked differences in pre-exercise concentrations (600 vs. 300 
mmol·kg-1 dw) (Impey et al., 2016). Furthermore, when taken together with previous data that 
demonstrate post-exercise muscle glycogen concentrations regulate exercise-induced PGC-1α 
mRNA expression (Pilegaard et al., 2005; Psilander, 2014; Fiorenza et al., 2018) and total 
protein abundance (Mathai et al., 2008) these findings raise the possibility that the regulation 
of gene expression may occur through changes in the absolute concentrations of glycogen 
obtained post-exercise. 
 
In summary, we provide novel data by demonstrating that graded pre-exercise muscle glyco-
gen (within a range of 600-200 mmol.kg-1 dw) does not modulate the exercise-induced nuclear 
abundance of AMPK or PGC-1α nor does it affect the expression of genes with regulatory 
roles in mitochondrial biogenesis and substrate utilization.  Practically, these data suggest that 
the additional stress of low pre-exercise muscle glycogen may not be required when perform-
ing high-intensity exercise that already subjects skeletal muscle to a sufficient metabolic chal-
lenge and may be better suited during conditions that do not elicit such cellular perturbations 
(e.g. prolonged low-intensity exercise completed below lactate threshold). Restriction of CHO 
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availability for the latter training sessions would also circumvent the impairment in self-se-
lected training intensity observed when high-intensity exercise is performed with reduced 
muscle glycogen (Yeo et al., 2008; Lane et al., 2013). Given that post-exercise muscle glyco-
gen concentrations were reduced to low levels across all trials (i.e. 100-250 mmol·kg-1 dw), 
our data raise the possibility that the absolute post-exercise muscle glycogen concentrations 
may also be an important factor in regulating exercise-induced skeletal muscle signalling re-






















































Exogenous CHO feeding during exercise does not blunt 





















We examined the effects of ingesting graded quantities of exogenous CHO during steady state 
exercise on the modulation of skeletal muscle signalling pathways associated with the regula-
tion of mitochondrial biogenesis. In a repeated measures design, eight endurance trained 
males ingested graded quantities of exogenous carbohydrate (0, 45 or 90 g CHO.h-1) during 3 
h of steady-state cycling at 100% of lactate threshold (208 ± 11 W) commenced with high 
muscle glycogen concentrations (0g; 767 ± 87, 45g; 742 ± 109, 90g; 698 ± 98 mmol·kg-1 dw) 
in the fed state. Exogenous CHO feeding during exercise did not alter the pattern of muscle 
glycogen utilisation during exercise (0g; 515 ± 93, 45g; 473 ± 133, 90g; 405 ± 132 mmol·kg-
1 dw, P > 0.05) and thus post-exercise muscle glycogen concentrations (0g; 252 ± 85, 45g; 
269 ± 88, 90g; 293 ± 109 mmol·kg-1 dw, P > 0.05) were similar between trials. Exercise-
induced comparable increases in AMPKThr172 (~4 fold), CaMKIIThr268 (~2 fold), and p53Ser15 
(~2 fold), (P < 0.05), independent of CHO availability whilst neither exercise nor CHO avail-
ability affected the phosphorylation of p38MAPKThr180/Tyr182 or CREBSer133. When taken to-
gether, these data demonstrate that exogenous CHO feeding during prolonged endurance ex-
ercise does not spare muscle glycogen or modulate exercise-induced signalling responses con-





















During exercise, transient perturbations to cellular homeostasis (e.g. the rise in cytoplasmic 
free Ca2+, increased free AMP, increased ADP/ATP ratio, reductions in muscle glycogen, in-
creased fatty acid availability and lactate accumulation) are able to activate specific signalling 
cascades regulating skeletal muscle plasticity (Hawley et al., 2014). Specifically, exercise in-
duced activation of AMP-activated protein kinase (AMPK), p38 mitogen activated protein 
kinase (p38 MAPK) and calmodulin dependent kinase II (CaMKII) appear to be central to the 
signal transduction network given their ability to converge upon and activate downstream 
transcription factors and co-activators to augment the transcription of genes that dictate the 
synthesis of new, functional proteins (Coffey & Hawley, 2007; Egan et al., 2010) 
 
Undertaking endurance exercise with low endogenous CHO availability (defined as a train-
low session; (Burke et al., 2018) induces significant metabolic shifts compared with when 
exercise is undertaken with high endogenous CHO availability. Indeed, at comparable sub-
maximal work intensities, exercise with low endogenous CHO availability substantially re-
duces glycogen utilisation (Arkinstall et al., 2004) whilst concomitantly increasing circulatory 
free fatty acid (FFA) availability (Wojtaszewski et al., 2003) and circulatory catecholamines 
(Hansen et al., 2005). Consequently, the altered metabolic milieu created through exercising 
with low endogenous CHO availability has a direct impact on molecular signalling events 
controlling training adaptation. This response appears largely mediated through AMPK-de-
pendent mechanisms given that AMPKThr172 phosphorylation (Yeo et al., 2010), AMPK-α2 
activity (Wojtaszewski et al., 2003) and nuclear abundance (Steinberg et al., 2006) are all 
augmented when acute exercise is commenced with low endogenous CHO availability. In 
contrast, data from chapter 4 and 5 suggest reducing pre-exercise muscle glycogen concentra-
tions do not alter exercise-induced signalling responses associated with mitochondrial biogen-
esis when concentrations are depleted to sufficiently low levels post-exercise. These data 
therefore raise the possibility that the absolute concentration of muscle glycogen post-exercise 
(opposed to that obtained pre-exercise) may also be an important factor in regulating such 
responses.  
 
Consuming exogenous CHO intake during exercise may provide one strategy to manipulate 
post-exercise muscle glycogen concentrations, given its potential ability to spare muscle gly-
cogen utilisation during exercise (Bjorkman et al., 1984; Erickson et al., 1987), especially in 
specific fibre types (Stellingwerff et al., 2007). In line with this rationale, exogenous CHO 
feeding during exercise appears to attenuate AMPK-α2 activity only when the pattern of mus-
cle glycogen utilisation is altered, and thus absolute post-exercise concentrations are elevated 
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compared with when CHO is not fed (Akerstrom et al., 2006; Lee-Young et al., 2006). Taken 
together, these data suggest that, as exogenous CHO feeding may exert its effects through 
changes in endogenous glycogen concentrations, absolute muscle glycogen concentrations 
may be the main substrate regulating exercise-induced AMPK signalling. Nonetheless, the 
effect of exogenous CHO feeding during exercise on alternative signalling pathways within 
human skeletal muscle remains incompletely explored and, given that exogenous CHO feed-
ing during exercise may blunt training-induced adaptations (Morton et al., 2009) provides an 
area of research that warrants further investigation. 
 
With this in mind, the aim of the present study was to examine the effects of graded exogenous 
CHO feeding during steady-state exercise on the modulation of selected skeletal muscle sig-
nalling pathways with putative roles in the regulation of mitochondrial biogenesis. As such, it 
was hypothesised that exogenous CHO feeding would only modulate cell signalling responses 
in concert with differences in the pattern of muscle glycogen utilisation during exercise and, 




Eight endurance-trained amateur male cyclists (mean ± SD: age, 31 ± 7 years; body mass 73.6 
± 6.1 kg; height, 177.0 ± 8.0 cm) took part in this study. Mean V̇O2peak, peak power output 
(PPO) and power output at lactate threshold (LT) for the cohort were 60.5 ± 5.4 mL kg-1 min-
1, 383 ± 21 W and 208 ± 11 W, respectively. None of the subjects had any history of muscu-
loskeletal or neurological disease nor were they under any pharmacological treatment during 
the course of the testing period. All subjects provided written informed consent and all proce-
dures conformed to the standards set by the Declaration of Helsinki (2008). The study was 
approved by the local Research Ethics Committee of Liverpool John Moores University. 
6.3.2 Experimental Design  
In a repeated-measures, randomised, cross-over design separated by a minimum of 7 days, 
subjects undertook 180 min of steady state cycling at 100% lactate threshold (208 ± 11 W) 
whilst consuming exogenous carbohydrate at a rate of either 0, 45 or 90 grams per hour. To 
promote high CHO availability prior to the main experimental trial, subjects undertook 90 min 
of glycogen depleting exercise followed by the consumption of a high CHO diet (11.6 g kg-1) 
and a high CHO meal (2 g kg-1) 3 h prior to exercise. Muscle biopsies were obtained from the 
vastus lateralis muscle immediately before and after the completion of the submaximal cycling 




Figure 6. 1. Schematic overview of the experimental protocol. Subjects completed an evening bout of 
glycogen depleting cycling exercise followed by the consumption of a high CHO diet for 24 h prior to 
the main experimental trial. Following a high CHO pre-exercise breakfast, subjects completed a bout 
steady state cycling, during which graded quantities of exogenous CHO were ingested. Muscle biopsies 
were obtained pre- and post-exercise. 
6.3.3 Preliminary testing 
At least 10 days prior to experimental trials, all subjects performed a two-part incremental 
cycle test to determine peak oxygen consumption (V̇O2peak), lactate threshold (LT) and peak 
power output (PPO) on an electronically braked cycle ergometer (Lode Excalibur Sport, Gro-
ningen, Netherlands). Following the completion of a 10 min warm-up at 75 W, the LT test 
began at 125 W and consisted of 4 min stages with 25 W increments in resistance until blood 
lactate concentrations increased above 4 mmol·L-1, with LT defined as the first deflection 
point in the blood lactate accumulation curve . On completion of the LT test, subjects were 
provided with a 15 min rest period, prior to the completion of the assessment for V̇O2peak. The 
test recommenced at a power output corresponding to that of the penultimate stage of the LT 
test and continued with 60 second stages with 25 W increments in resistance until volitional 
exhaustion. V̇O2peak was stated as being achieved by the following end-point criteria: (1) heart 
rate within 10 beats min-1 of age-predicted maximum, (2) respiratory exchange ratio > 1.1 and 
(3) plateau of oxygen consumption despite increased workload. Peak aerobic power was taken 
as the final stage completed during the incremental test.  
 
Subjects also undertook full familiarisation of the experimental trial, at least 7 days prior to 
the main experimental trials, and all refrained from CHO intake during the steady state cycling 
protocol, thus replicating the same nutritional conditions as per the 0g trials. 
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6.3.4 Glycogen depletion exercise 
On the day of glycogen depleting exercise, subjects reported to the laboratory at approximately 
5 pm to perform 90 min of intermittent glycogen depleting cycling, as previously completed 
in our laboratory (Taylor et al., 2013; Impey et al., 2016) and detailed within section 4.3.4. 
The pattern of exercise and total time to exhaustion in the subject’s initial trial was recorded 
and replicated in all subsequent trials. Subjects were permitted to consume water ad libitum 
during exercise, with the pattern of ingestion replicated during subsequent trials.  
6.3.5 Carbohydrate re-feeding strategy 
Immediately following glycogen depleting exercise, subjects were provided with CHO at a 
rate of 1.2 g kg-1 h-1 for 3 h through a mixture of drinks and bars (Go Energy, Science in Sport, 
Nelson, UK) in accordance with nutritional guidelines to optimise muscle glycogen resynthe-
sis (Thomas et al., 2018). In this way, subjects consumed 3.6 g kg-1 CHO, 0.6 g kg-1 protein 
and 0 g kg-1 fat across the first 3 h of recovery. For the following 24 h, subjects consumed a 
standardised high CHO diet (8 g kg-1 CHO, 2 g kg-1 protein and 1 g kg-1 fat) with fluid intake 
allowed ad libitum.  
6.3.6 Steady-state cycling  
On the morning of each experimental trial subjects arrived at the laboratory at 8 am and were 
provided with a standardised high CHO breakfast (2 g kg-1 CHO, 40 g protein and 35 g fat; 
comprising porridge oats, semi-skimmed milk, honey, orange juice, bread, jam, banana and 
eggs) which was consumed 3 h prior to commencing exercise. Immediately prior to exercise, 
an indwelling cannula (Safety lock 22G, BD Biosciences, UK) was inserted into the antecu-
bital vein in the anterior crease of the forearm and a resting blood sample was taken, followed 
by the collection of a muscle biopsy sample from the vastus lateralis. The steady-state cycling 
protocol consisted of 180 min of cycling at 100% LT (208 ± 11 W) at a self-selected cadence, 
during which carbohydrate was ingested at a rate of either 0 g h-1 (0g), 45 g h-1 (45g) or 90 g 
h-1 (90g). In both 45g and 90g trials, carbohydrate was provided in the form of gels (GO En-
ergy, Science in Sport, Nelson, UK) and rice cakes (21 g CHO per rice cake) whilst subjects 
in the 90g trial were also provided with a specially formulated maltodextrin based drink con-
taining 22 g CHO per 500 ml. Fluid intake during exercise was matched at 500 ml h-1 across 
all three trials, whereby subjects in the 0g and 45g trials consumed water flavoured with elec-
trolyte tablets (Go Hydro, Science in Sport, Nelson, UK) and subjects in the 90g trial con-
sumed the aforementioned maltodextrin drink. During exercise, heart rate (HR) and ratings of 
perceived exertion (RPE) were recorded every 15 min whilst expired air was collected via a 
mouthpiece connected to an online gas analysis system (MOXUS modular uptake system, AEI 
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technologies, Pittsburgh, PA) for a total of 5 min at regular 30 min intervals and substrate 
utilisation was assessed using the equations of Jeukendrup & Wallis (Jeukendrup & Wallis, 
2005).   
6.3.7 Muscle biopsies 
Skeletal muscle biopsies (~100 mg) were obtained from the vastus lateralis immediately pre- 
and post-exercise. Muscle biopsies were obtained from separate incision sites 2-3 cm apart 
using the Well-Blakesey conchotome technique under local anaesthesia (0.5% Marcaine) and 
immediately frozen in liquid nitrogen and stored at -80oC for later analysis.  
6.3.8 Muscle glycogen concentration  
Muscle glycogen concentrations were determined according to the acid hydrolysis method 
described by Van Loon et al (van Loon et al., 2000). Approximately 2-5 mg of freeze-dried 
tissue was powdered, dissected of all visible blood and connective tissue and subsequently 
hydrolysed by incubation in 500 μl of 1 M HCl for 3 h at 95oC. After cooling to room temper-
ature, samples were neutralised by the addition of 250 μl 0.12 mol L-1 Tris/2.1 mol L-1 KOH 
saturated with KCl. Following centrifugation, 200 μl of supernatant was analysed in duplicate 
for glucose concentration according to the hexokinase method using a commercially available 
kit (GLUC-HK; Randox Laboratories, Antrim, UK). Glycogen concentration is expressed as 
mmol·kg-1 dry weight and intra-assay coefficients of variation were <5%. 
6.3.9 SDS page & Western blotting 
Muscle samples were prepared, separated by SDS-PAGE and transferred to nitrocellulose 
membranes according to the method outlined in section 3.4.5. Following transfer, a stain-free 
image was obtained for total protein loading normalisation. Membranes were subsequently 
blocked in TBS-Tween containing 5% non-fat milk for 1 h and incubated overnight in primary 
antibodies; AMPKα (CST: 2532), p-AMPKThr172 (CST: 2531), p38MAPK (CST: 9212), p-
p38MAPKThr180/Tyr182 (CST: 9211), CaMKII (CST: 3362), p-CaMKIIThr268 (CST: 3361), p53 
(CST: 9282), p-p53 9284 (CST: 9281), CREB (CST: 9197), p-CREBSer133 (CST: 9198), before 
incubation in relevant secondary antibody (anti-rabbit (CST: 7074) for 1 h at room tempera-
ture the following morning. Proteins were detected via chemiluminescence (Millipore, Wat-
ford, UK) and quantified by densitometry as outlined in section 3.4.5. 
6.3.10 Statistical analysis 
All statistical analyses were performed using Statistical Package for the Social Sciences (SPSS 
Version 24). Comparison of average physiological responses across the exercise bout (i.e. 
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total substrate oxidation) were analysed using a one-way repeated-measures general linear 
model whereas changes in physiological and molecular responses between conditions (i.e. 
muscle glycogen, and activity of signalling molecules) were analysed using a two-way re-
peated measures general linear model, where the within factors were time and condition. 
Where a significant main effect was observed, pairwise comparisons were analysed according 
to Bonferroni post-hoc tests in order to locate specific differences. All data in text, figures and 
tables are presented as means ± SD with P values ≤ 0.05 indicating statistical significance. 
 
6.4 Results 
6.4.1 Skeletal muscle glycogen 
Subjects commenced exercise with similar muscle glycogen concentrations (P = 0.137) across 
all three trials (0g; 767 ± 87, 45g; 742 ± 109, 90g; 698 ± 98 mmol·kg-1 dw). Muscle glycogen 
was significantly reduced following 180 min of steady state cycling (0g; 252 ± 85, 45g; 269 
± 88, 90g; 293 ± 109 mmol·kg-1 dw) to similar concentrations in all trials (P = 0.502), demon-
strating no difference in absolute muscle glycogen utilisation (0g; 515 ± 93, 45g; 473 ± 133, 
90g; 405 ± 132 mmol·kg-1 dw) between the trials (P = 0.155) (Figure 6.2 A-B).  
 
 
Figure 6. 2. (A) Skeletal muscle glycogen concentration and (B) utilisation during exercise. #P < 0.05, 
significantly different from pre-exercise, Data is presented as mean ± SD 
 
6.4.2 Physiological responses to exercise 
Heart rate (HR) and rating of perceived exertion (RPE) were significantly elevated by exercise 
(P < 0.05) but did not differ between trials (P > 0.05) (Figure 6.3 A-B). Average rate of CHO 
oxidation was significantly higher in the 90g trial (2.3 ± 1.5 g.min-1) when compared with the 
0g (1.8 ± 1.6 g) trial (P = 0.01) with no significant differences between either 45g (2.1 ± 1.4 
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Similarly, average rate of lipid oxidation was significantly lower in the 90g trial (0.58 ± 0.05 
g.min-1) when compared with the 0g (0.78 ± 0.05 g.min-1) trial (P < 0.001) with no significant 
differences between either 45g (0.63 ± 0.04 g.min-1) and 90g or 45g and 0g trials (P > 0.05) 
(Figure 6.2 C-D).  
 
 
Figure 6. 3. (A) Heart rate and (B) during exercise. (C) Average rate of CHO and (D) lipid oxidation 
during exercise. §P < 0.05, significantly different from 90 g.h-1, Data is presented as mean ± SD. 
6.4.3 Skeletal muscle signalling 
Exercise significantly increased the phosphorylation of AMPKThr172 (P < 0.001) although in-
creases (~ 4-fold) were similar between conditions (P = 0.851). Similarly, exercise increased 
the phosphorylation of both CaMKIIThr286 (2-fold; P = 0.003) and p53Ser15 (2-fold; P.= 0.025) 
independent of CHO availability (P = 0.360 and P = 0.784, respectively). In contrast, neither 
p38 MAPKThr180/Tyr182 (main effect of condition; P = 0.645, time; P = 0.064)  or CREBSer133 
(main effect of condition; P = 0.601, time; P = 0.733) phosphorylation were significantly 
altered by either exercise or CHO availability, which both displayed large inter-individual 
variance in their responses. Western blots are shown in Figure 6.5. 
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Figure 6. 4. (A) AMPKThr172 phosphorylation, (B) p38Thr180/Tyr182 phosphorylation, (C) p53Ser15 phosphor-
ylation, (D) CREBSer133 phosphorylation and (E) CaMKIIThr286 phosphorylation at pre- and post-exer-






















































































































The aim of the present study was to test the hypothesis that exogenous CHO feeding during 
prolonged endurance exercise would modulate exercise-induced skeletal muscle signalling. 
Using trained male cyclists, we provide novel data by demonstrating that exogenous CHO 
feeding during 180 min of steady state exercise does not alter muscle glycogen utilisation nor 
does it alter post-exercise mitochondrial-related signalling. In the context of manipulating 
CHO availability around training, these data suggest that CHO feeding during exercise does 
not provide a glycogen sparing effect within skeletal muscle but does not impair the acute 
regulatory signalling associated with mitochondrial biogenesis. 
 
In order to ensure exercise was commenced with sufficient endogenous CHO availability, 
subjects performed a bout of evening glycogen depletion exercise followed by high CHO in-
take in the immediate 3 h recovery period (1.2 g.kg-1 per hour), the following day (8 g.kg-1) 
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and 3 h prior (3 g.kg-1) to commencing the steady state cycling protocol, in accordance with 
current nutritional guidelines (Thomas et al., 2018) to maximise both muscle and liver glyco-
gen. Whilst our intended model was successful in achieving pre-exercise glycogen concentra-
tions (0g; 767 ± 87, 45g; 742 ± 109, 90g; 698 ± 98 mmol·kg-1 dw) consistent with a CHO 
loaded state (Areta & Hopkins, 2018) the consumption of graded quantities of exogenous 
CHO during exercise did not significantly alter the pattern of glycogen utilisation (0g; 515 ± 
93, 45g; 473 ± 133, 90g; 405 ± 132 mmol·kg-1 dw) during exercise. These results are con-
sistent with previous findings (Stellingwerff et al., 2007; Gonzalez et al., 2015) that demon-
strate exogenous CHO feeding at a rate of 50 and 102 g.h-1, respectively, does not alter whole 
muscle glycogen utilisation during 3 h of endurance exercise. However, exogenous CHO feed-
ing does appear to significantly reduce muscle glycogen utilisation within type I fibres across 
3 h (Stellingwerff et al., 2007) and type IIa fibres across 2 h of endurance exercise (De Bock 
et al., 2006). With this in mind, future studies should aim to investigate the effects of exoge-
nous CHO feeding on muscle fibre type specific protein signalling, given the differential reg-
ulation of AMPK and downstream targets between fibre types (Kristensen et al., 2015).  
 
In relation to post-exercise signalling, we observed comparable exercise induced increases in 
AMPKThr172 phosphorylation between all trials, independent of exogenous CHO availability 
(Figure 6.4A). These findings support previous suggestions that CHO ingestion, either before 
or during exercise (or in combination) do not alter skeletal muscle AMPK signalling (De Bock 
et al., 2005; Akerstrom et al., 2006) when the rate of glycogen utilisation is unaltered. Thus, 
the comparable increases in AMPKThr172 phosphorylation observed within the present study 
are likely explained by the similar pattern of glycogen utilisation (~ 50%) across all trials 
given the well documented effects of muscle glycogen on AMPK signalling within skeletal 
muscle (Wojtaszewski et al., 2003; Steinberg et al., 2006; Yeo et al., 2010; Bartlett et al., 
2013). Given the physical tethering of AMPK to the glycogen granule via its ß-subunit, it is 
proposed that exercise-induced glycogen depletion results in the dissociation of AMPK from 
the glycogen granule and allows greater access for kinase phosphorylation (Steinberg et al., 
2006).  
 
In contrast to AMPK, we did not observe any change in the phosphorylation status of p38 
MAPKThr180/Tyr182 either in response to exercise or exogenous CHO feeding, though we note 
the large inter-individual variability between subjects. When taken together with previous data 
that demonstrate p38 MAPK phosphorylation is unaltered by endogenous CHO availability 
(Yeo et al., 2010; Bartlett et al., 2013) or pre-exercise CHO feeding (Stocks et al., 2019), 
these data provide further evidence to support the notion that substrate availability does not 
modulate the phosphorylation of p38 MAPK in whole muscle homogenate. Although p38 
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MAPK phosphorylation does not appear to be affected by exercise intensity (Egan et al., 2010; 
Bartlett et al., 2012), its phosphorylation status may be more sensitive to fluctuations in spe-
cific metabolites during exercise (Combes et al., 2015). Specifically, exercise-induced in-
creases in p38 MAPK phosphorylation appear to strongly correlate with fluctuations in both 
plasma lactate and ATP (Fiorenza et al., 2018). Given the continuous nature of the present 
exercise bout, when performed at 100% LT, large incremental fluctuations in plasma lactate 
would be unexpected (Baldwin et al., 2000) and thus, it could be suggested that insufficient 
metabolic stress may explain the lack of p38 MAPK phosphorylation. The lack of p38 MAPK 
phosphorylation is, however, interesting given the observed changes in CaMKII phosphory-
lation, as p38 MAPK phosphorylation also appears to be sensitive to cytosolic calcium 
(Wright et al., 2007a).  
 
Similar to that of AMPK, we observed comparable exercise induced increases in CaMKIIThr268 
phosphorylation between all trials. (Figure 6.4E). Although CaMKII phosphorylation appears 
to occur in an intensity dependent manner (Rose et al., 2006; Egan et al., 2010) the observed 
increases within the present data may reflect continuous calcium release from the SR with 
prolonged contraction (Baar, 2014) opposed to the intermittent oscillations likely observed 
with high-intensity exercise (Rose et al., 2006). With this in mind, the lack of observed change 
in CaMKII phosphorylation in response to high-intensity exercise within chapter 4 suggest 
that exercise duration may also be an important regulator of CaMKII phosphorylation due to 
the continuous exposure to calcium during prolonged exercise. Nonetheless, we also demon-
strate that exogenous CHO availability does not appear to modulate CaMKII phosphorylation. 
One mechanism by which exogenous CHO feeding may alter CaMKII signalling, would be 
via alterations in muscle glycogen depletion, given that low muscle glycogen (< 300 mmol·kg-
1 dw) is associated with impaired SR Ca2+ release (Gejl et al., 2014). However, given the 
comparable post-exercise muscle glycogen concentrations between trials, the present results 
are unsurprising. 
 
In addition to the primary upstream signalling kinases, metabolic adaptations within skeletal 
muscle are regulated by downstream transcription factors and co-activators, including p53 and 
CREB. The tumor suppressor protein p53 has recently emerged as part of the signalling net-
work controlling exercise-induced training adaptations and may be phosphorylated via up-
stream kinases AMPK and p38 MAPK (She et al., 2001; Jones et al., 2005). In accordance 
with this, the present study demonstrates comparable exercise-induced increases in p53Ser15 
phosphorylation in concert with the observed increase in AMPKThr172 phosphorylation. Alt-
hough augmented p53Ser15 phosphorylation has been observed in response to endurance exer-
cise with low muscle glycogen (Bartlett et al., 2013), the present data suggest that p53 may 
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not be sensitive to exogenous carbohydrate availability. Given the ability of both AMPK and 
CaMKII to phosphorylate CREB (Egan et al., 2010), we also examined CREB signalling in 
response to both exercise and exogenous CHO feeding. However, despite the observed in-
creases in post-exercise AMPK and CaMKII phosphorylation, we observed no change in the 
phosphorylation status of CREBSer133 either in response to exercise or exogenous CHO feed-
ing. These findings may be explained by our chosen sampling time point, given that increases 
in CREB phosphorylation are typically observed 3 h post-exercise and are actually reduced 
immediately upon the completion of exercise (Egan et al., 2010; Stocks et al., 2019) as seen 
in the present data. Unfortunately, owing to a lack of muscle tissue, we were unable to measure 
the transcription of genes with putative roles in mitochondrial biogenesis, namely PGC-1α 
given its purported role as a master regulator. Nonetheless, others have reported that PGC-1α 
mRNA expression is unaffected by exogenous CHO feeding during exercise (Cluberton et al., 
2005). 
 
In summary, we provide novel data by demonstrating that steady state endurance exercise 
induces phosphorylation of signalling kinases AMPK and CaMKII and downstream transcrip-
tion factor p53, independent of exogenous CHO availability. These data extend previous find-
ings by characterising the response of alternative signalling pathway responses to carbohy-
drate feeding during endurance exercise and, when taken together, indicate that exogenous 
CHO feeding does not modulate post-exercise signalling responses regulating mitochondrial 
























































7.1 Achievement of aims and objectives  
 
The primary aim of this thesis was to examine the effects of both endogenous and exogenous 
CHO availability on the regulation of molecular pathways associated with mitochondrial bio-
genesis. On this basis, a secondary aim was to investigate the existence of a potential muscle 
glycogen threshold and provide an understanding of its potential upper and lower limits. 
Aim 1 - To examine the effects of graded reductions in pre-exercise muscle glycogen 
(below 300 mmol·kg-1 dw) on skeletal muscle cell signalling and gene expression re-
sponses associated with the regulation of mitochondrial biogenesis and substrate metab-
olism (Study 1, Chapter 4). 
When matched for work done, commencing exercise with low muscle glycogen appears to 
augment many acute signalling responses that regulate training adaptation. However, the ab-
solute concentration of muscle glycogen required to achieve such responses is unclear. Using 
a sleep-low, train-low model, the data presented within this chapter demonstrate that further 
reductions in pre-exercise muscle glycogen below 300 mmol·kg-1 dw do not augment early 
post-exercise signalling or transcriptional responses and, in fact, may impair exercise capacity. 
A novel aspect of the chosen study design was that we employed a sampling point in both the 
H-CHO and M-CHO trials that was matched to the point of exhaustion in the L-CHO trial, 
thus allowing for the assessment of mitochondrial related signalling events at both work-
matched and exhaustive exercise time points, whilst also allowing for the assessment of exer-
cise capacity.  
Aim 2 – To examine the effects of graded reductions in pre-exercise muscle glycogen 
(between the range of 100-600 mmol·kg-1 dw) on skeletal muscle cell signalling and gene 
expression responses associated with the regulation of mitochondrial biogenesis and sub-
strate metabolism (Study 2, Chapter 5). 
Having observed no additional benefit of stepwise reductions in pre-exercise muscle glycogen 
concentrations below 300 mmol·kg-1 dw (100-300 mmol·kg-1 dw) on exercise-induced cell 
signalling or gene expression following exhaustive exercise in study 1, study 2 required the 
investigation of a wider range of muscle glycogen concentrations to be used during work-
matched, non-exhaustive exercise. Using a modified version of the sleep-low, train-low model 
from study 1 (in order to allow for greater muscle glycogen resynthesis) the data presented in 
this study extend the findings of study 1 and demonstrate no benefit of commencing exercise 
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with reduced muscle glycogen on early signalling and gene expression responses regulating 
mitochondrial biogenesis.  
Aim 3 – To examine the effects of graded exogenous CHO intake during exercise on 
skeletal muscle cell signalling responses associated with the regulation of mitochondrial 
biogenesis (Study 3, Chapter 6). 
In addition to muscle glycogen, exogenous CHO feeding during exercise also has the ability 
to induce changes in metabolism and thus modulate skeletal muscle signalling regulating mi-
tochondrial biogenesis, although the early signalling responses to CHO feeding during exer-
cise are not well characterised. Furthermore, data derived from both study 1 and 2 raise the 
possibility that post-exercise muscle glycogen may also be an important factor in regulating 
such responses and thus, exogenous CHO feeding may provide a practical model in which 
post-exercise muscle glycogen can be modified whilst matching total work done. However, 
the data within chapter 6 demonstrate that feeding graded quantities of CHO during exercise 
(ranging from 0 to 90 g h-1) does not alter muscle glycogen utilisation or post-exercise signal-
ling cascades regulating mitochondrial biogenesis. 
7.2 General discussion & practical implications  
Since the initial discovery and description of glycogen in 1857, its role has evolved consider-
ably, from that of a simple energy source through to a potential regulator of molecular signal-
ling events in response to exercise. The concept of train-low is founded on the premise that 
undertaking endurance exercise with reduced muscle glycogen induces significant metabolic 
shifts compared with when exercise is undertaken with high CHO availability. For instance, 
at comparable work intensities, exercise with low CHO availability substantially reduces gly-
cogen utilisation (Arkinstall et al., 2004) whilst concomitantly increasing circulatory free fatty 
acid (FFA) availability (Wojtaszewski et al., 2003) and circulatory catecholamines (Hansen 
et al., 2005). Consequently, the altered metabolic milieu created through exercising with low 
CHO availability has a direct impact on molecular signalling events controlling training ad-
aptation, which appears to occur through the AMPK/PGC-1α pathway.  
 
Does pre-exercise muscle glycogen concentration regulate training responses? 
Given that the enhanced training response associated with train-low is potentially mediated 
by muscle glycogen availability, examination of available train-low studies (Figure 2.10) that 
demonstrate augmented mitochondrial-related signalling suggest these responses are particu-
larly evident when absolute pre- exercise muscle glycogen concentrations are < 300 mmol·kg-
1 dw and elude to the potential existence of a glycogen threshold. Nonetheless, it should be 
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acknowledged that augmented skeletal muscle signalling is not always observed with reduced 
pre-exercise muscle glycogen (Lane et al., 2015; Impey et al., 2016; Hammond et al., 2019) 
or that any potential threshold does not allude to the suggestion that individuals will not adapt 
to endurance exercise if they do not exercise with glycogen concentrations below the proposed 
limit. In support of this, the data generated from study 1 and 2 demonstrate that, in the context 
of the high-intensity endurance exercise, reducing pre-exercise muscle glycogen confers no 
additional benefit to molecular signalling events that govern exercise-induced adaptation. De-
spite marked differences in pre-exercise muscle glycogen, the lack of augmented effect may 
be explained by the fact that absolute glycogen concentrations were reduced to concentrations 
already associated with enhanced mitochondrial-related signalling (i.e. < 300 mmol·kg-1 dw) 
across all trials (Figure 7.1) likely reflective of the high-intensity nature of the exercise proto-
cols undertaken. This rationale seems plausible given that muscle glycogen appears to modu-
late the activity of AMPK through its physical tethering of the glycogen binding domain lo-
cated on the β sub-unit, and thus, it is the absolute concentration of glycogen (regardless of 
whether is achieved through pre-exercise nutritional manipulation or degradation during ex-
ercise) that is the primary driver, allowing for the de-attachment of AMPK from the glycogen 
granule and increased access for AMPK phosphorylation. When taken together, these data 
raise the possibility that obtaining low absolute muscle glycogen concentrations post-exercise 
may also be an important factor in augmenting mitochondrial-related signalling. 
Does post-exercise muscle glycogen concentration regulate training responses? 
 
In support of this rationale, post-exercise muscle glycogen concentrations appear to regulate 
exercise-induced PGC-1α mRNA expression (Psilander, 2014; Fiorenza et al., 2018) and total 
protein abundance (Mathai et al., 2008), whilst the maintenance of low post-exercise muscle 
glycogen prolongs exercise induced increases in PGC-1α mRNA expression. Furthermore, 
our lab has previously demonstrated comparable signalling responses can still be achieved 
despite marked differences in pre-exercise muscle glycogen (600 vs. 300 mmol·kg-1 dw) when 
muscle glycogen is depleted to similar levels (~ 100 mmol.kg-1 dw) post-exercise (Impey et 
al., 2016). Upon this basis, the high rates of glycogen utilisation and subsequent achievement 
of low post-exercise glycogen concentrations in study 1 and 2 raise the possibility that when 
post-exercise muscle glycogen concentrations are depleted to concentrations associated with 
mitochondrial-related signalling (i.e. < 300 mmol·kg-1 dw; Figure 7.1) the impact of pre-ex-
ercise glycogen availability is reduced. Collectively, these data raise the possibility that abso-
lute post-exercise glycogen concentrations (in combination with the amount of glycogen 
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utilised during exercise) may play an important role in regulating mitochondrial-related sig-
nalling although further research is now warranted to directly test this hypothesis. 
 
 
Figure 7. 1. Mean post-exercise muscle glycogen concentrations across experimental trials in study 1, 
2 and 3. Individual post-exercise muscle glycogen concentrations are shown in grey circles. Mean pre-
exercise muscle glycogen concentrations are represented by dashed bars to indicate the magnitude of 
glycogen depletion during the exercise bout. Data indicate that mean post-exercise muscle glycogen 
concentrations across all experimental trials reached low (i.e. < 300 mmol·kg-1 dw) levels. 
 
Sending the signal: The interaction of muscle glycogen concentrations and exercise 
stress 
 
The goal of endurance training is to induce an array of physiological and metabolic adapta-
tions and is underpinned by disruptions in cellular homeostasis required to induce the activa-
tion of signalling networks that govern such responses. Whilst the manipulation of muscle 
glycogen concentrations presents one strategy to induce such cellular perturbations, the im-
portance of key training variables (e.g. intensity and duration) should not be overlooked given 
their role in regulating mitochondrial related signalling (Stephens et al., 2002; Egan et al., 
2010; Granata et al., 2017). As such, the role of nutrient availability should be considered 
within the context of the specific exercise being undertaken whereby the manipulation of mus-
cle glycogen may only induce modulatory effects on skeletal muscle that has not been sub-
jected to sufficient local metabolic challenge via the manipulation of both exercise intensity 
and duration. In essence, when exercise stress is low, commencing the exercise bout with low-
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pre-exercise glycogen concentrations may provide a viable strategy to induce perturbations to 
cellular homeostasis required to activate mitochondrial related signalling cascades. However, 
if exercise is of sufficient intensity and duration to induce cellular perturbations (and coinci-
dently the attainment of low absolute muscle glycogen concentrations) commencing such ex-






Figure 7. 2. Schematic summary of the alterations in skeletal muscle signalling originating from this 
thesis. Commencing high-intensity endurance exercise with low pre-exercise muscle glycogen concen-
trations does not appear to augment mitochondrial related-signalling events when exercise induces suf-
ficient glycogen depletion, and results in low post-exercise glycogen concentrations. High-intensity 
endurance exercise results in AMPK phosphorylation and translocation to the nucleus and results in the 
augmented mRNA expression of both PGC-1α and p53 whilst continuous exercise may also phosphor-
ylate CaMKII. Furthermore, feeding exogenous CHO during exercise does not attenuate AMPK, 




Practically, these data ultimately lend support to the concept of ‘fuelling for the work required’ 
whereby CHO availability is adjusted in accordance with the demands of the specific training 
session to be completed. When considering the glycogen cost of habitual training sessions, it 
should be noted that driving glycogen depletion would likely be more difficult and require 
considerably more work in well-trained individuals (Gejl et al., 2017) given they display an 
enhanced capacity for glycogen storage and reduced utilisation during exercise (Karlsson et 
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al., 1974; Henriksson, 1977; Coyle et al., 1988; Areta & Hopkins, 2018). In practice, it appears 
that careful consideration of the individuals training status and the metabolic demands of each 
training session is required to ensure appropriate day-to-day periodisation of CHO in order to 
create a metabolic milieu conducive to facilitating the metabolic adaptations associated with 
train-low. 
 
7.3 Limitations  
 
Amalgamating train-low models – In both chapter 4 and 5, we adopted a sleep-low, train-
low model that utilised an amalgamation of multiple train-low models (e.g. low glycogen, 
fasted exercise, post-exercise CHO restriction), all of which are able to independently modify 
acute signalling responses to exercise. With this in mind, the effect of absolute muscle glyco-
gen concentrations may have been dampened and may confine the applicability of the present 
data to the sleep-low, train-low model. Furthermore, given that the pre-exercise biopsy was 
sampled within ~14 h of glycogen depleting exercise in study 1, it is difficult to determine 
whether mRNA expression was already elevated at pre-exercise which may also result in a 
dampened response to exercise. Although the time-course of gene expression is not well char-
acterized, some the mRNA expression of certain genes measured within this chapter are ele-
vated for up to 24 h post-exercise which coincides with the present pre-exercise sampling time 
point. Based upon this, future studies may wish to employ a longer period between exercise 
bouts, as can be observed within chapter 5.  
 
Translation of acute signalling data – Whilst an understanding of the acute signal transduc-
tion network that regulates mitochondrial biogenesis provides useful insights into the early 
responses that regulate training adaptation, there appears to be a disconnect between the acti-
vation of such pathways and functional increases in protein abundance (Hornberger, 2016; 
Granata et al., 2018). Furthermore, the assessment of post-translational modifications (i.e. 
phosphorylation) within chapter 4 and 6 can only act as a proxy marker for the activity of such 
proteins. Therefore, future studies will benefit from the development of specific kinase activ-
ity assays in order to provide a more detailed understanding of intracellular signalling in re-
sponse to carbohydrate manipulation.  
 
Subcellular fractionation – Although the fractionation protocol used within this thesis was 
successful in achieving samples enriched with either nuclear or cytosolic proteins, it should 
be noted that this method is unable to provide ‘pure’ fractions without any contamination from 
other cellular regions. Furthermore, our fractionation protocol was performed on frozen tissue 
samples which may have resulted in the fracture of nuclei and therefore selectively limit 
 129 
analysis of these fractions to those that survived the freeze/thaw process. Unfortunately, due 
to a lack of muscle lysate generated from the fractionation protocol, it was not possible to 
measure the phosphorylation status of several proteins which would yield important infor-
mation to their sub-fraction activation in response to exercise.  
 
Dietary protocols – Whilst the dietary protocols used in this thesis were successful in induc-
ing differences in muscle glycogen concentrations, it should be noted such differences also 
result in differences in energy availability between trials and thus, the responses observed may 
not solely be related to carbohydrate manipulation per se. Although recent data demonstrate 
that acute alterations in energy availability do not influence mRNA expression in response to 
exercise (Hammond et al., 2019) its effect on other early signalling responses to exercise (i.e. 
protein phosphorylation) are not well understood.  
 
7.4 Recommendations for future research 
 
Recommendation 1 – Based upon the data obtained from chapter 5, it appears that AMPK 
nuclear translocation may, in part, regulate the exercise-induced increase in PGC-1α mRNA 
expression. However, future studies should examine the phosphorylation status of AMPK, as 
well as other signalling kinases and transcription factors, within the nucleus in order to further 
elucidate the molecular mechanisms that may underpin adaptation to exercise and the modu-
latory role CHO availability may have on this pathway. Furthermore, measurement of trans-
location and phosphorylation status of such proteins within mitochondrial fractions would 
provide a more comprehensive understanding of such pathways.  
 
Recommendation 2 – Whilst the data presented within this thesis has primarily focused on 
the transcription of genes and post-translational modification of proteins known to be regu-
lated by either exercise and/or substrate availability within skeletal muscle this represents a 
small, selective part of the signal transduction network that regulates skeletal muscle adapta-
tion. With this in mind, the adoption of global ‘omic’ approaches to quantify metabolic, tran-
scriptional and phosphorylation responses to exercise with low CHO availability would allow 
for a greater understanding of the signal transduction network that is regulated by CHO avail-
ability and help to identify novel regulators of train-low. Furthermore, this approach would 
allow for the adoption of multiple linear regression analysis to allow for a better understanding 
of the relationships between changes in metabolic and molecular variables in response to low 
CHO exercise.  
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Recommendation 3 – The data obtained from both chapter 4 and 5, appear to suggest that 
post-exercise muscle glycogen may be a critical factor regulating signalling responses to ex-
ercise. Given that muscle glycogen utilisation during exercise is intensity-dependent, future 
studies should address whether train-low sessions should be left to low-intensity exercise ses-
sions (which typically do not result in substantial depletion of muscle glycogen) or whether 
the completion of high-intensity exercise to further drive glycogen depletion is required. In 
light of this, an understanding of the modulatory role of training status should also be consid-
ered given the differential use of muscle glycogen between trained and untrained individuals.  
 
Recommendation 4 – The data obtained from chapter 6, demonstrate that exogenous CHO 
feeding during exercise does not modulate post-exercise signalling responses to exercise. 
However, given that exogenous CHO feeding may spare muscle glycogen in a fibre-type de-
pendent manner, future studies should now investigate fibre-type specific signalling in re-
sponse to CHO feeding, given that AMPK and its downstream targets are activated in a fibre-
type dependent manner (Kristensen et al., 2015).  
 
7.5 Closing thoughts  
In summary, the data presented within this thesis demonstrate that neither pre-exercise muscle 
glycogen nor exogenous CHO feeding during exercise appear to significantly modify early 
signalling responses to endurance exercise. These data raise the possibility that the absolute 
concentration of muscle glycogen post-exercise may also be an important factor in regulating 
the molecular responses that underpin exercise adaptation although this now warrants direct 
investigation. From a practical perspective, these data suggest that performing exercise with 
reduced CHO availability may not be required when exercise is of sufficient intensity and/or 
duration to induce sufficient changes to the cellular milieu and the depletion of sufficient mus-
cle glycogen. As such, low CHO training may be best suited to situations where exercise in-
tensity and/or duration is insufficient to elicit metabolic perturbations (e.g. prolonged low-
intensity exercise completed below lactate threshold). Restriction of CHO availability for the 
latter training sessions would also circumvent the impairment in self-selected training inten-
sity observed when high-intensity exercise is performed with reduced muscle glycogen (Yeo 
et al., 2008; Lane et al., 2013). Nonetheless, these data now pose several fundamental ques-
tions that are relevant across many sporting models, in order to further our understanding of 
the train-low paradigm (see section 7.4). When considered in this way, it is remarkable that 
the study of only 500 g of substrate (the approximate whole- body storage of CHO) remains 
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